Qubits aren’t a league table.
Hardware quality, speed and the task matter alongside scale. Look for demonstrated results and distinguish physical from logical qubits.
Understand the metricsQUBITWIRE / MARKET DESK
Quantum, at a glance.
Companies, context and your watchlist.My view
Research
Understand the selected business, inspect its sources and open optional market data.
Currently open for researchTech MahindraNSE:TECHM · INR
Try a name, IONQ, NASDAQ:RGTI or a technology.
New here? Understand a company in three steps.
- Find a company and see what it does.
Open a company overview for its technology focus, original sources and reported financial context.
- Check how the business connects to quantum.
Exposure groups describe business activity. A diversified company’s share price reflects its wider business. A research review date is separate from a milestone date.
- Save it or compare it with another business.
Use Save company to return later, or select two Compare buttons to read the businesses side by side.
Explore by business exposure. Inclusion is not an investment ranking.
73 companiesCompany research
73 companiesExplore the businesses behind quantum.Native prices and charts are not connected.
About this board
73 of 73 company profiles in this view. 18 listing mappings have a recorded identity review. Native quote and chart coverage is unavailable.
A reviewed mapping records an identity check, not certification that a listing is active today. Use company sources to verify current status. Optional provider views are separate and their timing and coverage can vary.
- Accenture works on post-quantum security and crypto-agility services, including a documented investment in QuSecure. The connection concerns migrating and managing classical cryptography rather than developing a quantum computer.
Quantum security
Quantum communication, random-number generation, product authentication and post-quantum cryptography. The technologies differ, and post-quantum cryptography runs on classical systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Crypto-agility services and investment
Original sourceReview date unavailable - Supplies GPUs, CPUs, FPGAs and adaptive chips used for quantum simulation, qubit control and hybrid quantum-classical research, including a collaboration with IBM.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum control · simulation · hybrid computing
Original sourceProfile reviewed - Air Liquide’s quantum connection combines specialty-materials expertise with an ALIAD investment in Quobly. The collaboration supports the manufacturing processes around silicon-based quantum processors.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Specialty materials and venture exposure
Original sourceReview date unavailable - Google Quantum AI develops superconducting quantum processors, including Willow, and quantum error-correction research.
Diversified technology
Large businesses with quantum programs. Their shares reflect substantial activity beyond quantum. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Google Quantum AI · superconducting chips
Original sourceProfile reviewed - AWS offers the Braket quantum computing service and conducts quantum hardware research, including its Ocelot chip prototype.
Diversified technology
Large businesses with quantum programs. Their shares reflect substantial activity beyond quantum. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Amazon Braket · quantum chip research
Original sourceProfile reviewed - AmpliTech markets cryogenic low-noise amplifiers for quantum-computing installations, alongside a broader RF and communications portfolio. Its quantum-related product range also includes supporting power-supply technology.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Cryogenic low-noise RF amplification
Original sourceReview date unavailable - Applied Materials contributes fabrication and materials expertise to quantum-hardware development. Its relationship with Qolab includes an investment by Applied Ventures and collaboration on manufacturing processes for superconducting quantum devices.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Fabrication and materials engineering
Original sourceReview date unavailable - Aqarios develops optimization software combining quantum and classical methods. IBM documents its Constrained Quantum Optimizer as a Qiskit Function with specific access and preview conditions.
Quantum computing
Businesses developing quantum computers, quantum software or photonic quantum systems. Conventional photonics can also appear in their portfolios. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum optimization software
Original sourceReview date unavailable - Develops its 12CQ quantum processor chip and related quantum technologies for computing, sensing and healthcare.
Quantum computing
Businesses developing quantum computers, quantum software or photonic quantum systems. Conventional photonics can also appear in their portfolios. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum processor chips · spin qubits
Original sourceProfile reviewed - Supplies quantum-safe encryption and cryptographic discovery software. In its October 8 update, Arqit estimated unaudited FY26 revenue of US$975,000–US$1,000,000, against US$530,000 in FY25; the fiscal year ended September 30.
Quantum security
Quantum communication, random-number generation, product authentication and post-quantum cryptography. The technologies differ, and post-quantum cryptography runs on classical systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum-safe encryption · PQC migration
Original sourceProfile reviewed - Bruker supplies scientific instruments relevant to spin-based quantum research and qubit characterization. Its Compact-Q DEER offering provides a specific experimental-tool connection within the wider scientific-instrument business.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Spin and qubit research instrumentation
Original sourceReview date unavailable - Develops post-quantum security and quantum infrastructure, including quantum emulation and control through its QPerfect subsidiary.
Quantum security
Quantum communication, random-number generation, product authentication and post-quantum cryptography. The technologies differ, and post-quantum cryptography runs on classical systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Post-quantum security · quantum infrastructure
Original sourceProfile reviewed - Cadence provides chip and system-design software used by quantum-hardware developers. Equal1 is a named customer using its design and verification tools for silicon quantum-system engineering.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum-hardware design software
Original sourceReview date unavailable - Capgemini maintains quantum research and application services through its quantum lab. Its investment relevance comes from enterprise experimentation, software and integration work rather than ownership of a proprietary quantum processor.
Diversified technology
Large businesses with quantum programs. Their shares reflect substantial activity beyond quantum. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum research and application services
Original sourceReview date unavailable - Provides optical-network encryption with post-quantum cryptography support and integration with quantum key distribution systems. A 2026 trial combined its Waveserver platform with Toshiba QKD on a live commercial network.
Quantum security
Quantum communication, random-number generation, product authentication and post-quantum cryptography. The technologies differ, and post-quantum cryptography runs on classical systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Post-quantum encryption · optical networks · QKD integration
Original sourceProfile reviewed - Develops quantum networking technology through its research program, including a Universal Quantum Switch prototype designed to connect quantum systems over telecom fiber.
Diversified technology
Large businesses with quantum programs. Their shares reflect substantial activity beyond quantum. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum networking · entanglement distribution · switching
Original sourceProfile reviewed - Cloudflare provides post-quantum network-security features, including hybrid key exchange for IPsec. The company’s technical documentation distinguishes implemented encryption capabilities from its broader roadmap toward additional post-quantum protection.
Quantum security
Quantum communication, random-number generation, product authentication and post-quantum cryptography. The technologies differ, and post-quantum cryptography runs on classical systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Post-quantum network encryption
Original sourceReview date unavailable - Supplies photonics technology and develops hardware quantum entropy sources with Quside for quantum-safe encryption.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Photonics · quantum entropy sources
Original sourceProfile reviewed - Creotech Quantum develops control and measurement electronics for quantum experiments and processors, alongside quantum-communication technology. Its offering includes the Sinara/ARTIQ ecosystem and related scientific instrumentation.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum-control electronics and communication systems
Original sourceReview date unavailable - Supplies quantum annealing systems, cloud access and software, and develops gate-model quantum computing.
Quantum computing
Businesses developing quantum computers, quantum software or photonic quantum systems. Conventional photonics can also appear in their portfolios. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum annealing · gate-model systems
Original sourceProfile reviewed - Supplies cryogenic test and measurement systems and dilution refrigerators used in quantum hardware development.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Cryogenic testing · dilution refrigeration
Original sourceProfile reviewed - Fortinet adds post-quantum cryptographic controls to its network-security software. Relevant capabilities include hybrid cryptographic processing and protections for supported management and network-access paths.
Quantum security
Quantum communication, random-number generation, product authentication and post-quantum cryptography. The technologies differ, and post-quantum cryptography runs on classical systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Post-quantum network-security controls
Original sourceReview date unavailable - Fujikura develops high-density wiring and connectors for superconducting quantum computers. Its documented program addresses signal transmission and assembly requirements in cryogenic environments.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Cryogenic cables and connectors
Original sourceReview date unavailable - Develops superconducting quantum computers with RIKEN and integrates quantum computing with classical computing infrastructure.
Diversified technology
Large businesses with quantum programs. Their shares reflect substantial activity beyond quantum. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Superconducting systems · hybrid computing
Original sourceProfile reviewed - Manufactures enabling components for quantum systems through cryogenic electronics, advanced packaging and semiconductor process development. Its October 6, 2026 Xanadu partnership adds a specific 300 mm pathway for silicon-nitride circuits and single-photon detectors.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum chip manufacturing · cryogenic CMOS · photonics
Original sourceProfile reviewed - Hamamatsu Photonics develops optical components used in quantum-computing research, including light detection, modulation and laser-related technology. Its documented work spans optical requirements associated with several quantum-computing approaches.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Optical components and instrumentation
Original sourceReview date unavailable - Hewlett Packard Enterprise works on the classical infrastructure that connects quantum processors to high-performance computing. Its quantum collaborations focus on integration and scaling across multiple hardware and software partners, rather than a standalone HPE quantum processor.
Diversified technology
Large businesses with quantum programs. Their shares reflect substantial activity beyond quantum. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Hybrid infrastructure and systems integration
Original sourceReview date unavailable - Hitachi is developing silicon-based quantum-computing technology with research and semiconductor partners. The documented program covers device engineering and integration rather than simply buying access to another company’s cloud service.
Diversified technology
Large businesses with quantum programs. Their shares reflect substantial activity beyond quantum. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Silicon quantum-system research
Original sourceReview date unavailable - Provides indirect quantum computing exposure through its retained ownership interest in publicly traded Quantinuum.
Diversified technology
Large businesses with quantum programs. Their shares reflect substantial activity beyond quantum. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Equity stake in Quantinuum
Original sourceProfile reviewed - Develops software infrastructure and programming tools for quantum applications across different hardware platforms. Its August 4, 2026 results report says Beryllium reached early-access users and the Ember-1 superconducting testbed opened to select first users.
Quantum computing
Businesses developing quantum computers, quantum software or photonic quantum systems. Conventional photonics can also appear in their portfolios. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum software infrastructure
Original sourceProfile reviewed - Builds quantum computing systems and software, with a roadmap toward fault-tolerant quantum computing and quantum chip manufacturing.
Diversified technology
Large businesses with quantum programs. Their shares reflect substantial activity beyond quantum. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum systems · cloud · software
Original sourceProfile reviewed - Infineon supports trapped-ion device engineering, semiconductor manufacturing, packaging and photonics through its collaboration with ZuriQ. Its post-quantum security work protects classical systems and is a separate activity.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum-device engineering and security chips
Original sourceProfile reviewed - Develops neutral-atom quantum computers, precision sensors, atomic clocks and quantum software.
Quantum computing
Businesses developing quantum computers, quantum software or photonic quantum systems. Conventional photonics can also appear in their portfolios. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Neutral atoms · precision sensing
Original sourceProfile reviewed - Researches silicon spin-qubit quantum processors and supporting technology using semiconductor manufacturing capabilities.
Diversified technology
Large businesses with quantum programs. Their shares reflect substantial activity beyond quantum. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Silicon spin qubits · chip fabrication
Original sourceProfile reviewed - Builds trapped-ion quantum computers and a broader quantum networking, sensing and security platform.
Quantum computing
Businesses developing quantum computers, quantum software or photonic quantum systems. Conventional photonics can also appear in their portfolios. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Trapped-ion systems · networking · sensing
Original sourceProfile reviewed - Builds full-stack superconducting quantum computers for research, enterprises and high-performance computing centers.
Quantum computing
Businesses developing quantum computers, quantum software or photonic quantum systems. Conventional photonics can also appear in their portfolios. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Superconducting systems · on-premises
Original sourceProfile reviewed - Provides quantum control systems, test and measurement equipment, and software for quantum performance validation.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum control · test · validation
Original sourceProfile reviewed - Lattice develops low-power FPGAs and platform firmware. Its Sentry 5.0 stack adds post-quantum cryptography to firmware protection and attestation, integrating AMI Tektagon. Lattice completed its acquisition of AMI in July 2026.
Quantum security
Quantum communication, random-number generation, product authentication and post-quantum cryptography. The technologies differ, and post-quantum cryptography runs on classical systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
PQC firmware protection and FPGA security
Original sourceProfile reviewed - Microchip develops conventional security chips with hardware support for post-quantum cryptography. Its TS1800 and TS50x announcement distinguishes a fuller platform root of trust from a simpler secure-boot controller and specifies early-adopter access.
Quantum security
Quantum communication, random-number generation, product authentication and post-quantum cryptography. The technologies differ, and post-quantum cryptography runs on classical systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Post-quantum root-of-trust and secure-boot controllers
Original sourceProfile reviewed - Offers Azure Quantum cloud services and develops quantum hardware and software through its quantum research program.
Diversified technology
Large businesses with quantum programs. Their shares reflect substantial activity beyond quantum. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Azure Quantum · quantum hardware research
Original sourceProfile reviewed - Mitsubishi Electric is exploring quantum methods for industrial engineering. A June 2026 non-binding memorandum with Quantinuum targets simulation and design applications. Separate joint research addresses connections between quantum devices and classical infrastructure.
Diversified technology
Large businesses with quantum programs. Their shares reflect substantial activity beyond quantum. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Industrial quantum applications and networked quantum information research
Original sourceProfile reviewed - Supplies photonics, laser and instrumentation products used in quantum technology development through its specialist brands.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Photonics · lasers · instrumentation
Original sourceProfile reviewed - Researches superconducting quantum annealing hardware and supplies quantum-related computing solutions and services.
Diversified technology
Large businesses with quantum programs. Their shares reflect substantial activity beyond quantum. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum annealing research
Original sourceProfile reviewed - Nokia develops quantum-safe network technology, including optical-transport security demonstrated with KDDI. The relevant activity protects data moving between infrastructure sites rather than carrying out quantum computation.
Quantum security
Quantum communication, random-number generation, product authentication and post-quantum cryptography. The technologies differ, and post-quantum cryptography runs on classical systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum-safe optical transport
Original sourceReview date unavailable - Develops optical quantum computing architectures, photonic devices and related technologies with university and industry partners.
Diversified technology
Large businesses with quantum programs. Their shares reflect substantial activity beyond quantum. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Optical quantum computing
Original sourceProfile reviewed - Supplies CUDA-Q software, GPU acceleration and NVQLink connectivity for quantum simulation, control and hybrid computing.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Hybrid quantum-classical computing
Original sourceProfile reviewed - NXP integrates post-quantum cryptography into conventional embedded chips. Its August 2026 MCX A5 announcement describes a PQC hardware root of trust for industrial devices; the company also documents hybrid ML-DSA and ECDSA support in i.MX 95 secure-enclave firmware.
Quantum security
Quantum communication, random-number generation, product authentication and post-quantum cryptography. The technologies differ, and post-quantum cryptography runs on classical systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Post-quantum security for embedded processors and industrial microcontrollers
Original sourceProfile reviewed - OVHcloud offers access to partner quantum processors through its Quantum Platform and is researching quantum-network integration. Its role is cloud access and infrastructure, not ownership of every processor available through the service.
Diversified technology
Large businesses with quantum programs. Their shares reflect substantial activity beyond quantum. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum cloud access and infrastructure research
Original sourceReview date unavailable - Supplies atomic-layer etching and deposition equipment used to fabricate quantum devices, including equipment purchased by Rigetti.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum device fabrication equipment
Original sourceProfile reviewed - Palo Alto Networks documents version-specific post-quantum capabilities for TLS connections in PAN-OS 12.1 and has announced work with IBM on quantum-safe readiness. This is classical network security and cryptographic migration, not a proprietary quantum computer.
Quantum security
Quantum communication, random-number generation, product authentication and post-quantum cryptography. The technologies differ, and post-quantum cryptography runs on classical systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum-safe readiness and network security
Original sourceReview date unavailable - Develops neutral-atom quantum processors and associated cloud, software and hybrid computing solutions.
Quantum computing
Businesses developing quantum computers, quantum software or photonic quantum systems. Conventional photonics can also appear in their portfolios. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Neutral-atom quantum processors
Original sourceProfile reviewed - Quanta Computer participates in quantum infrastructure through engineering partnerships and a completed investment in Rigetti. Its documented relationships also include industrial hardware work with Quantinuum.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum infrastructure and investment
Original sourceReview date unavailable - Combines quantum computing hardware with cloud access, developer tools and chemistry and materials software.
Quantum computing
Businesses developing quantum computers, quantum software or photonic quantum systems. Conventional photonics can also appear in their portfolios. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Trapped-ion computing · quantum software
Original sourceProfile reviewed - Develops Q-ID authentication tags that use atomic-scale optical fingerprints to verify products with a smartphone.
Quantum security
Quantum communication, random-number generation, product authentication and post-quantum cryptography. The technologies differ, and post-quantum cryptography runs on classical systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum authentication · anti-counterfeiting
Original sourceProfile reviewed - Develops photonic quantum machines and integrated photonics, including semiconductor manufacturing and advanced packaging.
Quantum computing
Businesses developing quantum computers, quantum software or photonic quantum systems. Conventional photonics can also appear in their portfolios. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Photonic quantum machines · foundry
Original sourceProfile reviewed - Develops quantum random number generators and related hardware and software for cybersecurity applications.
Quantum security
Quantum communication, random-number generation, product authentication and post-quantum cryptography. The technologies differ, and post-quantum cryptography runs on classical systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum random number generation
Original sourceProfile reviewed - Manufactures quantum-secure communication equipment and also supplies superconducting computing components, control systems and quantum measurement technology.
Quantum security
Quantum communication, random-number generation, product authentication and post-quantum cryptography. The technologies differ, and post-quantum cryptography runs on classical systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum communication · QKD · computing
Original sourceProfile reviewed - Ralliant provides exposure to test and measurement businesses including Tektronix. Relevant products include arbitrary waveform generators used to create the precise classical control signals needed in quantum experiments.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum-control test instrumentation
Original sourceReview date unavailable - Develops superconducting quantum processors and hybrid quantum-classical computing systems, with its own fabrication facility.
Quantum computing
Businesses developing quantum computers, quantum software or photonic quantum systems. Conventional photonics can also appear in their portfolios. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Superconducting quantum processors
Original sourceProfile reviewed - SAP has researched quantum optimization inside enterprise software, including a 2023 vehicle-space proof of concept connected to IBM Quantum. Its September 2026 security FAQ separately documents a Cryptography Center of Excellence and staged post-quantum migration work.
Diversified technology
Large businesses with quantum programs. Their shares reflect substantial activity beyond quantum. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Enterprise optimization research and quantum workflow integration
Original sourceProfile reviewed - Develops security semiconductors, public-key infrastructure and post-quantum products. On October 12, SEALSQ announced VaultIC409, an embedded secure element built on its QS7001 platform, with engineering samples planned for Q2 2027.
Quantum security
Quantum communication, random-number generation, product authentication and post-quantum cryptography. The technologies differ, and post-quantum cryptography runs on classical systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Post-quantum security chips
Original sourceProfile reviewed - Siemens researches the engineering around quantum computing, including digital twins that model environmental disturbances before installation. Its software researchers also discuss algorithms and readout constraints for industrial simulation with quantum partners.
Diversified technology
Large businesses with quantum programs. Their shares reflect substantial activity beyond quantum. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum system integration research and industrial simulation
Original sourceProfile reviewed - SoftBank Corp. researches quantum-computing applications and infrastructure with Quantinuum. Its published work examines areas such as quantum chemistry and data analysis within a longer-term quantum and AI data-center vision.
Diversified technology
Large businesses with quantum programs. Their shares reflect substantial activity beyond quantum. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum-classical infrastructure and algorithm research
Original sourceReview date unavailable - Soitec supplies engineered semiconductor substrates relevant to silicon quantum processors. Its documented work with Quobly and STMicroelectronics includes enriched-silicon FD-SOI wafers entering fabrication workflows.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Isotopically engineered semiconductor substrates
Original sourceReview date unavailable - Collaborates with Quobly to adapt its FD-SOI semiconductor processes and 300mm manufacturing infrastructure for silicon quantum processors. ST also participated in Quobly's 2026 Series A financing.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Silicon quantum processors · FD-SOI manufacturing
Original sourceProfile reviewed - Synopsys supplies design and simulation technology relevant to quantum-hardware engineering. Its Quantum Scaling Alliance role connects semiconductor design workflows to the challenge of building more complex quantum systems.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Electronic design and simulation tools
Original sourceReview date unavailable - Tata Consultancy Services works on quantum applications and enterprise integration. Its documented collaboration with IBM and Andhra Pradesh connects software and use-case development to a planned quantum-computing facility.
Diversified technology
Large businesses with quantum programs. Their shares reflect substantial activity beyond quantum. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum applications and enterprise integration
Original sourceReview date unavailable - Tech Mahindra is developing middleware with I-HUB QTF for a trapped-ion quantum-computing platform. Its role connects quantum hardware to control electronics and software execution.
Diversified technology
Large businesses with quantum programs. Their shares reflect substantial activity beyond quantum. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Quantum middleware engineering
Original sourceReview date unavailable - Thales provides cryptographic security products with post-quantum capabilities. Its Luna 8 hardware security module is designed to manage and protect keys as organizations transition toward newer cryptographic algorithms.
Quantum security
Quantum communication, random-number generation, product authentication and post-quantum cryptography. The technologies differ, and post-quantum cryptography runs on classical systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Post-quantum hardware security modules
Original sourceReview date unavailable - Develops silicon photonics manufacturing capabilities with Xanadu for fault-tolerant photonic quantum computers.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Silicon photonics foundry
Original sourceProfile reviewed - ULVAC has documented cryogenic infrastructure supporting quantum-related research and development. The company’s relevant connection is the vacuum and low-temperature engineering environment around quantum devices.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Vacuum and cryogenic development infrastructure
Original sourceReview date unavailable - Western Digital’s documented quantum connection is an investment and nanofabrication collaboration with Qolab. The work applies materials and precision-manufacturing expertise to superconducting quantum-hardware development.
Enabling technology
Chips, fabrication, photonics and instruments that support quantum systems. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Nanofabrication collaboration and venture exposure
Original sourceReview date unavailable - Develops photonic quantum hardware and PennyLane software. Its October 6, 2026 GlobalFoundries agreement targets industrialization of low-loss silicon-nitride circuits and single-photon detectors on a 300 mm Malta, New York line.
Quantum computing
Businesses developing quantum computers, quantum software or photonic quantum systems. Conventional photonics can also appear in their portfolios. This describes business activity, not a stock rating.
How these groups are definedTechnology focus
Photonic quantum computing
Original sourceProfile reviewed
Business exposure describes the company’s connection to quantum. It is not an investment ranking.
CURRENTLY OPEN FOR RESEARCH · TECHM
Diversified technology
Large businesses with quantum programs. Their shares reflect substantial activity beyond quantum. This describes business activity, not a stock rating.
How these groups are definedTech Mahindra
NSE: TECHM · INR · India
Quantum middleware engineering
What does physical vs. logical qubits mean?
Physical qubits are the underlying devices. A logical qubit encodes information across physical resources to manage errors.
Tech Mahindra is developing middleware with I-HUB QTF for a trapped-ion quantum-computing platform. Its role connects quantum hardware to control electronics and software execution.
Business exposure
Profile review date unavailable · Original source ↗The August 2026 announcement targets completion in December 2026 and commercialization afterward. Tech Mahindra develops middleware for the partner’s hardware; no owned complete quantum system or material quantum revenue is established.
Check the issuer source- Recorded issuer
- Tech Mahindra
- Listing
- NSE:TECHM
- Instrument
- Type not separately reviewed
- Quote currency
- INR
- Identity checked
- Not separately reviewed
Identity evidence and exposure boundary
Listing details come from the company directory. This record has no separate recent identity review. Provider coverage, timing and availability may vary.
The August 2026 announcement targets completion in December 2026 and commercialization afterward. Tech Mahindra develops middleware for the partner’s hardware; no owned complete quantum system or material quantum revenue is established.
Listing identity is distinct from a current tradability check. Quantum revenue share and undisclosed ownership percentages remain unknown.
NSE: TECHM · Quote currency: INR
TradingView shows the quote time and market status. Exchange delays apply; availability varies by listing.
Stock prices and movements from TradingView
Show market data to allow TradingView content. TradingView receives connection information, including your IP address. Your other privacy choices stay unchanged.
Open on TradingViewTHE RESEARCH FILE
1 research sourceGo beyond the ticker.
Inspect the evidence. These research sources can cover a wider scope than the sources used in a QRank assessment.
Quantum evidenceOriginal sources, claims and their limits
QubitWire’s editorial summaries connect the sources below to this company. Source type and publication date are separate from our review date. This is research context, not an investment rating.
Directory source · Issuer and listing contextTech Mahindra: documented quantum activity
QUBITWIRE SUMMARY OF THE SOURCE
Tech Mahindra is developing middleware with I-HUB QTF for a trapped-ion quantum-computing platform. Its role connects quantum hardware to control electronics and software execution.
Published: Publication date not recordedEditorial review: Date unavailable
The August 2026 announcement targets completion in December 2026 and commercialization afterward. Tech Mahindra develops middleware for the partner’s hardware; no owned complete quantum system or material quantum revenue is established.
Read the original sourceFinancial scope
The source ledger does not calculate a quantum revenue percentage. Use the listed issuer’s filings to check reporting periods, segment disclosure and financial contribution.
Check the issuer sourcePublished source historyDates and source coverage
A history of source publications, not a calendar of upcoming events. A published target or announcement is not proof that a milestone was delivered.
Publication dates have not been recorded for this company’s sources. Original links remain available in Quantum evidence.
1 source has no recorded publication date and is not placed on the timeline.
Terms worth knowingRead the technology and the financials in context
Physical vs. logical qubits
Physical qubits are the underlying devices. A logical qubit encodes information across physical resources to manage errors.
Why it matters here: Counts are not interchangeable. Ask which operations, error rates and resource overheads were demonstrated together.
Operating cash use
Net cash used in operating activities over the reporting period, as shown in the cash-flow statement.
Why it matters here: This includes operating cash receipts, payments and working-capital changes. It differs from accounting loss, capital expenditure and financing cash flows; it does not by itself predict a funding date.
Share dilution
An increase in shares or potential shares that can reduce an existing holder’s percentage ownership.
Why it matters here: Read share issuance, options, warrants and convertible financing together. A headline cash balance does not describe the cost of raising it.
Bookings vs. revenue
Bookings generally describe customer commitments under a company’s own definition. Revenue follows the applicable accounting recognition rules.
Why it matters here: A signed order, funded award or partnership announcement may not be revenue recognized in the current period.
My research notebookQuestions, source bookmarks and a place to returnLocal only
Private to this browser. Notes are not sent to QubitWire, included in Share view or synced to your account. Anyone with access to this browser may read them. Clearing site data removes them.
NEXT RESEARCH QUESTION
Which quantum milestones have been delivered, and how much does quantum contribute to the wider business?
Editorial research question, not a scheduled event.THE FINANCIAL QUESTION
Read company-wide results alongside quantum disclosures. Other divisions can dominate revenue and share-price performance.
Keep up with the companies you follow.
Follow companies to find their published coverage here. Email alerts are not enabled.
How we classify quantum exposure
QubitWire assigns one primary category from documented company activity. Categories can overlap; a computing or security classification does not mean the whole business is quantum. Read each company’s business context and original sources.
- Quantum computing
- Businesses developing quantum computers, quantum software or photonic quantum systems. Conventional photonics can also appear in their portfolios.
- Diversified technology
- Large businesses with quantum programs. Their shares reflect substantial activity beyond quantum.
- Enabling technology
- Chips, fabrication, photonics and instruments that support quantum systems.
- Quantum security
- Quantum communication, random-number generation, product authentication and post-quantum cryptography. The technologies differ, and post-quantum cryptography runs on classical systems.
Classification owner: QubitWire editorial. The original directory cohort was reviewed . Each profile shows its recorded review date, or states when it is unavailable. These dates are separate from market prices and subsequent research notes.
Editorial standardsSuggest a correctionResearch library, context and methodology
Research context
Research context across the sector
30 notes connect research, programme support, partnerships and deployment plans. Parent companies, subsidiaries and private businesses are identified separately.
Compare the exposure, then compare the evidence
A hardware developer, a diversified technology company and a component supplier have different business exposures. A scientific milestone does not determine a security’s valuation.
- Quantum activity
- What part of the company’s work is quantum, and is it a developer, supplier or user?
- Evidence
- What was announced, estimated or actually measured? Keep the task and its conditions attached.
- Financial disclosure
- Which terms are disclosed? Separate funding ceilings, obligations, cash receipts and recognized revenue.
- Uncertainty
- What remains unreported, untested or planned? Missing information is unknown, not zero.
Market data has its own clock. The provider’s quote time describes the price; a source-check date describes research. Delays and unavailable data remain visible in the market view. These notes are information, not investment recommendations.
Read the evidence comparison guide →IonQOctober financing: pricing is a separate event from closing
IonQ’s October 14 release prices 20.5 million common shares and pre-funded warrants for 29.5 million shares at $40 each, plus seven-year warrants for 100 million shares with a $69.46 exercise price. These are the 2026 terms. The headline $2 billion is not operating revenue, verified net settled cash or proceeds from future exercise of the additional warrants.
Source checkedResearch question: The final prospectus and a closing announcement or filing establishing net proceeds and settlement.
- IonQ October 2026 offering ↗ · 14 Oct 2026
D-WaveRevenue, orders and remaining obligations answer different questions
For the quarter ended June 30, D-Wave reports $3.1 million revenue and $2.1 million bookings. It defines bookings as orders expected to generate future revenue. Its $40.7 million remaining-performance-obligation balance is measured at the period end. Quarterly revenue is a flow; remaining obligations are a balance. These figures should not be added together or treated as cash received.
Source checkedResearch question: The next filed period and changes in recognition timing, cancellations and contract obligations.
- D-Wave Q2 report and metric definitions ↗ · 6 Aug 2026
XanaduEquity-facility capacity is different from cash raised
Xanadu’s Q2 release reports $67.2 million raised through its synthetic at-the-market facility during the quarter. The facility permits up to $300 million over three years; that authorization is not the amount already raised. Financial figures in the release are in US dollars unless specified otherwise. XNDU’s Nasdaq and TSX listings do not make every displayed amount the same currency. Preserve the venue, share class and source convention.
Source checkedResearch question: The next filing’s issued share count, facility usage and cash-flow disclosure.
- Xanadu Q2 report ↗ · 5 Aug 2026
- Xanadu filed Q2 report ↗ · 5 Aug 2026
InfleqtionUse the revised Q2 release, not the superseded figures
Infleqtion’s August 17 update changes reported Q2 revenue from $12.6 million to $13.5 million and FY2026 revenue guidance from about $43 million to about $45.1 million. The company attributes the changes to revenue-recognition timing for two government contracts, with corresponding reductions in 2024 and 2025. The company says cash and operating cash flow are unchanged. A timing adjustment is not new cash generation, and guidance remains a forecast.
Source checkedResearch question: The filed 10-Q and later reporting should retain the revised comparative periods and identify any further correction.
- Infleqtion updated Q2 report ↗ · 17 Aug 2026
QuantinuumPost-IPO results retain GAAP and adjusted labels
Quantinuum’s Q2 release reports $8 million revenue for the quarter ended June 30. It presents GAAP net loss and adjusted EBITDA loss as different measures and supplies definitions and reconciliation tables. Adjusted EBITDA is not GAAP net income or cash from operations. The reported IPO gross proceeds are a financing event, not quarterly sales.
Source checkedResearch question: The next filed quarter and the reconciliation explaining differences between GAAP and adjusted results.
- Quantinuum Q2 release ↗ · 11 Aug 2026
- Quantinuum filed Q2 release ↗ · 11 Aug 2026
IBMDiversified technology
Anderon’s federal award, IBM’s own investment plans and the planned Swiss System Two installation are separate events. The releases do not establish how or when each item contributes to recognized revenue.
Source checkedResearch question: Which funding conditions, delivery milestones and financial disclosures connect the announcement to economic results?
- Commerce finalizes CHIPS R&D award to Anderon ↗ · 16 Sept 2026
- Anderon finalizes agreement for $1 billion CHIPS award ↗ · 16 Sept 2026
- IBM and Lockheed Martin Swiss quantum innovation hub ↗ · 10 Sept 2026
AnderonSubsidiary context
Anderon is an IBM subsidiary. Its manufacturing plans belong in the parent-company context; the announcement does not establish a separately traded Anderon security.
Source checkedResearch question: What rights, ownership and obligations belong to the subsidiary versus the parent?
- Commerce finalizes CHIPS R&D award to Anderon ↗ · 16 Sept 2026
- Anderon finalizes agreement for $1 billion CHIPS award ↗ · 16 Sept 2026
NVIDIADiversified enabling technology
CUDA-Q Logical and related orchestration tools form part of NVIDIA’s broader software strategy. The announcement does not disclose a separate quantum revenue segment.
Source checkedResearch question: Which benefits are tool adoption and which, if any, appear in separately disclosed financial results?
- NVIDIA expands CUDA-Q for fault-tolerant quantum computing ↗ · 14 Sept 2026
IonQCompany research
IonQ’s radar work is a specific research experiment. A connection to booked sales would require separate commercial or financial disclosure.
Source checkedResearch question: What commercial agreement or audited disclosure, if any, connects the experiment to revenue?
QuantinuumIssuer identity and manufacturing support
Quantinuum’s September 11 issuer release identifies Nasdaq: QNT. Its separate CHIPS award supports manufacturing R&D; the benchmark preprint addresses technical performance rather than ownership or valuation.
Source checkedResearch question: Does the existing Investing record map to the correct security and current ownership structure?
- Quantinuum investor conference participation ↗ · 11 Sept 2026
- Commerce finalizes CHIPS R&D award to Quantinuum ↗ · 8 Sept 2026
- Benchmarking the computational power of quantum computers ↗ · 10 Sept 2026
IQMOrder with planned delivery
IQM’s Eldorado purchase agreement includes an IQM Spark installation planned for Q1 2027 and separate cloud access. No contract value or recognized-revenue figure is established here.
Source checkedResearch question: When is installation expected, and what source will later confirm acceptance rather than announcement?
- IQM to deliver a quantum computer to Eldorado, Brazil ↗ · 17 Sept 2026
PasqalApplication-development partnership
Pasqal’s collaboration with USA Rare Earth and Riven Systems proposes quantum-versus-classical comparisons for separation chemistry. Technical and commercial outcomes remain to be demonstrated.
Source checkedResearch question: What technical and commercial milestones would establish that the partnership produced durable value?
- USA Rare Earth, Pasqal and Riven Systems partnership ↗ · 17 Sept 2026
D-WaveGovernment funding
D-Wave’s final CHIPS R&D award is up to $100 million for semiconductor manufacturing work. Funding milestones and accounting treatment should be assessed separately from operating sales.
Source checkedResearch question: Are funding milestones, accounting treatment and business-model differences explained?
- Commerce finalizes CHIPS R&D award to D-Wave ↗ · 8 Sept 2026
Hewlett Packard EnterpriseInfrastructure partner context
HPE supplies the classical supercomputing context for its collaboration with QuEra. The announcement does not quantify revenue attributable to quantum computing.
Source checkedResearch question: What portion of the announced stack is conventional HPC infrastructure?
- QuEra and HPE: on-premises HPC collaboration ↗ · 22 Sept 2026
Alphabet / Google Quantum AIDiversified research exposure
Google’s appearance in the QUOPS preprint offers evidence about a particular technical comparison. It does not provide an estimate of Alphabet’s quantum business value.
Source checkedResearch question: What exactly was evaluated, and does that evidence say anything about commercial readiness?
- Benchmarking the computational power of quantum computers ↗ · 10 Sept 2026
USA Rare EarthMaterials-industry partner
USA Rare Earth is the materials-processing partner in the Pasqal and Riven Systems project. Its participation does not make it a quantum-hardware vendor or establish quantum-derived revenue.
Source checkedResearch question: What does the experiment seek to improve, and how will conventional alternatives be compared?
- USA Rare Earth, Pasqal and Riven Systems partnership ↗ · 17 Sept 2026
RiverlanePrivate-company context
Riverlane works on error-correction infrastructure and has announced plans for a Maryland headquarters. This note provides ecosystem context; it does not represent a listed security or an offer of private shares.
Source checkedResearch question: What evidence separates research progress, hiring plans and commercial deployment?
- Riverlane establishes U.S. headquarters in Maryland ↗ · 17 Sept 2026
- Riverlane APS 2026 real-time QEC demonstration ↗ · 1 Apr 2026
InfleqtionTechnical evidence
The Sqale report describes a specific circuit improvement. It provides no revenue figure or basis for a valuation conclusion. Keep technical progress separate from commercial performance.
Source checkedResearch question: Which issuer disclosures connect technical milestones to delivered customer services and recognized revenue?
- Infleqtion’s technical account of the Sqale experiment ↗ · 24 Sept 2026
IonQ / FIUDeployment milestones
FIU’s announcement supports a planned campus deployment in late 2027. The university release does not state a contract price or revenue-recognition schedule.
Source checkedResearch question: Which delivery, acceptance and financial disclosures confirm how the agreement progresses?
- FIU’s planned IonQ campus installation ↗ · 23 Sept 2026
Quantinuum / UWANon-binding access agreement
The non-binding MOU proposes academic cloud access and collaboration. It is not a completed deployment, quantified sale or measured application benefit. Track confirmed access, published results and any later disclosed commercial terms separately.
Source checkedResearch question: Which definitive agreement, verified access or financial disclosure changes the current planned status?
Xanadu / BlueforsCooling infrastructure economics
Xanadu’s September 29 Bluefors agreement targets a less obvious expense in photonic computing: cooling the detectors. The issuer describes a collaboration worth multiple millions of U.S. dollars to develop modular cryogenic infrastructure for single-photon detectors near 2 kelvin. Xanadu says its proposed compact module could remove industrial cryoplants from future data centres. Neither measured savings nor the exact collaboration value is disclosed. The investor question is whether a manufacturable module can validate the proposed cooling capacity and costs; the concept has yet to establish lower deployment or operating expenditure.
Source checkedResearch question: What prototype results, manufacturing costs and commercial terms would verify the proposed reduction in cooling infrastructure?
Quantum Computing Inc.Backlog and manufacturing investment
QCi’s investor presentation furnished on October 2 separates its commercial backlog from sales already recognized. It reports US$42.5 million of backlog as of June 30, compared with US$9.2 million of revenue for the first six months of 2026. These are historical figures, not October operating results. The presentation also estimates US$70–90 million for Fab 2 and other capital expenditure; that is planned spending, not expenditure already incurred. The commercial mix includes advanced packaging, photonics components and design services alongside quantum systems. Our research question is which deliveries convert backlog into revenue, at what margins, and how manufacturing spending progresses. The backlog total alone does not measure quantum-computing sales.
Source checkedResearch question: Which deliveries convert backlog into recognized revenue, at what margins, and how does actual manufacturing spending compare with the capital estimate?
- QCi October 2026 investor presentation, slides 18–19 ↗ · 2 Oct 2026
- QCi Form 8-K filing index, October 2, 2026 ↗ · 2 Oct 2026
Infineon / ZuriQEnabling technology · manufacturing
The collaboration is a manufacturing and integration exposure. A reported component demonstration and a repeatable operating system are different milestones. Commercial terms are undisclosed; the partnership is not evidence of a quantum pure-play business or an earnings contribution.
Source checkedResearch question: What direct technical evidence establishes repeatability, yield and larger-system integration?
Read the related QubitWire analysis →
Read the evidence, conditions and next test →
- Infineon’s collaboration announcement ↗ · 7 Oct 2026
- ZuriQ’s account of the same collaboration ↗ · 7 Oct 2026
IBMExternal evaluation · diversified technology
IBM’s Stage C selection puts its roadmap under external scrutiny. It is an evaluation milestone, not an achieved application or a disclosed revenue event. Read future tests separately from any later cash or commercial disclosure.
Source checkedResearch question: Which hardware tests and engineering assumptions change the roadmap?
Read the related QubitWire analysis →
Read the evidence, conditions and next test →
- IBM’s Stage C announcement ↗ · 7 Oct 2026
- DARPA’s selection and evaluation scope ↗ · 7 Oct 2026
IonQConditional programme support
IonQ describes potential programme support, with later funding dependent on appropriations and DARPA actions. A ceiling is distinct from an executed obligation, cash received and recognized revenue. No amount is added to a revenue total here.
Source checkedResearch question: What later disclosure establishes the obligation, receipt or revenue classification?
Read the related QubitWire analysis →
Read the evidence, conditions and next test →
- IonQ’s Stage C agreement and conditions ↗ · 7 Oct 2026
NVIDIABroad science commitment
The new science commitment spans several fields. A quantum-only allocation is undisclosed. Track identifiable tools, access and programme deliverables; faster design work and measured quantum applications are different evidence. The earlier CUDA-Q note provides the software context.
Source checkedResearch question: Which specific deliverables support quantum research, and what has actually been provided?
Read the related QubitWire analysis →
Read the evidence, conditions and next test →
- NVIDIA’s five-year science commitment ↗ · 8 Oct 2026
OratomicPrivate ecosystem context
A private-company development can inform understanding of the sector without creating a tradable stock row. Oratomic’s financing and the March theoretical resource estimate are separate events. No public ticker, price or investment route is supplied.
Source checkedResearch question: What measured result would support the architecture’s assumptions?
Read the related QubitWire analysis →
Read the evidence, conditions and next test →
- Oratomic’s cumulative financing announcement ↗ · 8 Oct 2026
- Original March research preprint · v1 ↗ · 30 Mar 2026
Honeywell Aerospace / Honeywell TechnologiesSeparate issuers and quantum activities
Honeywell Aerospace (Nasdaq: HONA) became an independent company on June 29, 2026. It is the photonics-foundry partner named in Infleqtion's October 6 optical-cavity prototype announcement. Honeywell Technologies (Nasdaq: HON), whose legal issuer name remains Honeywell International Inc., is a different security; its filing for the quarter ended June 30 records a 48% noncontrolling Quantinuum interest. The cavity announcement establishes a fabrication collaboration, not a complete handheld quantum system, disclosed production yield or quantified revenue contribution.
Source checkedResearch question: Which legal issuer owns the relevant activity, and what later technical or financial disclosure establishes its commercial contribution?
IonQ / ElisityTransaction filing
IonQ’s October 13 SEC filing separates $1.15 billion in closing stock consideration before adjustments, up to $150 million in revenue-linked earnout shares, and a further $100 million restricted-stock-unit retention pool for continuing Elisity employees. The retention pool is additional to merger consideration; the awards would be granted after closing and vest over four years. Share counts use the agreement’s collared 20-trading-day volume-weighted average price. These are pending transaction terms, not completed issuance, cash spending or a guaranteed earnout.
Source checkedResearch question: What share count and retention awards are disclosed at closing, and which revenue milestones later determine the earnout?
- IonQ Form 8-K — Elisity agreement and retention-pool terms ↗ · 13 Oct 2026
- SEC filing index — accession 0001193125-26-419609 ↗ · 13 Oct 2026
Infleqtion / Innovate UKSensing development award
Infleqtion says Innovate UK awarded £9 million for the second phase of its Quantum Direction Finding project, developing a deployable Rydberg-atom radio-frequency sensor with Leonardo. The October 13 release describes product development and operational-environment validation following an earlier prototype. GOV.UK independently names ColdQuanta UK among supported projects but does not publish its individual award amount. This is sensing exposure within a company that also builds quantum computers. The announcement does not establish cash received, recognized revenue or customer purchases; funding terms and milestone fulfillment still matter.
Source checkedResearch question: Which grant milestones, payment timing and accounting treatment will later disclosures establish, and what field-test evidence demonstrates deployability?
A BETTER RESEARCH HABIT
Three things a stock chart won’t tell you.
A milestone isn’t a business model.
Ask what customers pay for, whether orders become revenue and how much cash the business needs to keep developing.
Read the company filingsA quantum connection has many forms.
A specialist, a chip supplier and a diversified technology company can have very different economics. Compare the business before the price.
Business evidence researchCompany financing, reported results and private-company context
Read financing, reported results and commercial commitments in their original scope. Private-company context is research, not a tradable-security listing.
IonQExisting listed issuer
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: IonQ announced pricing of a $2.0 billion offering comprising common shares, prefunded warrants and additional long-term warrants.
Still conditional: The reviewed release establishes pricing, not a completed closing, net proceeds received or future warrant exercise.
IonQ’s financing update belongs in a dated capital-structure record. The central question is how much cash becomes available at closing and what claims on future ownership accompany it. Common shares, prefunded warrants and ordinary warrants should be retained as distinct instruments rather than reduced to one imprecise share count. A useful investor card should link the pricing release to the prospectus, closing disclosure and subsequent balance sheet. It should also identify whether a displayed capitalization measure uses basic shares or a stated diluted assumption. Future warrant exercise can bring additional cash and dilution together, but neither is guaranteed by an announcement. The practical update is a financing timeline with instrument terms, net proceeds and usage of cash added only when documented. This offers a clearer view of development capacity than equating a headline raise with current liquidity.
Tie net closing proceeds to the exact common-share and warrant instruments. The concrete next evidence is: closing notice, prospectus and next balance sheet with issued-share reconciliation. Future warrant exercises are contingent; gross pricing is not the same as deployable cash. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Pricing stage
- label
- Catalyst date
- value
- 2026-10-14
- label
- Security treatment
- value
- New York Stock Exchange: IONQ
Dated milestones
- date
- 2026-10-14
- event
- Equity offering pricing
- status
- Pricing stage
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Tie net closing proceeds to the exact common-share and warrant instruments.
- risk
- Future warrant exercises are contingent; gross pricing is not the same as deployable cash.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Closing notice, prospectus and next balance sheet with issued-share reconciliation.
- Test
- Tie net closing proceeds to the exact common-share and warrant instruments.
- Limit
- Future warrant exercises are contingent; gross pricing is not the same as deployable cash.
Basis for comparison
- dimensions
- Net proceeds
- instrument counts
- acquisition commitments
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- Future warrant exercises are contingent; gross pricing is not the same as deployable cash.
- How much of new cash is committed to acquisitions or facilities?
- Which share-count date and dilution convention does the chart use?
Measures to follow
- Net cash received at verified closing
- Basic and scenario-diluted share counts by instrument
- Operating and investment cash consumption
Documents still needed
- Prospectus and closing date
- Fees/net proceeds reconciliation
- Prefunded and ordinary warrant exercise/settlement conditions
Reporting currency
USDOriginal sources and scope
- IonQ prices 2026 equity offering ↗Source dated 14 Oct 2026
Pricing announcement only; no closing/net-cash receipt inferred. Distinct from October 2025 $2bn offering.
- IonQ reports second quarter 2026 results ↗Source dated 5 Aug 2026
SkyWater closed July 31, after quarter-end. The release separates the acquired business from its reported results and outlook, while Q2 adjusted EBITDA already includes $24.7 million of pre-close commercial SkyWater R&D. Later consolidation values are not supplied here.
D-Wave QuantumExisting listed issuer
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: D-Wave completed the acquisition of Quantum Circuits, adding a superconducting gate-model development program.
Still conditional: A roadmap for a new gate-model system is not a delivery or recognized revenue event.
D-Wave’s ownership record now needs two technical threads. Annealing customers and gate-model development may require different products, support and capital, so a combined qubit number would be a poor guide to either engineering progress or commercial exposure. The investor update should instead follow acquisition integration, attributable spending and the next accepted product milestone. Historical results from Quantum Circuits remain relevant, but they should be mapped to their original system and date. A financing or acquisition can broaden strategic options while increasing the number of projects management must execute. Readers should therefore look for reporting that separates established customer activity from new development work and explains how shared resources are allocated. The next useful evidence is a delivered gate-model configuration or a documented integration milestone, accompanied by transparent cash-use and operating disclosures.
Separate annealing operations, acquired gate-model work and acquired bookings. The concrete next evidence is: next results filing with integration costs, revenue recognition and the bookings/RPO definitions carried forward. A larger bookings balance may reflect timing or scope changes before it appears in recognized revenue. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Ownership and reporting scope
- label
- Catalyst date
- value
- 2026-01-20
- label
- Security treatment
- value
- Nasdaq: QBTS
Dated milestones
- date
- 2026-01-20
- event
- Completed acquisition and portfolio expansion
- status
- Ownership and reporting scope
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Separate annealing operations, acquired gate-model work and acquired bookings.
- risk
- A larger bookings balance may reflect timing or scope changes before it appears in recognized revenue.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Next results filing with integration costs, revenue recognition and the bookings/RPO definitions carried forward.
- Test
- Separate annealing operations, acquired gate-model work and acquired bookings.
- Limit
- A larger bookings balance may reflect timing or scope changes before it appears in recognized revenue.
Basis for comparison
- dimensions
- Revenue by period
- bookings scope
- RPO and acquisition cash
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- A larger bookings balance may reflect timing or scope changes before it appears in recognized revenue.
- Do announced product dates have customer acceptance evidence?
- Does reporting distinguish acquired research from current revenue?
Measures to follow
- Accepted gate-model product milestones
- Annealing versus new-program commercial activity
- Integration spending and operating cash use
Documents still needed
- Latest segment/product disaggregation
- Updated acquired-business operating status
- Delivery evidence replacing roadmap language
Reporting currency
USDReporting period
Historical acquisition 2026-01-20; supplementary operating evidence for six months ended 2026-06-30Original sources and scope
- D-Wave completes Quantum Circuits acquisition ↗Source dated 20 Jan 2026
Acquisition completed January 20, 2026. NYSE was the historical venue at that event; current parent venue is Nasdaq, confirmed in QI-070 following QI-071 transfer announcement.
- D-Wave reports second quarter 2026 results ↗Source dated 6 Aug 2026
H1 revenue, bookings and June 30 RPO have different measurement boundaries; confirms Nasdaq QBTS after transfer.
- D-Wave announces transfer of stock-exchange listing to Nasdaq ↗Source dated 14 Jul 2026
Transfer announcement is prospective as issued; later Q2 release confirms current Nasdaq listing.
QuantinuumExisting listed issuer
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: Quantinuum announced IPO closing with approximately $1.68 billion gross proceeds before fees and expenses.
Still conditional: Historic gross proceeds are not current cash, net proceeds or evidence of technical success.
The useful follow-up to a large IPO is a bridge from financing to deployed resources. Readers should see gross proceeds, transaction costs, the resulting cash position and later uses of cash on separate dates. A company can have substantial development capacity while still facing difficult technical and commercial milestones. Quantinuum’s profile should therefore pair financial periods with specific hardware and software outcomes rather than assuming the funding scale validates the roadmap. The most informative additions are an updated balance sheet, a cash-flow statement and product-specific evidence of access or customer acceptance. A public listing also changes the quality of information available: recurring filings can replace scattered financing headlines with a consistent reporting history. That history should be built carefully from the issuer’s own documents, with amended figures and changed definitions retained visibly.
Connect the listed share class to the complete economic-interest structure and reconciled operating figures. The concrete next evidence is: next 10-Q with Class A shares, operating-company units and unchanged or explained non-GAAP definitions. A public float count can misstate enterprise economics, and adjusted margin excludes costs that still require analysis. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Public ownership and accounting
- label
- Catalyst date
- value
- 2026-06-05
- label
- Security treatment
- value
- Nasdaq Global Market: QNT
Dated milestones
- date
- 2026-06-05
- event
- Completed IPO; capital deployment follow-up
- status
- Public ownership and accounting
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Connect the listed share class to the complete economic-interest structure and reconciled operating figures.
- risk
- A public float count can misstate enterprise economics, and adjusted margin excludes costs that still require analysis.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Next 10-Q with Class A shares, operating-company units and unchanged or explained non-GAAP definitions.
- Test
- Connect the listed share class to the complete economic-interest structure and reconciled operating figures.
- Limit
- A public float count can misstate enterprise economics, and adjusted margin excludes costs that still require analysis.
Basis for comparison
- dimensions
- Economic interests
- GAAP/adjusted reconciliation
- contract timing
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- A public float count can misstate enterprise economics, and adjusted margin excludes costs that still require analysis.
- Are IPO proceeds being mistaken for a current balance?
- Do different product businesses have comparable revenue recognition?
Measures to follow
- Cash and investments at reported quarter end
- Operating/investing cash use
- Commercial access tied to product-specific capability
Documents still needed
- Net IPO proceeds reconciliation
- Latest filed statements and share count
- Dated product/customer milestones
Reporting currency
USDReporting period
IPO closed 2026-06-05; supplementary quarter and six-month evidence ended 2026-06-30Original sources and scope
- Quantinuum closes upsized IPO ↗Source dated 5 Jun 2026
The IPO notice identifies Quantinuum Inc. and Nasdaq Global Market symbol QNT. Historical proceeds are not a current cash balance.
- Quantinuum reports second quarter 2026 results — SEC exhibit ↗Source dated 11 Aug 2026
Q2 margins use different GAAP and adjusted cost definitions. The reconciliation and Up-C economic-interest denominator govern the comparison; no market valuation is supplied.
- Quantinuum Form 10-Q for quarter ended June 30, 2026 ↗Source dated 13 Aug 2026
Supply agreement, lack of minimum purchase, supplier prepayment and related-party history belong to distinct fields.
InfleqtionExisting listed issuer
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: The amended release reports Q2 2026 revenue of $13.5 million, replacing $12.6 million, after recognition timing changed for two government contracts; cash was unchanged.
Still conditional: Updated full-year guidance is a forecast and the adjustment is not evidence of incremental customer cash.
Infleqtion’s investor card should use the amended results and preserve the superseded release as a versioned reference. The important change is accounting timing: revenue moved between periods without creating an additional cash receipt. A sector comparison that keeps the older number or treats the adjustment as fresh commercial demand would misread the event. The next update should connect the amended income statement to the corresponding filing and cash-flow statement, with the reporting period explicit. Readers also need to distinguish government contract revenue from grant income and from an announced future award. This is a useful case for a corrections-aware financial database: record the original release date, the amendment date, which values changed and which did not. Such a record supports a fairer comparison of operating progress without interpreting every revised revenue figure as a new sale.
Make every chart use the same amended version of the affected reporting period. The concrete next evidence is: subsequent filing that carries the correction through comparative revenue and related contract balances. Mixing original and amended figures produces misleading growth even when the arithmetic is correct. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Amended financial history
- label
- Catalyst date
- value
- 2026-08-17
- label
- Security treatment
- value
- New York Stock Exchange: INFQ
Dated milestones
- date
- 2026-08-17
- event
- Amended financial results
- status
- Amended financial history
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Make every chart use the same amended version of the affected reporting period.
- risk
- Mixing original and amended figures produces misleading growth even when the arithmetic is correct.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Subsequent filing that carries the correction through comparative revenue and related contract balances.
- Test
- Make every chart use the same amended version of the affected reporting period.
- Limit
- Mixing original and amended figures produces misleading growth even when the arithmetic is correct.
Basis for comparison
- dimensions
- Amendment date
- restated comparatives
- cash effect
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- Mixing original and amended figures produces misleading growth even when the arithmetic is correct.
- Has the comparison table refreshed all affected historical periods?
- Are contract revenue and grant income being aggregated incorrectly?
Measures to follow
- Amended period revenue with version date
- Operating cash flow and contract balances
- Computing/sensing/customer concentration where disclosed
Documents still needed
- Supersession link to August 12 release
- Amended Q2 filing and comparable prior periods
- Separate October Innovate UK award status
Reporting currency
USDReporting period
Three months ended 2026-06-30; amended release dated2026-08-17 and filed2026-08-18Original sources and scope
- Infleqtion amended Q2 results and FY26 guidance ↗Source dated 17 Aug 2026
Filed Aug18. Supersedes Aug12 release. Noncash recognition timing changed; cash unchanged.
XanaduExisting listed issuer
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: The SEC-filed October 19 release establishes provisional approval for up to US$10 million and a one-year QBI contract extension.
Still conditional: Final funding execution, completed deliverables, actual receipts and accounting recognition remain separate. No promotion to Stage C or completed system validation is inferred.
Xanadu’s support update now has a complete SEC-filed primary release, resolving the original retrieval limitation. The watch card should retain the provisional status and maximum amount in its headline. It should also give future executed terms, deliverables and receipts their own dated fields. A research extension can finance further investigation without establishing a commercial customer, finished machine or recognized revenue. The next useful financial disclosure would explain any attributable receipt or recognition, while a technical update would report what evidence the research produced. These streams may progress at different speeds; neither should be used as a substitute for the other.
Follow agreement execution and completed work separately from the support ceiling. The concrete next evidence is: executed terms or later issuer financial disclosure identifying attributable receipt or recognition. Provisional approval does not establish cash collected, revenue recognized or commercial system validation. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Provisional research support
- label
- Catalyst date
- value
- 2026-10-19
- label
- Security treatment
- value
- Nasdaq and Toronto Stock Exchange: XNDU
Dated milestones
- date
- 2026-10-19
- event
- Provisional QBI support and extension
- status
- Provisional research support
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Follow agreement execution and completed work separately from the support ceiling.
- risk
- Provisional approval does not establish cash collected, revenue recognized or commercial system validation.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Executed terms or later issuer financial disclosure identifying attributable receipt or recognition.
- Test
- Follow agreement execution and completed work separately from the support ceiling.
- Limit
- Provisional approval does not establish cash collected, revenue recognized or commercial system validation.
Basis for comparison
- dimensions
- Support stage
- deliverables
- receipts and recognition
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- Provisional approval does not establish cash collected, revenue recognized or commercial system validation.
- Does “up to” disappear when the data is displayed?
- Is technical evaluation being confused with a successful evaluation result?
Measures to follow
- Award ceiling and eligible scope
- Milestones completed and payments disclosed
- Related expenditure and accounting presentation
Documents still needed
- Executed final funding terms and payment conditions
- Completed deliverables and any disclosed receipts
- Recognition evidence in a later financial filing
Reporting currency
USDOriginal sources and scope
- Xanadu provisionally approved for additional DARPA QBI support — SEC exhibit ↗Source dated 19 Oct 2026
Provisional approval, up to US $10 million, one-year extension; not evidence of cash receipt, revenue or completed technical validation.
- Xanadu and GlobalFoundries strategic partnership ↗Source dated 6 Oct 2026
The issuer identifies Xanadu Quantum Technologies Limited and NASDAQ/TSX symbol XNDU. Manufacturing transfer remains prospective.
IQMExisting listed issuer
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: IQM’s completed Nasdaq listing uses American depositary shares under IQMX.
Still conditional: No unverified ADS-to-ordinary-share ratio, second listing or live share count is supplied here.
IQM needs one company record with separately identified securities. An American depositary share should not create an additional quantum company in a sector total, and its quoted price should not be multiplied by an unrelated ordinary-share count. The useful update is an issuer-and-instrument mapping linked to the depositary agreement and the latest filing. On the operating side, system sales should be dated by order, shipment, commissioning and customer acceptance, because those stages can differ materially. Combining clean security identity with clean delivery identity gives readers a more meaningful view of exposure. The next evidence should establish the correct conversion ratio and share-count date before any market-capitalization calculation, then connect current commercial reporting to accepted installations. Public trading is a financing milestone; it remains separate from proving the performance of a system installed at a customer site.
Map the quoted ADS to its issuer and underlying security before aggregating capitalization. The concrete next evidence is: issuer/depositary documentation of the ratio, corporate actions and outstanding security counts. A symbol identifies a security; multiple instruments or venues cannot simply be added as independent companies. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Listed security mechanics
- label
- Catalyst date
- value
- 2026-07-02
- label
- Security treatment
- value
- Nasdaq: IQMX
Dated milestones
- date
- 2026-07-02
- event
- Listed security structure and deployment reporting
- status
- Listed security mechanics
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Map the quoted ADS to its issuer and underlying security before aggregating capitalization.
- risk
- A symbol identifies a security; multiple instruments or venues cannot simply be added as independent companies.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Issuer/depositary documentation of the ratio, corporate actions and outstanding security counts.
- Test
- Map the quoted ADS to its issuer and underlying security before aggregating capitalization.
- Limit
- A symbol identifies a security; multiple instruments or venues cannot simply be added as independent companies.
Basis for comparison
- dimensions
- ADS ratio
- underlying shares
- issuer identity
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- A symbol identifies a security; multiple instruments or venues cannot simply be added as independent companies.
- Are multiple securities double counted as issuers?
- Does any capitalization calculation mix different instruments?
Measures to follow
- Verified issuer/instrument/venue mapping
- Accepted systems versus orders
- Cash use and customer delivery obligations
Documents still needed
- Depositary agreement and conversion ratio
- Latest issuer share-count disclosure
- Customer-specific commissioning/acceptance stages
Original sources and scope
- IQM Quantum Computers begins trading on Nasdaq ↗Source dated 1 Jul 2026
The July 1 completion release specifies trading from July 2 and one ordinary share per ADS. Shares, ADSs and warrants remain distinct instruments.
PasqalExisting listed issuer
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: Pasqal reported €4.9 million first-half revenue and €70.4 million booked-and-awarded business at June 30; the latter includes grants, tax credits and multiyear customer contracts.
Still conditional: Booked-and-awarded business is not period revenue, cash received or a directly comparable customer-only backlog measure.
Pasqal’s commercial metric should be stored with its definition attached. The categories inside booked-and-awarded business have different conditions and timing, so the total cannot be treated as a near-term sales forecast. A useful investor card disaggregates what is contractually ordered by customers, what depends on public support and what reflects tax treatment, where the issuer supplies the detail. It should also keep the half-year reporting window separate from any later financing-date cash balance. These distinctions matter when comparing young quantum companies whose revenue mix and disclosure vocabulary differ. The next valuable addition is a roll-forward explaining new awards, recognized revenue, cancellations and remaining conditions. Without that bridge, a large total may describe opportunity or support without telling readers how much becomes recurring commercial activity. Preserve the issuer’s terminology while making its limits visible.
Disaggregate orders and grants before comparing the measure with another company’s backlog. The concrete next evidence is: next report separating customer contracts, public awards, conditions and recognized revenue. Booked-and-awarded activity is not interchangeable with either revenue or noncancellable backlog. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Mixed commercial and public-award measure
- label
- Catalyst date
- value
- 2026-09-24
- label
- Security treatment
- value
- Nasdaq: PSQL
Dated milestones
- date
- 2026-09-24
- event
- First-half results and mixed commercial metric
- status
- Mixed commercial and public-award measure
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Disaggregate orders and grants before comparing the measure with another company’s backlog.
- risk
- Booked-and-awarded activity is not interchangeable with either revenue or noncancellable backlog.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Next report separating customer contracts, public awards, conditions and recognized revenue.
- Test
- Disaggregate orders and grants before comparing the measure with another company’s backlog.
- Limit
- Booked-and-awarded activity is not interchangeable with either revenue or noncancellable backlog.
Basis for comparison
- dimensions
- Scope definition
- cancellation terms
- revenue conversion
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- Booked-and-awarded activity is not interchangeable with either revenue or noncancellable backlog.
- Are tax credits being called customer orders?
- Are half-year revenue and later-date cash being placed on one undated snapshot?
Measures to follow
- Revenue by hardware/services and period
- Booked/awarded composition and conversion
- Cash dates before and after financing
Documents still needed
- Definition stored beside every metric
- Component breakdown and roll-forward
- Latest comparable statements and customer acceptance
Reporting currency
EURReporting period
Six months ended2026-06-30Original sources and scope
- Pasqal reports first-half 2026 results ↗Source dated 24 Sept 2026
Six months ended June 30. Booked and awarded business includes grants, tax credits and multiyear contracts. Separately dates June 30 and August 27 cash.
Rigetti ComputingExisting listed issuer
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: Rigetti announced a dedicated Systems Delivery organization while concentrating processor development under its technology organization.
Still conditional: The reorganization’s expected benefits and processor fidelity target remain prospective until measured.
Rigetti’s update is a useful reminder that selling hardware and delivering it repeatedly require different operating capabilities. A new organization chart can assign responsibility, but it cannot demonstrate faster commissioning or better customer uptime. The investor card should therefore translate the change into observable outcomes: installation lead time, accepted systems, service effort and the relationship between customer commitments and delivery capacity. Processor performance remains a separate technical series with a fixed benchmark definition. The next reporting period can be assessed for evidence that the operating change reduced bottlenecks rather than merely moving them between teams. Readers should also look for the costs of field support and manufacturing growth, because commercial adoption can create working-capital and staffing demands before it produces attractive economics. Track the execution outcomes of the reorganization instead of treating the announcement itself as completed scale.
Connect service capacity to accepted systems while measuring recurring cash needs separately. The concrete next evidence is: next quarterly cash-flow statement plus dated customer acceptance and support evidence. A noncash warrant gain can improve accounting loss without funding engineers, installation or equipment. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Delivery organization and operating cash
- label
- Catalyst date
- value
- 2026-08-19
- label
- Security treatment
- value
- Nasdaq: RGTI
Dated milestones
- date
- 2026-08-19
- event
- Operational reorganization
- status
- Delivery organization and operating cash
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Connect service capacity to accepted systems while measuring recurring cash needs separately.
- risk
- A noncash warrant gain can improve accounting loss without funding engineers, installation or equipment.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Next quarterly cash-flow statement plus dated customer acceptance and support evidence.
- Test
- Connect service capacity to accepted systems while measuring recurring cash needs separately.
- Limit
- A noncash warrant gain can improve accounting loss without funding engineers, installation or equipment.
Basis for comparison
- dimensions
- Cash used in operations
- acceptance cycle
- service burden
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- A noncash warrant gain can improve accounting loss without funding engineers, installation or equipment.
- Does demand exceed qualified delivery capacity?
- Are technical targets being displayed as achieved specifications?
Measures to follow
- Order-to-acceptance cycle time
- Accepted deployments and support burden
- Cash/working capital required per delivery cohort
Documents still needed
- Customer acceptance dates
- Manufacturing and field-service cost detail
- Measured processor benchmark versus stated target
Reporting currency
USDReporting period
Delivery organization announced 2026-08-19; supplementary cash-flow evidence for six months ended 2026-06-30Original sources and scope
- Rigetti creates systems delivery organization ↗Source dated 19 Aug 2026
Reorganization effective Aug18; deployment scale and fidelity target are forward-looking.
- Rigetti Form 10-Q for quarter ended June 30, 2026 ↗Source dated 6 Aug 2026
The six-month cash-flow and warrant-fair-value amounts describe the same reporting interval. A noncash warrant gain is not financing cash.
Quantum Computing Inc.Existing listed issuer
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: QCi and INmune Bio announced a first-stage commercial engagement using quantum optimization, AI and conventional analytics for investigational-drug research, with options for additional work.
Still conditional: Future phases, comparative performance and useful clinical outcomes are not established by the agreement.
The financially meaningful distinction is between an initial commercial engagement and the optional work that may follow. The reviewed announcement does not provide enough information to assign a contract value or future revenue stream. A useful QCi card should therefore track disclosed consideration, accepted deliverables and whether the customer exercises additional phases. The scientific comparison also matters to the business case: the companies plan to test where optimization adds value against conventional methods. That result should be evaluated separately from any eventual clinical finding. Investors should not infer that an investigational treatment works because a computing supplier is involved. The next substantive milestone is a completed analysis with an agreed baseline and a customer decision about further work, followed by attributable financial reporting if disclosed. This keeps a potentially useful commercial foothold visible without converting an early project into a validated medical or computational breakthrough.
Mark each contract phase as committed, accepted, optional or exercised. The concrete next evidence is: a signed extension or customer-backed result with scope, payment status and a matched classical comparison. Optional phases and promising model outputs do not establish repeated revenue or validated medical outcomes. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Research collaboration
- label
- Catalyst date
- value
- 2026-10-14
- label
- Security treatment
- value
- Nasdaq: QUBT
Dated milestones
- date
- 2026-10-14
- event
- Initial commercial research engagement
- status
- Research collaboration
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Mark each contract phase as committed, accepted, optional or exercised.
- risk
- Optional phases and promising model outputs do not establish repeated revenue or validated medical outcomes.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- A signed extension or customer-backed result with scope, payment status and a matched classical comparison.
- Test
- Mark each contract phase as committed, accepted, optional or exercised.
- Limit
- Optional phases and promising model outputs do not establish repeated revenue or validated medical outcomes.
Basis for comparison
- dimensions
- Committed phase value
- acceptance criteria
- follow-on decisions
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- Optional phases and promising model outputs do not establish repeated revenue or validated medical outcomes.
- Are optional phases being counted as orders?
- Is research collaboration being mistaken for clinical efficacy?
Measures to follow
- Paid scope and accepted first-stage deliverables
- Optional-phase conversion
- Matched-baseline computational contribution
Documents still needed
- Contract consideration if disclosed
- Completion and customer follow-on decision
- Public methodology with clinical claims kept separate
Reporting currency
USDOriginal sources and scope
- QCi and INmune Bio research collaboration ↗Source dated 14 Oct 2026
Commercial first-stage engagement with options. Comparative analysis is planned; no clinical efficacy, approval or quantum advantage demonstrated here.
GlobalFoundriesExisting listed issuer
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: GlobalFoundries finalized an agreement making it eligible for up to $375 million over five years, tied to specified milestones for its quantum technology business.
Still conditional: The ceiling is not an immediate payment, customer revenue or a disclosed measure of quantum segment profitability.
GlobalFoundries offers exposure to quantum manufacturing within a much broader semiconductor company. Its award should be tracked as a conditional support program, with separate fields for the ceiling, period, milestones and disclosed receipts. A useful investor view then asks how much incremental manufacturing capability the program creates and whether outside customers use it. The existence of a quantum initiative should not cause the company’s entire revenue base to be labelled quantum revenue. Nor should an award be treated as a purchase order from a commercial customer. The next evidence is a combination of program execution, qualified process availability and attributable customer activity, where disclosed. This provides a practical way to follow an enabling business while recognizing that its financial sensitivity to quantum demand may be much smaller than the visibility of its quantum announcements suggests.
Separate the award ceiling from milestone achievement and cash available for the proposed facility work. The concrete next evidence is: definitive agreement amendments, milestone certification and a financial receipt disclosure. A diversified foundry’s total revenue cannot be attributed to quantum use or inferred from an award ceiling. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Conditional industrial support
- label
- Catalyst date
- value
- 2026-09-08
- label
- Security treatment
- value
- Nasdaq: GFS
Dated milestones
- date
- 2026-09-08
- event
- Definitive milestone-linked R&D award
- status
- Conditional industrial support
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Separate the award ceiling from milestone achievement and cash available for the proposed facility work.
- risk
- A diversified foundry’s total revenue cannot be attributed to quantum use or inferred from an award ceiling.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Definitive agreement amendments, milestone certification and a financial receipt disclosure.
- Test
- Separate the award ceiling from milestone achievement and cash available for the proposed facility work.
- Limit
- A diversified foundry’s total revenue cannot be attributed to quantum use or inferred from an award ceiling.
Basis for comparison
- dimensions
- Milestone status
- attributable receipts
- quantum allocation
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- A diversified foundry’s total revenue cannot be attributed to quantum use or inferred from an award ceiling.
- Is the whole issuer incorrectly categorized as quantum pure-play?
- Are award ceilings being aggregated into current liquidity?
Measures to follow
- Milestone payments and associated expenditures
- Qualified quantum process availability
- Attributable quantum customer activity where disclosed
Documents still needed
- Agreement/payment schedule detail
- Quantum-business reporting boundary
- Customer process qualification and accepted output
Reporting currency
USDOriginal sources and scope
- GlobalFoundries finalizes conditional quantum R&D award ↗Source dated 8 Sept 2026
Up to $375 million over five years, tied to specified milestones, is distinct from immediate cash or customer revenue. The issuer identifies Nasdaq symbol GFS.
OratomicPrivate industry context; no public security added
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: Oratomic announced cumulative funding of $775 million.
Still conditional: The total is not a single incremental round, current cash balance, revenue or a demonstrated technical capability.
Oratomic’s watch card should begin with a financing chronology and a technical evidence chronology. The two are related because capital can fund experiments, facilities and staff, but they answer different questions. The financing record needs round dates, whether amounts are incremental or cumulative and any disclosed instrument terms. The technical record needs company-built prototypes and a clear link from measured primitives to architecture assumptions. A private-company valuation, if later verified, would still describe a particular transaction rather than a readily tradable public-market value. The next useful addition is evidence showing what the capital has enabled at a specific milestone, with the remaining engineering dependencies made explicit. Until then, this is a private industry watch entry, with no ticker, quote or implied access to a security.
Identify distinct rounds before connecting funding to engineering and infrastructure obligations. The concrete next evidence is: dated round-level financing disclosure and a hardware milestone with defined test conditions. A cumulative headline can be double counted and does not reveal the remaining unrestricted balance. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Cumulative startup financing
- label
- Catalyst date
- value
- 2026-10-08
- label
- Security treatment
- value
- Private/industry watch; no verified public security
Dated milestones
- date
- 2026-10-08
- event
- Cumulative financing announcement
- status
- Cumulative startup financing
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Identify distinct rounds before connecting funding to engineering and infrastructure obligations.
- risk
- A cumulative headline can be double counted and does not reveal the remaining unrestricted balance.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Dated round-level financing disclosure and a hardware milestone with defined test conditions.
- Test
- Identify distinct rounds before connecting funding to engineering and infrastructure obligations.
- Limit
- A cumulative headline can be double counted and does not reveal the remaining unrestricted balance.
Basis for comparison
- dimensions
- Round hierarchy
- deployment commitments
- demonstrated hardware
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- A cumulative headline can be double counted and does not reveal the remaining unrestricted balance.
- Is a cumulative total counted twice?
- Are resource estimates presented as existing machines?
Measures to follow
- Incremental versus cumulative capital
- Prototype milestones and remaining dependencies
- Capital commitments versus unrestricted resources where disclosed
Documents still needed
- Round-by-round primary documentation
- Registered entity and ownership status
- Independent technical or customer milestone
Reporting currency
USDOriginal sources and scope
- Oratomic announces total funding of $775m ↗Source dated 8 Oct 2026
Total since launch, not an additional single $775m round. Funding is not delivered technical capability.
QuantWarePrivate industry context; no public security added
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: QuantWare announced a $178 million (€152 million) Series B.
Still conditional: Manufacturing expansion and architecture scale remain execution questions; the financing is not evidence of production yield.
The business question for QuantWare is whether manufacturing investment produces repeatable, accepted output for customers. A large capacity target can describe the design opportunity while leaving fabrication, packaging and calibration yield unresolved. The watch card should therefore connect each facility milestone to qualified processes and shipped devices that meet a stated specification. Customer diversification also matters: a foundry-like supplier can be exposed to several hardware programs, but only if its processes are usable by those customers in practice. The next useful data are accepted-device counts, lot consistency, lead times and the division between custom development work and repeat production. These measures would make the supplier’s progress easier to compare than its architecture’s theoretical capacity alone. Keep financing totals in their announced currencies and avoid inferring either a public ticker or a current cash balance from the round.
Test whether funded capacity becomes qualified supply at reproducible yield. The concrete next evidence is: factory commissioning evidence, product qualification and customer acceptance under the stated architecture. Capital capacity and design capacity are different from delivered chips and useful working devices. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Manufacturing finance
- label
- Catalyst date
- value
- 2026-05-05
- label
- Security treatment
- value
- Private/industry watch; no verified public security
Dated milestones
- date
- 2026-05-05
- event
- Series B and manufacturing expansion
- status
- Manufacturing finance
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Test whether funded capacity becomes qualified supply at reproducible yield.
- risk
- Capital capacity and design capacity are different from delivered chips and useful working devices.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Factory commissioning evidence, product qualification and customer acceptance under the stated architecture.
- Test
- Test whether funded capacity becomes qualified supply at reproducible yield.
- Limit
- Capital capacity and design capacity are different from delivered chips and useful working devices.
Basis for comparison
- dimensions
- Yield
- accepted output
- capacity utilization
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- Capital capacity and design capacity are different from delivered chips and useful working devices.
- Does nominal capacity exceed qualified output?
- Are many customer logos supported by repeat orders?
Measures to follow
- Accepted-device yield and lot consistency
- Repeat production versus custom engineering
- Customer lead time and concentration
Documents still needed
- Qualified capacity and production start evidence
- Customer acceptance data
- Financing instrument and cash-use disclosure if available
Reporting currency
USD and EUR as stated; no conversion performedOriginal sources and scope
- QuantWare raises $178 million ↗Source dated 5 May 2026
VIO40K architecture capacity is a design claim, not a delivered working-qubit count.
Quantum MotionPrivate industry context; no public security added
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: Quantum Motion announced a $160 million Series C.
Still conditional: Projected cost, space and energy advantages need matched full-system evidence; the financing does not establish them.
Quantum Motion’s watch card should test whether an industrial manufacturing route translates into a usable and economical quantum installation. The meaningful chain runs from fabrication yield through cryogenic operation to customer acceptance. Each step can create costs that are invisible in a processor-only comparison. A useful business update should ask what production work is outsourced, what remains proprietary and how much calibration or support each accepted system requires. The next evidence would combine a repeatable device distribution with an operating configuration and clearly bounded resource measurements. A claim of lower energy use should include the supporting equipment and the work completed, not just power at one component. For private-company coverage, the financing is relevant context for the development program, while investability and transaction-specific terms remain separate and unverified here.
Connect capital to measurable fabrication, tuning and integration work. The concrete next evidence is: representative-wafer results and customer or fabrication-partner evidence of repeatable processing. Funding does not establish production economics, and selected-device results can hide variability. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Silicon-development finance
- label
- Catalyst date
- value
- 2026-05-07
- label
- Security treatment
- value
- Private/industry watch; no verified public security
Dated milestones
- date
- 2026-05-07
- event
- Series C commercialization financing
- status
- Silicon-development finance
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Connect capital to measurable fabrication, tuning and integration work.
- risk
- Funding does not establish production economics, and selected-device results can hide variability.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Representative-wafer results and customer or fabrication-partner evidence of repeatable processing.
- Test
- Connect capital to measurable fabrication, tuning and integration work.
- Limit
- Funding does not establish production economics, and selected-device results can hide variability.
Basis for comparison
- dimensions
- Process yield
- tuning effort
- integration milestones
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- Funding does not establish production economics, and selected-device results can hide variability.
- Does an industrial process eliminate or merely relocate calibration costs?
- Are system comparisons made at equal workload quality?
Measures to follow
- Usable devices per fabrication lot
- Whole-system resources at a defined task
- Customer acceptance and support effort
Documents still needed
- Manufacturing partner and process qualification evidence
- Full cost/energy comparison method
- Private financing terms if publicly disclosed
Reporting currency
USDOriginal sources and scope
- Quantum Motion raises $160 million Series C ↗Source dated 7 May 2026
Broad cost or energy comparisons require a specified comparative methodology; funding alone does not establish them.
Photonic Inc.Private industry context; no public security added
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: Photonic announced a final round total above US$200 million/C$275 million, including its earlier first close.
Still conditional: The first-close amount must not be added to the final total; no current cash or liquidity is inferred.
Photonic’s financing update is a useful place to enforce a basic data rule: a subtotal and the total containing it are not two rounds. The watch card should store the closing sequence, the announced currencies and whether any amount is incremental. The business case then depends on how a modular architecture performs after the cost of connecting modules is included. The next useful evidence would show a reproducible inter-module task and identify the resources required while connections are attempted. A larger financing can support that work, but it does not answer the technical question. For a private company, financial comparability is also limited by the absence of the recurring public filings available for listed peers. Report the verified transaction milestone, identify disclosure gaps and follow observable development outcomes without manufacturing a public-market valuation.
Keep the final cumulative amount linked to earlier closes and preserve original currencies. The concrete next evidence is: subsequent capital or milestone disclosure that states whether amounts are new, cumulative or converted. Adding a final close to its included first close inflates funding; converting twice creates another duplication. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Final round close
- label
- Catalyst date
- value
- 2026-05-12
- label
- Security treatment
- value
- Private/industry watch; no verified public security
Dated milestones
- date
- 2026-05-12
- event
- Final financing close
- status
- Final round close
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Keep the final cumulative amount linked to earlier closes and preserve original currencies.
- risk
- Adding a final close to its included first close inflates funding; converting twice creates another duplication.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Subsequent capital or milestone disclosure that states whether amounts are new, cumulative or converted.
- Test
- Keep the final cumulative amount linked to earlier closes and preserve original currencies.
- Limit
- Adding a final close to its included first close inflates funding; converting twice creates another duplication.
Basis for comparison
- dimensions
- Round ID
- original currency
- incremental amount
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- Adding a final close to its included first close inflates funding; converting twice creates another duplication.
- Have both first close and final total been counted?
- Does the architecture comparison include communication overhead?
Measures to follow
- Round totals reconciled across closes
- Inter-module task success and overhead
- Milestone completion against deployed capital where disclosed
Documents still needed
- Incremental final-close amount if disclosed
- Integrated-system experimental evidence
- Updated legal/ownership and financial reporting availability
Reporting currency
USD and CAD as issuer states; no conversion performedOriginal sources and scope
- Photonic Inc closes investment round above US$200m/C$275m ↗Source dated 12 May 2026
The final round total includes the January first close; the two figures are not additive.
Qilimanjaro Quantum TechPrivate industry context; no public security added
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: Qilimanjaro completed its €19.6 million first close; the full company and SETT releases now establish the investor participation.
Still conditional: A later final close remains expected. Instrument terms, unrestricted cash and a customer procurement decision are not established by the equity announcement.
Qilimanjaro’s first close is now supported by complete primary text and an investor-side confirmation. Record the completed capital stage while keeping the expected later close separate. The most useful commercial question is whether financed industrial work produces a repeatable system that a customer accepts. Investor identity can explain strategic interest, but a share subscription does not establish a product sale. A subsequent watchlist update should connect disclosed spending or qualification work to an identifiable delivery result. Financing terms and net deployable proceeds remain fields to verify; they should not be estimated from the headline amount.
Distinguish investor participation from procurement demand and a future round extension. The concrete next evidence is: final-close release if completed, financing instruments and separately evidenced customer acceptance. An equity investor is not automatically a paying customer, and an expected close remains prospective. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Completed first close
- label
- Catalyst date
- value
- 2026-10-14
- label
- Security treatment
- value
- Private/industry watch; no verified public security
Dated milestones
- date
- 2026-10-14
- event
- Series A first close completed
- status
- Completed first close
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Distinguish investor participation from procurement demand and a future round extension.
- risk
- An equity investor is not automatically a paying customer, and an expected close remains prospective.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Final-close release if completed, financing instruments and separately evidenced customer acceptance.
- Test
- Distinguish investor participation from procurement demand and a future round extension.
- Limit
- An equity investor is not automatically a paying customer, and an expected close remains prospective.
Basis for comparison
- dimensions
- Closed capital
- instrument terms
- customer orders
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- An equity investor is not automatically a paying customer, and an expected close remains prospective.
- Is an expected final round being reported as already raised?
- Are public and industrial investors’ commitments documented separately?
Measures to follow
- Completed financing versus later planned closes
- Verified use of proceeds
- Accepted product/manufacturing milestones
Documents still needed
- Financing instruments and net deployable proceeds
- Later final-close completion and incremental amount if disclosed
- Independent customer procurement or acceptance evidence
Reporting currency
EUROriginal sources and scope
- Qilimanjaro announces €19.6 million Series A first close ↗Source dated 14 Oct 2026
The company reports a completed €19.6 million first close. A later close remains expected.
- SETT invests €9.6 million in Qilimanjaro Quantum Tech ↗Source dated 14 Oct 2026
Confirms first-close investor allocation; investment is not a procurement contract.
Monarch QuantumPrivate industry context; no public security added
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: Monarch reported a $55 million growth round and more than $60 million in customer contracts; its combined capital-and-contracts figure exceeds $115 million.
Still conditional: The combined figure is not financing raised, cash available or recognized revenue.
Monarch’s disclosure should be split into two ledgers before it enters a sector funding table. Financing provides capital; customer contracts describe commercial commitments whose delivery, billing and recognition can occur over time. Adding them produces a broad activity figure, but it removes the meaning of either measure. A useful watch card follows the financing separately and asks what portion of the contract base becomes accepted, repeatable product deliveries. For an integrated photonics supplier, production consistency, module qualification and customer concentration are particularly relevant. The next evidence should identify accepted units or programs and explain whether contracts include development work, repeat manufacturing or optional scope. That would help readers assess an enabling business whose importance may lie in making other companies’ quantum systems easier to build, without treating a mixed headline total as proof of cash generation.
Maintain separate ledgers for financing, committed customer work and recognition. The concrete next evidence is: instrument-level financing disclosure and a contract-status table showing delivery and cancellation conditions. A combined headline can overstate capital available today and hide future delivery obligations. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Capital and contracts
- label
- Catalyst date
- value
- 2026-03-31
- label
- Security treatment
- value
- Private/industry watch; no verified public security
Dated milestones
- date
- 2026-03-31
- event
- Growth financing and customer-contract disclosure
- status
- Capital and contracts
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Maintain separate ledgers for financing, committed customer work and recognition.
- risk
- A combined headline can overstate capital available today and hide future delivery obligations.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Instrument-level financing disclosure and a contract-status table showing delivery and cancellation conditions.
- Test
- Maintain separate ledgers for financing, committed customer work and recognition.
- Limit
- A combined headline can overstate capital available today and hide future delivery obligations.
Basis for comparison
- dimensions
- Capital received
- contracted work
- acceptance and margin
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- A combined headline can overstate capital available today and hide future delivery obligations.
- Is a mixed capital-plus-contracts total entered as funding?
- Do contracts depend on customers’ unresolved technical roadmaps?
Measures to follow
- Financing and contract commitments in separate fields
- Accepted module deliveries and repeat orders
- Customer concentration and development/production mix
Documents still needed
- Contract definition and duration
- Recognized revenue/cash data if disclosed
- Production acceptance and repeatability evidence
Reporting currency
USDOriginal sources and scope
- Monarch Quantum funding and customer contracts ↗Source dated 31 Mar 2026
Issuer-supplied member release: $55m growth capital plus >$60m customer contracts; >$115m is mixed total, not cash raised.
QC82Private industry context; no public security added
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: QC82 announced $1.5 million to support technical development, testing infrastructure and early manufacturing.
Still conditional: A later priced round was prospective in the announcement; no completion or valuation is inferred.
QC82’s watch record should focus on the conversion from laboratory capability to a component that an outside buyer can qualify. For early hardware suppliers, test equipment and characterization procedures can be as consequential as production tools because they define what a shipped unit actually guarantees. The next milestones are therefore a complete component specification, reproducible performance across units and customer acceptance under stated optical conditions. Funding should be recorded by instrument and close date when disclosed; a planned future round remains a separate field. The business evidence will become stronger if product measurements show consistency and if customers choose repeat purchases after evaluation. Until then, the profile is a private supplier watch entry with technical and commercial questions, not an implied public investment opportunity.
Use funding as a development milestone and ask which detector specification becomes independently testable next. The concrete next evidence is: a dated detector datasheet or paper with operating conditions and prototype-to-product status. Early funding and product ambitions provide no reliable revenue run rate or qualified manufacturing yield. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Early detector development
- label
- Catalyst date
- value
- 2026-01-29
- label
- Security treatment
- value
- Private/industry watch; no verified public security
Dated milestones
- date
- 2026-01-29
- event
- Early financing and laboratory build-out
- status
- Early detector development
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Use funding as a development milestone and ask which detector specification becomes independently testable next.
- risk
- Early funding and product ambitions provide no reliable revenue run rate or qualified manufacturing yield.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- A dated detector datasheet or paper with operating conditions and prototype-to-product status.
- Test
- Use funding as a development milestone and ask which detector specification becomes independently testable next.
- Limit
- Early funding and product ambitions provide no reliable revenue run rate or qualified manufacturing yield.
Basis for comparison
- dimensions
- Efficiency
- dark counts
- timing and validation cost
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- Early funding and product ambitions provide no reliable revenue run rate or qualified manufacturing yield.
- Does the detector meet the customer’s complete protocol requirements?
- Is the next financing still planned rather than closed?
Measures to follow
- Complete detector characterization
- Unit-to-unit acceptance consistency
- Evaluation-to-repeat-purchase progression
Documents still needed
- Verified registered entity
- Product specification and availability
- Actual later financing close if announced
Reporting currency
USDOriginal sources and scope
- QC82 closes financing ↗Source dated 29 Jan 2026
Article dated Jan30, body Jan29. $1.5m financing; laboratory and early manufacturing are development activities.
CavilinQPrivate industry context; no public security added
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: The University of Chicago reported an $8.8 million seed financing for CavilinQ.
Still conditional: Commercial interconnect modules and modular-system demonstrations were development goals, not completed deployments in the source.
CavilinQ’s financing should be followed through a sequence of technically specific milestones. The first question is whether the company reproduces the relevant atom-photon interface outside the founding research setup. The next is whether an external processor partner can use it without an exceptional amount of custom engineering. A useful private watch card should record those transitions alongside the supplier’s intended customer and interface scope. It should also distinguish university validation of the company’s origin from validation of a commercial product. The next additions should be a company-built prototype, a clearly bounded performance report and a partner integration result. Those outcomes would give readers a stronger view of the business than a generic projection of the entire quantum-networking market. No tradable security or current private valuation is asserted here.
Identify the first independently characterizable interface result and its intended customer integration. The concrete next evidence is: technical data on loss, fidelity and repeated success rate plus a legal-identity confirmation. A seed round can finance research before a product or a contract exists; neither should be assumed. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Seed-stage interfaces
- label
- Catalyst date
- value
- 2026-04-02
- label
- Security treatment
- value
- Private/industry watch; no verified public security
Dated milestones
- date
- 2026-04-02
- event
- Seed financing and spinout commercialization
- status
- Seed-stage interfaces
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Identify the first independently characterizable interface result and its intended customer integration.
- risk
- A seed round can finance research before a product or a contract exists; neither should be assumed.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Technical data on loss, fidelity and repeated success rate plus a legal-identity confirmation.
- Test
- Identify the first independently characterizable interface result and its intended customer integration.
- Limit
- A seed round can finance research before a product or a contract exists; neither should be assumed.
Basis for comparison
- dimensions
- Interface evidence
- customer qualification
- capital stage
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- A seed round can finance research before a product or a contract exists; neither should be assumed.
- How much of the evidence belongs to the research lab rather than the company product?
- Can the interface serve repeat customers without redesign?
Measures to follow
- Company-reproduced interface performance
- External integration effort
- Prototype-to-qualified-module progression
Documents still needed
- Registered entity and product specification
- Primary technical report
- Partner acceptance and commercial terms if disclosed
Reporting currency
USDOriginal sources and scope
- CavilinQ seed funding and technology background ↗Source dated 2 Apr 2026
University commercialization account and founder interview; source says QVT led round.
DiffraqtionPrivate industry context; no public security added
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: Diffraqtion’s announcement reports $4.2 million combining dilutive financing and nondilutive support.
Still conditional: The combined amount should not be called an all-equity round or unrestricted cash balance; satellite applications remain development plans.
Diffraqtion’s record should separate the two funding mechanisms and connect each to its eligible work. Equity and a research contract can carry different spending conditions, timing and obligations, even when announced together. The technical business case also needs a disciplined comparison: identify the imaging task, photon budget and conventional baseline before adopting any performance multiplier. A laboratory optical result may be valuable while still leaving field qualification and a complete service model unresolved. The next evidence should establish a reproducible prototype and the conditions under which the proposed imaging benefit survives practical operation. For readers, that creates a clear progression from financing to instrument qualification to potential deployment, without presenting a planned constellation as an operating commercial network. Keep the sensing category separate from general-purpose quantum-computing exposure.
Separate equity capital from conditional support before judging resources and ownership. The concrete next evidence is: instrument-level funding breakdown and a reproducible imaging comparison at matched photon budgets. A mixed amount gives neither dilution nor cash certainty; marketed multipliers need a defined baseline. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Mixed equity and non-dilutive support
- label
- Catalyst date
- value
- 2026-01-13
- label
- Security treatment
- value
- Private/industry watch; no verified public security
Dated milestones
- date
- 2026-01-13
- event
- Mixed pre-seed and research-support financing
- status
- Mixed equity and non-dilutive support
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Separate equity capital from conditional support before judging resources and ownership.
- risk
- A mixed amount gives neither dilution nor cash certainty; marketed multipliers need a defined baseline.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Instrument-level funding breakdown and a reproducible imaging comparison at matched photon budgets.
- Test
- Separate equity capital from conditional support before judging resources and ownership.
- Limit
- A mixed amount gives neither dilution nor cash certainty; marketed multipliers need a defined baseline.
Basis for comparison
- dimensions
- Funding instruments
- eligible spend
- matched imaging results
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- A mixed amount gives neither dilution nor cash certainty; marketed multipliers need a defined baseline.
- Are different funding mechanisms aggregated without conditions?
- Does the claimed imaging gain survive realistic scenes and environments?
Measures to follow
- Equity versus restricted/nondilutive support
- Imaging performance at a matched resource budget
- Prototype and field-qualification milestones
Documents still needed
- Funding-component breakdown
- Primary optical-method evaluation
- Field-test and customer scope
Reporting currency
USDOriginal sources and scope
- Diffraqtion closes pre-seed financing ↗Source dated 13 Jan 2026
The company announcement combines dilutive and nondilutive funding in its $4.2 million total. It does not independently establish resolution or processing-speed superiority.
Silicon Quantum ComputingPrivate industry context; no public security added
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: The NRFC page records an initial A$20 million investment and a later additional A$40 million.
Still conditional: The tranches require dated treatment; no USD conversion, current cash balance or technical yield is inferred.
Silicon Quantum Computing’s investment record should preserve the sequence of public-capital commitments and the stated development program. Readers can then ask which equipment, manufacturing processes or accepted devices emerge from the support. The commercial test is not simply whether individual structures can be fabricated precisely; it is whether the company can produce useful devices repeatedly and integrate them into a workable system. A useful watch card should therefore track throughput, accepted-device consistency and the resource cost of scaling the process. The next additions are attributable milestone documents and measured manufacturing outcomes, not an assumed relationship between dollars invested and qubits produced. Keeping the original Australian-dollar figures also avoids an unexplained exchange-rate effect in a sector comparison, especially when announcements span several dates.
Preserve announced investor allocations without assuming capital is an accepted hardware sale. The concrete next evidence is: completed investment terms and later fabrication/qualification milestones with attributable outcomes. Government investment and procurement are different economic relationships with different evidence requirements. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Public-backed private financing
- label
- Catalyst date
- value
- 2026-06-11
- label
- Security treatment
- value
- Private/industry watch; no verified public security
Dated milestones
- date
- 2026-06-11
- event
- Public investment tranche update
- status
- Public-backed private financing
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Preserve announced investor allocations without assuming capital is an accepted hardware sale.
- risk
- Government investment and procurement are different economic relationships with different evidence requirements.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Completed investment terms and later fabrication/qualification milestones with attributable outcomes.
- Test
- Preserve announced investor allocations without assuming capital is an accepted hardware sale.
- Limit
- Government investment and procurement are different economic relationships with different evidence requirements.
Basis for comparison
- dimensions
- Investor allocation
- manufacturing reproducibility
- acceptance
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- Government investment and procurement are different economic relationships with different evidence requirements.
- Are incremental tranches double counted or misconverted?
- Can precision be maintained while production throughput grows?
Measures to follow
- Tranche commitments and attributable milestones
- Accepted-device throughput and consistency
- Integration cost and working-system evidence
Documents still needed
- Investment terms and payment status
- Manufacturing milestone reports
- Customer or independent acceptance evidence
Reporting currency
AUDOriginal sources and scope
- Silicon Quantum Computing NRFC investment ↗Source dated 11 Jun 2026
The page initially reported A $20 million on March 24; a June 11 update adds A $40 million. These are distinct tranches in the stated Australian-dollar currency.
Quantum MachinesPrivate industry context; no public security added
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: Quantum Machines announced the acquisition of PCB Engineering and associated engineering capacity in Budapest.
Still conditional: No incremental revenue, synergy amount or product-performance improvement is established by the acquisition announcement.
A control supplier’s growth can be followed through how well it supports customers after installation. The acquisition may expand engineering capacity, but the investor-facing question is whether that capacity improves product reliability, release cadence or deployment efficiency. A useful watch card should identify the integration work and the customer outcomes it is intended to support. It should also distinguish recurring product activity from custom engineering, since those business models scale differently. The next evidence would include versioned product releases, externally confirmed installation improvements and repeat customer use. Those operational signals are more informative than an unsupported market-share claim or a simple count of ecosystem partners. Financial terms should remain blank unless disclosed, and private-company coverage should avoid implying that the supplier has a public ticker or readily accessible market valuation.
Track operating integration and the economics of qualified board production. The concrete next evidence is: closed-transaction terms if disclosed and subsequent delivery, quality or service evidence. A capability acquisition can add working-capital and integration needs before reducing bottlenecks. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Supply-chain acquisition
- label
- Catalyst date
- value
- 2026-06-17
- label
- Security treatment
- value
- Private/industry watch; no verified public security
Dated milestones
- date
- 2026-06-17
- event
- Engineering acquisition
- status
- Supply-chain acquisition
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Track operating integration and the economics of qualified board production.
- risk
- A capability acquisition can add working-capital and integration needs before reducing bottlenecks.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Closed-transaction terms if disclosed and subsequent delivery, quality or service evidence.
- Test
- Track operating integration and the economics of qualified board production.
- Limit
- A capability acquisition can add working-capital and integration needs before reducing bottlenecks.
Basis for comparison
- dimensions
- Delivery time
- qualification yield
- integration cost
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- A capability acquisition can add working-capital and integration needs before reducing bottlenecks.
- Does expansion improve repeatable delivery or add custom-service obligations?
- Are partner logos mistaken for paying customers?
Measures to follow
- Customer installation/support effort
- Repeat product use and release reliability
- Standard product versus custom engineering mix
Documents still needed
- Acquisition terms if disclosed
- Post-integration product outcomes
- Independent customer operating evidence
Original sources and scope
- Quantum Machines acquires PCB Engineering ↗Source dated 17 Jun 2026
Delft CircuitsPrivate industry context; no public security added
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: Delft Circuits reported an €8 million extension bringing the referenced financing to €15 million.
Still conditional: A planned 2026 financing is not treated as completed; the December event is not breaking news at this cutoff.
The useful update is a manufacturing and qualification watch rather than a recycled funding headline. Cryogenic interconnect suppliers need repeatable electrical and thermal performance across products that survive installation and thermal cycling. The business evidence should therefore connect production expansion to accepted customer configurations, failure rates and lead times. A useful card also asks whether growth comes from repeatable standard assemblies or labor-intensive custom designs. The next reporting milestone should show how a financing-supported production change affected those outcomes. Funding totals must retain their original scope: an extension and the total containing it are not separate amounts to add. This creates a substantive infrastructure view of the quantum sector while recognizing that a private supplier’s cash flow and profitability may remain undisclosed.
Keep an extension inside its round history and check planned later rounds independently. The concrete next evidence is: a dated completed financing notice and product evidence showing thermal and signal-integrity performance. Plans for future financing do not establish a completed close or available capital. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Funding extension
- label
- Catalyst date
- value
- 2025-12-03
- label
- Security treatment
- value
- Private/industry watch; no verified public security
Dated milestones
- date
- 2025-12-03
- event
- Historical financing extension and production watch
- status
- Funding extension
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Keep an extension inside its round history and check planned later rounds independently.
- risk
- Plans for future financing do not establish a completed close or available capital.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- A dated completed financing notice and product evidence showing thermal and signal-integrity performance.
- Test
- Keep an extension inside its round history and check planned later rounds independently.
- Limit
- Plans for future financing do not establish a completed close or available capital.
Basis for comparison
- dimensions
- Close hierarchy
- product qualification
- customer concentration
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- Plans for future financing do not establish a completed close or available capital.
- Is a historical funding event being republished as current?
- Does cable density come with higher failure or integration costs?
Measures to follow
- Accepted assemblies and thermal-cycle reliability
- Lead time and manufacturing yield
- Standard/custom product mix
Documents still needed
- Current financing status
- Customer qualification and repeat orders
- Production capacity versus accepted output
Reporting currency
EUROriginal sources and scope
- Delft Circuits announces financing extension ↗Source dated 3 Dec 2025
Header Dec2/dateline Dec3. €8m extension brings announced financing to €15m; planned 2026 round is not completed.
BlueforsPrivate industry context; no public security added
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: Xanadu and Bluefors announced collaboration on modular cryogenic infrastructure for photonic quantum hardware.
Still conditional: The partnership describes prototype development, not completed manufacture or a disclosed revenue amount.
Bluefors’ watch card should assess the system requirements behind a partnership rather than assign it an invented contract value. A modular prototype can be commercially relevant if it meets a customer’s loaded thermal requirements and simplifies expansion or maintenance. The next evidence should therefore show the tested configuration, operating load and acceptance stage. For an infrastructure supplier, quantum exposure can also be broader than one customer program, but that breadth should be established through disclosed business data rather than inferred from a familiar brand. A useful profile follows prototype delivery, qualification and repeat deployment, while keeping the customer’s own quantum-computing roadmap separate. The partnership may create an important engineering path; only later documents can establish its revenue, margin or cash contribution. No financial period or currency is assigned where the reviewed source does not provide one.
Identify who owns prototype work, acceptance obligations and the later delivery decision. The concrete next evidence is: joint qualification results and any separately disclosed orders or repeat installations. A development partnership need not disclose revenue or guarantee a commercially deployed cryogenic architecture. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Infrastructure partnership
- label
- Catalyst date
- value
- 2026-09-29
- label
- Security treatment
- value
- Private/industry watch; no verified public security
Dated milestones
- date
- 2026-09-29
- event
- Prototype-development partnership
- status
- Infrastructure partnership
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Identify who owns prototype work, acceptance obligations and the later delivery decision.
- risk
- A development partnership need not disclose revenue or guarantee a commercially deployed cryogenic architecture.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Joint qualification results and any separately disclosed orders or repeat installations.
- Test
- Identify who owns prototype work, acceptance obligations and the later delivery decision.
- Limit
- A development partnership need not disclose revenue or guarantee a commercially deployed cryogenic architecture.
Basis for comparison
- dimensions
- Qualification stage
- installed capacity
- service commitments
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- A development partnership need not disclose revenue or guarantee a commercially deployed cryogenic architecture.
- Is a development collaboration being recorded as a delivered order?
- Does a cooling-capacity target imply working qubits that have not been demonstrated?
Measures to follow
- Prototype delivery and loaded thermal acceptance
- Expansion/maintenance performance
- Repeat deployment and attributable commercial activity
Documents still needed
- Prototype configuration and test results
- Contract economics if disclosed
- Customer acceptance and rollout stage
Original sources and scope
- Xanadu and Bluefors modular cryogenic partnership ↗Source dated 29 Sept 2026
Prototype development plans, not a delivered deployment.
WelinqPrivate industry context; no public security added
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: Welinq announced a QDrive memory sale to the Institute of Physics of the Slovak Academy of Sciences.
Still conditional: Price, revenue-recognition timing and a completed network deployment are not supplied by this record.
A named sale is a useful early commercial signal because it identifies a real buyer and a component the buyer intends to use. The next question is acceptance: does the installed device meet the protocol’s requirements with the customer’s own source, detectors and control system? A useful Welinq watch card should follow that transition and distinguish a one-off research purchase from repeatable demand. The memory’s performance should be evaluated through write, storage and retrieval together, since the complete cycle determines usable network activity. Commercial terms should remain undisclosed unless a primary document provides them. The next meaningful additions are customer integration results, sustained reliability and follow-on use. That gives readers an evidence-based view of a developing component market without assigning the entire projected quantum-internet opportunity to one research sale.
Follow delivery and acceptance before inferring repeat demand or recurring service income. The concrete next evidence is: customer confirmation of delivered configuration, integration results and a separately disclosed repeat purchase. One sale cannot establish broad adoption, a recurring-revenue base or the profitability of manufacturing. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Named component sale
- label
- Catalyst date
- value
- 2026-01-13
- label
- Security treatment
- value
- Private/industry watch; no verified public security
Dated milestones
- date
- 2026-01-13
- event
- Named component sale
- status
- Named component sale
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Follow delivery and acceptance before inferring repeat demand or recurring service income.
- risk
- One sale cannot establish broad adoption, a recurring-revenue base or the profitability of manufacturing.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Customer confirmation of delivered configuration, integration results and a separately disclosed repeat purchase.
- Test
- Follow delivery and acceptance before inferring repeat demand or recurring service income.
- Limit
- One sale cannot establish broad adoption, a recurring-revenue base or the profitability of manufacturing.
Basis for comparison
- dimensions
- Accepted units
- memory performance
- repeat purchase evidence
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- One sale cannot establish broad adoption, a recurring-revenue base or the profitability of manufacturing.
- Is sale being equated with completed deployment?
- Does laboratory performance transfer to the customer configuration?
Measures to follow
- Customer acceptance and usable-event rate
- Sustained memory reliability
- Repeat or follow-on customer use
Documents still needed
- Installed configuration and acceptance date
- Contract economics only if disclosed
- Customer-published protocol results
Original sources and scope
- Welinq sells QDrive quantum memory in Europe ↗Source dated 13 Jan 2026
QphoXPrivate industry context; no public security added
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: QphoX launched its Quantum Transducer and identified IBM as an early evaluator.
Still conditional: Evaluation does not establish purchase scale, accepted performance, recognized revenue or a deployed quantum network.
The business milestone to follow is the conversion of an evaluation into a qualified product relationship. A prominent evaluator can give a component meaningful exposure, but the next evidence must say what was tested and whether it met the intended use case. For a transducer, efficiency, noise, bandwidth and the full operating environment should be measured together. A useful watch card then asks how much integration work the customer must perform and whether the same component can serve another customer without substantial redesign. Those questions connect a scientific interface to a repeatable supplier business. Financial terms and private valuation should remain blank where undisclosed. The most informative next update is an accepted configuration or externally described protocol result, followed by repeat use or a disclosed commercial commitment.
Distinguish a launch and named evaluation from qualification, procurement and a completed deployment. The concrete next evidence is: evaluator result and purchase or acceptance evidence under the intended cryogenic and optical conditions. An evaluation relationship may produce useful feedback without becoming a revenue-generating deployment. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Product evaluation
- label
- Catalyst date
- value
- 2026-03-12
- label
- Security treatment
- value
- Private/industry watch; no verified public security
Dated milestones
- date
- 2026-03-12
- event
- Product launch and named evaluation
- status
- Product evaluation
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Distinguish a launch and named evaluation from qualification, procurement and a completed deployment.
- risk
- An evaluation relationship may produce useful feedback without becoming a revenue-generating deployment.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Evaluator result and purchase or acceptance evidence under the intended cryogenic and optical conditions.
- Test
- Distinguish a launch and named evaluation from qualification, procurement and a completed deployment.
- Limit
- An evaluation relationship may produce useful feedback without becoming a revenue-generating deployment.
Basis for comparison
- dimensions
- Noise and efficiency
- qualification stage
- conversion to orders
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- An evaluation relationship may produce useful feedback without becoming a revenue-generating deployment.
- Is evaluation being mislabelled as a large customer win?
- Does the intended protocol require performance beyond the tested operating point?
Measures to follow
- Evaluation-to-qualification conversion
- Joint efficiency/noise/bandwidth specification
- Repeatability across customer integrations
Documents still needed
- Evaluation result and accepted use case
- Complete component operating requirements
- Commercial commitment if disclosed
Original sources and scope
- QphoX launches quantum transducer product ↗Source dated 12 Mar 2026
Product launch and IBM evaluation are different from operating a distributed fault-tolerant workload.
ORCA ComputingPrivate industry context; no public security added
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: ORCA’s PT-3 launch material describes a Digital Realty London deployment and a hybrid protein-generation application comparison.
Still conditional: The announcement is dated October 15, 2026. The stated advantage is company-attributed; independent replication and commercial economics remain to be established.
The investor-relevant question is whether a customer will repeatedly pay for a workflow that performs better under a defined resource budget. A hybrid demonstration can be informative, but it needs to isolate the contribution of the quantum stage and identify the actual endpoint measured. Better computational candidates do not automatically imply laboratory success, much less a medical outcome. A useful ORCA watch card should therefore connect deployment availability, reproducible application performance and the customer’s decision to continue using the system. It should also separate hardware sales, access arrangements and project services if commercial terms become available. The next evidence should include independent replication or a customer acceptance report with the full classical baseline, followed by disclosed repeat commercial activity. This treats the product launch as a testable business proposition without promoting an unverified advantage claim into established fact.
Tie product claims to matched customer workflows and attributable commercial evidence. The concrete next evidence is: reproducible whole-workflow benchmark and a named accepted deployment or separately disclosed contract. A launch is a product event; commercial advantage and repeatable sales require further evidence. This watch record should change when that evidence changes, with the original event and reporting period preserved so readers can distinguish a new outcome from a refreshed page.
Facts, comparisons and next evidence
At a glance
- label
- Commercial evidence stage
- value
- Hybrid product launch
- label
- Catalyst date
- value
- 2026-10-15
- label
- Security treatment
- value
- Private/industry watch; no verified public security
Dated milestones
- date
- 2026-10-15
- event
- Product/application claim and facility deployment
- status
- Hybrid product launch
- Remaining condition
- See this card’s remaining-condition panel for the complete unresolved scope.
Cash and revenue boundary
- Question
- Tie product claims to matched customer workflows and attributable commercial evidence.
- risk
- A launch is a product event; commercial advantage and repeatable sales require further evidence.
- realized or announced
- See this card’s announced-fact panel; the complete source-backed state is recorded there once.
- still conditional
- See this card’s remaining-condition panel; keep its qualifications attached to the fact.
What would change this assessment
- Evidence needed
- Reproducible whole-workflow benchmark and a named accepted deployment or separately disclosed contract.
- Test
- Tie product claims to matched customer workflows and attributable commercial evidence.
- Limit
- A launch is a product event; commercial advantage and repeatable sales require further evidence.
Basis for comparison
- dimensions
- Whole-job cost
- accepted use
- classical baseline quality
- rule
- Compare the same period, currency, instrument or contract status. Unknown values stay blank; no cross-company score is supplied.
Limits and missing evidence
- A launch is a product event; commercial advantage and repeatable sales require further evidence.
- Does a hybrid change hide a stronger classical baseline?
- Is an early biological-computing endpoint being overstated?
Measures to follow
- Repeat paid use or accepted deployment
- Matched-baseline application performance
- Hardware/access/services revenue mix if disclosed
Documents still needed
- Full reproducibility and ablation evidence
- Customer acceptance and commercial scope
Original sources and scope
- ORCA Computing launches PT-3 ↗Source dated 15 Oct 2026
The company announcement is dated October 15, 2026. Commercial-advantage language is attributed to the company and depends on its chosen baseline.
Qanova TechPrivate industry context; no public security added
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: Readout amplification scope is documented by primary sources.
Still conditional: Qualification, repeat customer demand, ownership detail and financial scale are not established in the reviewed material.
Qanova Tech belongs on an industry watchlist because its documented component role can be connected to a specific customer qualification decision. The practical question is whether useful signal gain can be obtained without adding unacceptable noise or narrowing the required bandwidth. The commercial evidence should follow that decision from a defined evaluation to acceptance, support and any separately disclosed repeat order. Product availability is useful, but it does not establish a revenue run rate or a return for shareholders.
Request gain, added noise, saturation, bandwidth and stability at the same temperature, frequency and pump conditions. Performance at one operating point may not transfer to the multichannel readout configuration a customer needs. A future financial update should identify the instrument and event if financing is disclosed, then keep that capital record separate from customer receipts. No public security has been verified, so this record is a company-development watch rather than a stock listing. The next meaningful change would be an independently attributable qualification or commercial milestone that reduces one of these named uncertainties.
Facts, comparisons and next evidence
At a glance
- label
- Watch category
- value
- Private quantum-component supplier
- label
- Documented role
- value
- Readout amplification
- label
- Public security
- value
- None verified
Dated milestones
- date
- 2025-04
- Date scope
- source publication date; unknown if undated
- event
- EPFL startup profile published
- status
- Published primary evidence; retain the narrower maturity statement
- what it does not establish
- Performance at one operating point may not transfer to the multichannel readout configuration a customer needs.
Cash and revenue boundary
- Question
- Whether useful signal gain can be obtained without adding unacceptable noise or narrowing the required bandwidth.
- risk
- Product scope does not establish sales, financing or valuation.
What would change this assessment
- Evidence needed
- Request gain, added noise, saturation, bandwidth and stability at the same temperature, frequency and pump conditions.
- Test
- Named configuration, dated customer or technical evidence and explicit commercial stage.
- Limit
- Performance at one operating point may not transfer to the multichannel readout configuration a customer needs.
Basis for comparison
- dimensions
- Interface and operating conditions
- Repeatable qualified performance
- Integration effort and customer acceptance
- rule
- Compare the same interface and test conditions; no financial multiples without verified financial data.
Limits and missing evidence
- Performance at one operating point may not transfer to the multichannel readout configuration a customer needs.
- Private-company financial and ownership data remain unverified.
Measures to follow
- Customer qualification stage
- Accepted configuration and support scope
- Repeat demand if disclosed
- Instrument-level financing only if primary terms become available
Documents still needed
- Legal identity and ownership
- Dated independent qualification
- Attributable customer acceptance
- Financial disclosure if available
Original sources and scope
- Qanova Tech — EPFL startup profile ↗Source dated 2025-04
Traveling-wave parametric amplifier and cryogenic-packaging development; company performance aspirations are not independently validated specifications.
- Qanova Tech receives a Quantum Innogrant at EPFL ↗Source dated 1 Nov 2024
Historical institutional support, not a 2026 financing event or proof of product qualification.
Basel Precision InstrumentsPrivate industry context; no public security added
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: Measurement and filtering scope is documented by primary sources.
Still conditional: Qualification, repeat customer demand, ownership detail and financial scale are not established in the reviewed material.
Basel Precision Instruments belongs on an industry watchlist because its documented component role can be connected to a specific customer qualification decision. The practical question is whether a filter or electronics chain improves usable measurement quality under the installation’s actual thermal budget. The commercial evidence should follow that decision from a defined evaluation to acceptance, support and any separately disclosed repeat order. Product availability is useful, but it does not establish a revenue run rate or a return for shareholders.
Ask for transfer functions, noise spectra, channel behavior, thermalization and repeatability in the intended cryostat configuration. Component filtering claims cannot be converted directly into a universal qubit-fidelity improvement. A future financial update should identify the instrument and event if financing is disclosed, then keep that capital record separate from customer receipts. No public security has been verified, so this record is a company-development watch rather than a stock listing. The next meaningful change would be an independently attributable qualification or commercial milestone that reduces one of these named uncertainties.
Facts, comparisons and next evidence
At a glance
- label
- Watch category
- value
- Private quantum-component supplier
- label
- Documented role
- value
- Measurement and filtering
- label
- Public security
- value
- None verified
Dated milestones
- date
- 2026-05-29
- Date scope
- source publication date; unknown if undated
- event
- Bluefors filtering collaboration announced
- status
- Published primary evidence; retain the narrower maturity statement
- what it does not establish
- Component filtering claims cannot be converted directly into a universal qubit-fidelity improvement.
Cash and revenue boundary
- Question
- Whether a filter or electronics chain improves usable measurement quality under the installation’s actual thermal budget.
- risk
- Product scope does not establish sales, financing or valuation.
What would change this assessment
- Evidence needed
- Ask for transfer functions, noise spectra, channel behavior, thermalization and repeatability in the intended cryostat configuration.
- Test
- Named configuration, dated customer or technical evidence and explicit commercial stage.
- Limit
- Component filtering claims cannot be converted directly into a universal qubit-fidelity improvement.
Basis for comparison
- dimensions
- Interface and operating conditions
- Repeatable qualified performance
- Integration effort and customer acceptance
- rule
- Compare the same interface and test conditions; no financial multiples without verified financial data.
Limits and missing evidence
- Component filtering claims cannot be converted directly into a universal qubit-fidelity improvement.
- Private-company financial and ownership data remain unverified.
Measures to follow
- Customer qualification stage
- Accepted configuration and support scope
- Repeat demand if disclosed
- Instrument-level financing only if primary terms become available
Documents still needed
- Legal identity and ownership
- Dated independent qualification
- Attributable customer acceptance
- Financial disclosure if available
Original sources and scope
- Bluefors collaborates with Basel Precision Instruments on cryogenic filtering ↗Source dated 29 May 2026
Confirms named cryogenic-filtering collaboration. Detailed attenuation and temperature results require the stated measurement conditions.
- Basel Precision Instruments product catalogue ↗
Low-noise electronics and cryogenic filters; product categories do not establish deployment volumes, margins or customer retention.
- Basel Quantum Center startups and spin-offs ↗
The university identifies Basel Precision Instruments, qprobe and YQuantum and their direct quantum-hardware roles.
qprobePrivate industry context; no public security added
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: Cryogenic device characterization scope is documented by primary sources.
Still conditional: Qualification, repeat customer demand, ownership detail and financial scale are not established in the reviewed material.
qprobe belongs on an industry watchlist because its documented component role can be connected to a specific customer qualification decision. The practical question is whether automated cold-device probing produces repeatable measurements quickly enough to improve fabrication feedback. The commercial evidence should follow that decision from a defined evaluation to acceptance, support and any separately disclosed repeat order. Product availability is useful, but it does not establish a revenue run rate or a return for shareholders.
Measure contact success, cooldown and move time, repeatability, wiring limits and compatibility with the actual sample format. Fast nominal probing can lose its advantage if contact failures, thermal recovery or manual interventions dominate. A future financial update should identify the instrument and event if financing is disclosed, then keep that capital record separate from customer receipts. No public security has been verified, so this record is a company-development watch rather than a stock listing. The next meaningful change would be an independently attributable qualification or commercial milestone that reduces one of these named uncertainties.
Facts, comparisons and next evidence
At a glance
- label
- Watch category
- value
- Private quantum-component supplier
- label
- Documented role
- value
- Cryogenic device characterization
- label
- Public security
- value
- None verified
Dated milestones
- Date scope
- source publication date; unknown if undated
- event
- Cryogenic product scope reviewed
- status
- Published primary evidence; retain the narrower maturity statement
- what it does not establish
- Fast nominal probing can lose its advantage if contact failures, thermal recovery or manual interventions dominate.
Cash and revenue boundary
- Question
- Whether automated cold-device probing produces repeatable measurements quickly enough to improve fabrication feedback.
- risk
- Product scope does not establish sales, financing or valuation.
What would change this assessment
- Evidence needed
- Measure contact success, cooldown and move time, repeatability, wiring limits and compatibility with the actual sample format.
- Test
- Named configuration, dated customer or technical evidence and explicit commercial stage.
- Limit
- Fast nominal probing can lose its advantage if contact failures, thermal recovery or manual interventions dominate.
Basis for comparison
- dimensions
- Interface and operating conditions
- Repeatable qualified performance
- Integration effort and customer acceptance
- rule
- Compare the same interface and test conditions; no financial multiples without verified financial data.
Limits and missing evidence
- Fast nominal probing can lose its advantage if contact failures, thermal recovery or manual interventions dominate.
- Private-company financial and ownership data remain unverified.
Measures to follow
- Customer qualification stage
- Accepted configuration and support scope
- Repeat demand if disclosed
- Instrument-level financing only if primary terms become available
Documents still needed
- Legal identity and ownership
- Dated independent qualification
- Attributable customer acceptance
- Financial disclosure if available
Original sources and scope
- qprobe cryogenic probing systems ↗
Company describes quantum-device probing and cryogenic stations; stated 2024 market introduction is historical, not independently measured throughput.
- Basel Quantum Center startups and spin-offs ↗
The university identifies Basel Precision Instruments, qprobe and YQuantum and their direct quantum-hardware roles.
YQuantumPrivate industry context; no public security added
Sources reviewed 20 Oct 2026. Event dates remain attached to the original evidence.
Announced or reported: Cryogenic packaging and signal conditioning scope is documented by primary sources.
Still conditional: Qualification, repeat customer demand, ownership detail and financial scale are not established in the reviewed material.
YQuantum belongs on an industry watchlist because its documented component role can be connected to a specific customer qualification decision. The practical question is whether packaging and bias components preserve the device’s required signal environment without excessive thermal or space cost. The commercial evidence should follow that decision from a defined evaluation to acceptance, support and any separately disclosed repeat order. Product availability is useful, but it does not establish a revenue run rate or a return for shareholders.
Require package modes, thermal contact, channel crosstalk and bias transfer response in a named installed configuration. A favorable partner experiment depends on the complete setup and cannot be assigned solely to the enclosure or filter. A future financial update should identify the instrument and event if financing is disclosed, then keep that capital record separate from customer receipts. No public security has been verified, so this record is a company-development watch rather than a stock listing. The next meaningful change would be an independently attributable qualification or commercial milestone that reduces one of these named uncertainties.
Facts, comparisons and next evidence
At a glance
- label
- Watch category
- value
- Private quantum-component supplier
- label
- Documented role
- value
- Cryogenic packaging and signal conditioning
- label
- Public security
- value
- None verified
Dated milestones
- Date scope
- source publication date; unknown if undated
- event
- Current quantum-component catalogue reviewed
- status
- Published primary evidence; retain the narrower maturity statement
- what it does not establish
- A favorable partner experiment depends on the complete setup and cannot be assigned solely to the enclosure or filter.
Cash and revenue boundary
- Question
- Whether packaging and bias components preserve the device’s required signal environment without excessive thermal or space cost.
- risk
- Product scope does not establish sales, financing or valuation.
What would change this assessment
- Evidence needed
- Require package modes, thermal contact, channel crosstalk and bias transfer response in a named installed configuration.
- Test
- Named configuration, dated customer or technical evidence and explicit commercial stage.
- Limit
- A favorable partner experiment depends on the complete setup and cannot be assigned solely to the enclosure or filter.
Basis for comparison
- dimensions
- Interface and operating conditions
- Repeatable qualified performance
- Integration effort and customer acceptance
- rule
- Compare the same interface and test conditions; no financial multiples without verified financial data.
Limits and missing evidence
- A favorable partner experiment depends on the complete setup and cannot be assigned solely to the enclosure or filter.
- Private-company financial and ownership data remain unverified.
Measures to follow
- Customer qualification stage
- Accepted configuration and support scope
- Repeat demand if disclosed
- Instrument-level financing only if primary terms become available
Documents still needed
- Legal identity and ownership
- Dated independent qualification
- Attributable customer acceptance
- Financial disclosure if available
Original sources and scope
- YQuantum quantum packaging, flux-bias and filtering products ↗
Footer verifies YQuantum GmbH. Product catalogue establishes direct fit; partner testimonials are not independent benchmark certificates.
- Basel Quantum Center startups and spin-offs ↗
The university identifies Basel Precision Instruments, qprobe and YQuantum and their direct quantum-hardware roles.
The revenue line moved. The cash did not.Company and financial analysis
An amended quantum-company release shows why a revenue chart needs a version history.
Sources reviewed 20 Oct 2026.
Infleqtion’s amended second-quarter release changed reported revenue from $12.6 million to $13.5 million after the timing of recognition changed for two government contracts. The company said cash was unchanged. The release was dated August 17 and filed August 18, 2026. That is a concrete financial update, but it is not an additional customer payment. [1]
The distinction becomes easier to follow when the statements are read as different views of the business. An income statement covers revenue and expenses over a period. A balance sheet describes a position at a date. A cash-flow statement explains movement in cash. The SEC’s educational guide treats these as related documents that answer different questions. [2]
Imagine a hypothetical research project whose work spans several reporting periods. The customer’s payment schedule and the accounting allocation of the work need not produce identical lines on a chart. If the accounting allocation is corrected, the reported history can change while the bank transactions remain exactly as they were. This illustration does not describe the detailed contractual mechanics of Infleqtion’s adjustment; those belong to the company’s filing.
For a reader, the first practical task is version control. A search engine may surface the original release, a company page may show the amended one, and a comparison table may still contain the earlier value. None of those dates should disappear during data entry. A useful record preserves the original publication, links the superseding document and identifies every field that changed. It also records the fields explicitly described as unchanged.
Growth comparisons require the same care. If a correction affects more than the current period, a percentage calculated from the new numerator and an old denominator can become misleading. The analyst should rebuild the comparison from consistent versions rather than updating the most visible number alone. This is a data-quality problem before it becomes an interpretation problem. A neat chart is only useful when its periods and versions match.
The next step is to identify what business question remains open. A revenue adjustment may say little about new demand, repeat customers or the economics of delivering a system. Those questions need contracts, customer activity and cost information. Cash generation needs its own statement. Treating every upward revenue revision as a fresh commercial success collapses several different forms of evidence into a single optimistic reading.
A good quantum-company financial card can make the distinction visible with three short labels: reporting period, document version and cash effect. The labels should sit beside the figure rather than in a remote disclaimer. Readers can then tell whether they are seeing a newly completed sale, a recognition change, a forecast revision or a correction to previously published information. The same design helps when the revision is downward.
The broader lesson is that financial accuracy includes the history of the numbers. Quantum businesses are often judged through a small set of highly visible announcements. A corrections-aware record makes those announcements more useful by showing how they fit together. In this case, the amended revenue belongs in the current comparison, while the explicit absence of a cash change belongs in the explanation. Both facts are necessary to understand the update.
Related QubitWire coverage and context →
Original sources and scope
- Infleqtion amended Q2 results and FY26 guidance ↗Source dated 17 Aug 2026
Filed Aug18. Supersedes Aug12 release. Noncash recognition timing changed; cash unchanged.
- Beginners guide to financial statements ↗
The SEC page identifies February 5, 2007 as its last review or update date; no original publication date is established here. General educational background, not a current company filing or an accounting opinion.
One funding headline needs two ledgersCompany and financial analysis
Capital and customer commitments can both matter without being added into a cash total.
Sources reviewed 20 Oct 2026.
Monarch Quantum’s March 2026 announcement combined a $55 million growth round with more than $60 million in customer contracts to describe over $115 million in capital and contracts. The categories are explicitly different. A funding database should preserve that difference instead of converting the combined figure into money raised, current cash or recognized revenue. [1]
The problem is not that either category lacks value. Financing can support development and production. A customer commitment can indicate demand and give a supplier a concrete program to execute. The problem appears when their sum is compared with another company’s equity round. The two numbers no longer measure the same thing, even though they share a currency symbol and can be placed in the same spreadsheet column.
A useful first ledger follows financing. It records the transaction date, the instrument, whether the amount is gross or net and whether it is incremental or cumulative. A second ledger follows customer commitments. It records the scope, duration, acceptance stages and any disclosed conditions. The analyst can connect the ledgers through the work the company is building, but should not erase their separate definitions to obtain a larger headline.
Consider a hypothetical optical-module supplier. It raises capital to build a test facility and signs a multiyear customer program. The program may require engineering work, prototype delivery and qualification before repeat manufacturing begins. Some of the financing may be spent long before the customer accepts a product. A contract can therefore create obligations as well as opportunity. Its existence alone does not reveal the timing or profitability of the eventual activity.
For quantum infrastructure, this distinction is especially practical. A supplier can be working on a real customer problem while the surrounding quantum system remains under development. The business question becomes whether the supplier’s component meets an agreed specification and whether the customer continues to need it as the architecture changes. Repeatable acceptance is stronger evidence of a scalable product business than an undifferentiated tally of announced relationships.
The next reporting step should follow conversion. Which customer programs produced accepted modules? Which required additional design work? Which led to repeat orders? Where financial details are disclosed, how do those events connect to revenue and cash? An analyst should ask for the answers without inventing them. A blank field marked undisclosed is more informative than a precise-looking estimate derived from a mixed headline total.
The visual presentation can stay simple. Show capital on one line and customer commitments on another, with a clear note that the categories are not added for funding comparisons. If a company itself publishes a combined total, retain the original wording as context while explaining the composition. This respects the source and gives the reader a consistent basis for comparing businesses.
The resulting story is richer than a financing league table. It shows what resources a company has announced, what customers have asked it to build and which evidence would connect those two facts. The most useful future update may be an accepted production module or a repeat customer decision. That is how a quantum supplier’s business becomes more concrete, even when detailed private-company financial statements remain unavailable.
Original sources and scope
- Monarch Quantum funding and customer contracts ↗Source dated 31 Mar 2026
Issuer-supplied member release: $55m growth capital plus >$60m customer contracts; >$115m is mixed total, not cash raised.
An award ceiling is the beginning of a funding recordCompany and financial analysis
A finalized agreement can still leave timing, conditions and receipts to be tracked.
Sources reviewed 20 Oct 2026.
GlobalFoundries’ September 2026 quantum R&D agreement makes it eligible for up to $375 million over five years, tied to specified milestones. The company describes a finalized agreement, not an immediate payment of the entire ceiling. That distinction should survive every summary, chart and automated update built from the announcement. [1]
There are several meaningful events inside a support program. A proposed award can become a signed agreement. Eligible work can begin. A milestone can be completed and accepted. A payment can be disclosed. An accounting entry can appear in a reporting period. These stages may be closely related, but one stage should not silently stand in for all the others. A useful funding record allows each to have its own date and evidence.
The ceiling answers a maximum-scope question. It does not by itself tell a reader how much unrestricted liquidity is available today. The schedule matters because a company may need to spend money before completing a deliverable or receiving support. The conditions matter because a program may cover only particular work. Those practical questions can change the development plan even when the headline amount remains unchanged.
A hypothetical manufacturer illustrates the issue. Suppose support is linked to qualifying a process and later demonstrating repeatable output. The first milestone might require equipment, staff and test runs. The second might require successful customer-relevant devices. A record that shows only the maximum award misses both the sequence of work and the uncertainty between stages. The useful comparison is what has been accepted, what remains and what resources each step requires.
The technical evidence should run beside the funding evidence. A signed agreement can support a serious development program without demonstrating that its intended manufacturing process already meets every target. Conversely, a completed technical test does not establish the amount or accounting treatment of a payment. Readers need both histories to understand what the program has actually changed. Neither should be used as a shortcut to the other.
For a diversified supplier, another boundary matters: the program’s scope within the whole company. A quantum-related award does not make every business line quantum revenue. A useful investor profile identifies the activity supported and uses segment or product disclosure where available. Where the company does not disclose a quantum revenue share, the profile should say that the share is not established rather than allocate the entire issuer to the theme.
A clear display can show five fields: agreement status, maximum amount, covered period, milestone status and disclosed receipts. An accounting note can link to the relevant filing when one becomes available. The display should retain the original currency and attach the reporting date to every amount. Unknown receipts should remain unknown; they should not default to either the ceiling or zero.
This creates a more useful update cycle. The next story can report a newly accepted process, a disclosed payment or a revised program condition without rewriting the original announcement as if it happened again. The award remains significant, while its practical contribution becomes progressively more measurable. That is the information readers need to follow public support from an agreement on paper to a functioning part of the quantum supply chain.
Related QubitWire coverage and context →
Original sources and scope
- GlobalFoundries finalizes conditional quantum R&D award ↗Source dated 8 Sept 2026
Up to $375 million over five years, tied to specified milestones, is distinct from immediate cash or customer revenue. The issuer identifies Nasdaq symbol GFS.
One quantum company can have several securitiesCompany and financial analysis
A clean watchlist distinguishes the organization, the instrument and the trading venue.
Sources reviewed 20 Oct 2026.
IQM’s July 2026 Nasdaq listing announcement identifies American depositary shares under IQMX. That is an issuer event and a security-structure fact. It should not create a second IQM in a quantum-company directory or justify a market-capitalization calculation using an unrelated share count. [1]
The SEC’s investor glossary explains that a depositary receipt can represent one or more underlying shares, or a fraction of one. The ratio matters when relating the receipt to the foreign shares. The issuer-specific depositary terms must therefore be checked before converting prices or counts; a familiar ticker is not enough. [2]
A robust record has three layers. The organization layer identifies the operating company and its technology. The issuer layer identifies the legal entity whose financial statements and ownership structure are being discussed. The security layer identifies the instrument, venue, currency and relevant identifiers. Sometimes these layers are simple. Sometimes an operating subsidiary, holding company and depositary instrument make the distinction essential.
Consider a deliberately hypothetical example in which one receipt represents several ordinary shares. Multiplying the receipt price by the number of ordinary shares would mix units. The result could look plausible while being systematically wrong. The correction is not a clever valuation adjustment; it is basic unit consistency. The same discipline applies to a chart that combines prices from different currencies or dates without saying so.
Sector counts create a second trap. Multiple listings may improve market access without creating additional businesses. Counting each ticker as a company can inflate the apparent size of the public quantum universe. A directory should therefore group verified securities under one issuer and link that issuer to the appropriate operating organizations. Acquired subsidiaries can retain technical profiles without being presented as independent public securities.
This structure also improves updates. A ticker change should update the instrument record and preserve the earlier identifier as history. A new listing should add a verified venue relationship. A merger should change the ownership map only when its status is established. None of these events should automatically rewrite the technical profile or assign a different capability score. Financing identity and hardware performance remain separate kinds of evidence.
For readers comparing businesses, the immediate benefit is clarity about what a displayed number means. Every price would need an instrument, currency and time; every share count would need a class and reporting date. This article supplies no live prices or valuation. It explains the prerequisites for calculating those figures accurately if a later analysis requires them.
A useful watchlist can make the hierarchy visible without becoming complicated. Show the company name first, then the verified issuer and its securities beneath it. Leave unverified conversion ratios blank and link the primary document needed to fill them. The result is a more trustworthy map of quantum exposure: each company appears once in the company count, while its genuine market access remains fully documented.
Original sources and scope
- IQM Quantum Computers begins trading on Nasdaq ↗Source dated 1 Jul 2026
The July 1 completion release specifies trading from July 2 and one ordinary share per ADS. Shares, ADSs and warrants remain distinct instruments.
- American Depositary Receipts: investor glossary ↗
General investor education; not issuer-specific depositary terms.
After a quantum acquisition, who owns the evidence?Company and financial analysis
A company map should change ownership without rewriting the history of an experiment.
Sources reviewed 20 Oct 2026.
IonQ completed its SkyWater acquisition in July 2026, while its October 12 Elisity announcement describes an agreement to acquire. Those are different transaction states. A directory that applies the same ownership label to both loses a fact that matters to readers: whether the business has actually changed hands. [1] [2]
The problem extends beyond the transaction table. A quantum business may have years of research results, named products, customer relationships and technical staff associated with its earlier identity. An acquisition does not make those records disappear. It also does not mean that every capability of the buyer was present in the acquired company’s earlier products. Accurate coverage needs both a historical identity and a current ownership relationship.
The most useful starting point is an evidence object that belongs to a system and a date. It identifies the experiment, its authors, the hardware configuration and the organization responsible at that time. A separate relationship records the later acquisition, including announcement and completion dates. The technical result can then remain intact while readers see who now controls or commercializes the relevant technology.
This prevents several common mistakes. An acquired business should not automatically remain in a list of independently tradable stocks. A pending target should not prematurely become a completed subsidiary. A supplier’s component result should not be relabelled as a full processor benchmark simply because its new parent builds processors. Each error arises from using one company-name field to represent several different relationships.
The same care helps with modality. A buyer may operate one type of quantum hardware and acquire another. Adding their physical counts can create a number with little technical meaning. Instead, preserve separate product families and their native measures. Readers can then understand the breadth of the portfolio without assuming that unlike machines form one integrated system or that a strategic combination has already produced a technical improvement.
Commercial records need their own transition. A product may continue under the acquired brand, move to a parent sales channel or become internal technology. Those outcomes require dated evidence. A completed acquisition proves the ownership event; it does not prove which products remain available or how external customers will be served. The next useful update is therefore a product, support or customer announcement that clarifies the operating model.
A good visual is a small ownership timeline beside an unchanged technical-history timeline. The ownership line shows proposed, agreed and completed states only where supported. The technical line shows experiments and delivered products at their original dates. A link between the lines can explain a later integration milestone when one is actually demonstrated. This makes consolidation visible without converting corporate strategy into a performance score.
The payoff is a directory that remains useful as the industry changes. Readers can trace who developed a technology, who owns it now and which entity’s financial disclosures are relevant. They can also see what still needs to be proved after the deal. That is more informative than either deleting the acquired company or treating it forever as if nothing had changed.
Related QubitWire coverage and context →
Original sources and scope
- IonQ completes SkyWater acquisition ↗Source dated 31 Jul 2026
SkyWater is now an IonQ subsidiary; the historical SKYT reference in this announcement is not an active standalone-listing claim.
- IonQ agrees to acquire Elisity ↗Source dated 12 Oct 2026
Definitive all-stock agreement up to $1.3bn; completion not established. Microsegmentation is conventional cybersecurity.
Cash runway needs a map of obligationsCompany and financial analysis
A bank balance and a recent spending rate are only the beginning of a development-capacity analysis.
Sources reviewed 20 Oct 2026.
IonQ’s October 2026 offering announcement establishes a priced financing involving several security types. The reviewed release does not by itself establish net cash received at a completed closing. A development-capacity analysis should start by resolving that stage before treating the headline amount as current liquidity. [1]
Cash-flow statements help explain how resources change. The SEC’s educational material distinguishes operating, investing and financing flows and shows how they reconcile a beginning cash balance to an ending one. A financing event can increase resources while equipment purchases and ordinary operations use them through different categories. [2]
A simple runway calculation divides a cash figure by a recent rate of cash use. That can be a useful first approximation, but only after the units and dates match. It becomes less informative when the business is changing quickly. A company moving from research into manufacturing may face a spending pattern unlike the quarter used in the denominator. The calculation should therefore be presented as a scenario, with its assumptions visible.
The next task is an obligations map. Identify committed facilities, planned equipment, acquisition payments, debt obligations and customer-delivery requirements where disclosed. Then distinguish firm commitments from management plans. The map should not subtract every possible expenditure as if it were certain, nor ignore a signed obligation because it has not yet appeared in a cash-flow period. It should show what is known and what remains conditional.
A hypothetical quantum supplier makes the difference clear. It may hold enough cash to repeat its recent research spending for a long time, yet also be preparing a production facility that changes the cash profile. Alternatively, a large development program may receive support only after milestones are accepted. The headline balance alone cannot answer whether the company can fund the timing gap. The analysis needs the sequence of inflows and outflows.
Technical dependencies belong in the map too. If a process qualification must succeed before equipment can be used productively, schedule uncertainty can affect the financial plan. That does not justify inventing a failure probability. It means the reader should see the dependency and the observable event that resolves it. A good scenario makes the consequence of a delay understandable without pretending to know the date of the next scientific breakthrough.
The most useful presentation is a dated resource bridge followed by a small set of explicitly labelled scenarios. Start with reported cash and investments at a specific date. Add only verified subsequent financing effects. Show known commitments separately from discretionary development plans. State which cash-use period informs each scenario and why it might differ from the future. Avoid turning a single quotient into a precise calendar promise.
This approach changes the question from how large a company’s balance is to what work that balance can support under stated conditions. It also makes future updates easier. A closing, an accepted milestone or a new facility commitment changes a specific part of the map. Readers can assess that change directly, without mistaking a financing headline for proof that every technical and commercial objective is fully funded.
Related QubitWire coverage and context →
Original sources and scope
- IonQ prices 2026 equity offering ↗Source dated 14 Oct 2026
Pricing announcement only; no closing/net-cash receipt inferred. Distinct from October 2025 $2bn offering.
- What is a statement of cash flows? ↗
Educational description of cash-flow categories; example values are not used.
A hardware order can create a service burden before repeat revenueCompany and financial analysis
The commercial test is whether the next installation becomes easier to deliver and support.
Sources reviewed 20 Oct 2026.
Rigetti announced a dedicated Systems Delivery organization in August 2026, separating delivery responsibilities from its focused processor-development organization. The change gives an identifiable operational subject to follow. Its effectiveness must be measured through later customer outcomes rather than assumed from the organizational announcement. [1]
A quantum hardware sale can involve more than shipping a box. The customer may need site preparation, installation, calibration, training and continued support. The exact scope depends on the product and contract. For business analysis, that creates a useful distinction between an accepted first installation and a repeatable delivery process. A company can demonstrate demand while still learning how to serve it economically.
The first installation often reveals information that is invisible in a product brochure. A customer’s environment, controls or operating procedures may differ from the supplier’s test setup. The important question is whether the resulting engineering work becomes a reusable improvement or remains custom effort for that site. A useful reporting record should preserve the configuration and the changes required to reach acceptance.
The next installation provides a stronger test. If documentation, software and packaging improve, the supplier may reduce commissioning effort while maintaining the same acceptance standard. If the standard becomes weaker, a shorter installation time would not establish progress. This is why quality and effort should be reported together. The comparison should include both supplier and customer work, rather than counting only the hours that happen to be visible to one party.
Support after acceptance matters as well. A system that requires frequent expert intervention can be useful for research but expensive to operate. The business profile should ask how much routine work a trained customer can perform, how quickly failures are diagnosed and whether software updates preserve reproducibility. These questions can be investigated without requesting confidential margins or inventing a cost model. They concern observable operating practice.
The financial interpretation should follow the evidence. An order may indicate demand, an accepted system may support recognition under the relevant contract, and a renewed service arrangement may indicate continued use. Those events should not be collapsed into one adoption count. Where disclosure is limited, report the stage that is established and identify the next stage that would strengthen the commercial case.
A useful visual would group installations into dated cohorts, with rows for shipment, commissioning, acceptance and sustained operation. Add the tested configuration and any disclosed support burden. The goal is to see whether delivery becomes more repeatable as experience accumulates. A rising number of orders is important, but a falling amount of exceptional work per accepted installation would answer a different and highly practical question.
This is how an organizational change becomes a business story worth revisiting. The next update should show whether responsibilities translated into shorter, more reliable delivery at an unchanged standard. If that evidence is absent, the reorganization remains a plan for execution. If it appears, readers gain a concrete reason to view commercialization as progress in an operating process, rather than a sequence of announcements.
Original sources and scope
- Rigetti creates systems delivery organization ↗Source dated 19 Aug 2026
Reorganization effective Aug18; deployment scale and fidelity target are forward-looking.
An optional project phase is not a repeat customerCompany and financial analysis
An initial pilot becomes stronger commercial evidence when a customer chooses the next step.
Sources reviewed 20 Oct 2026.
QCi and INmune Bio’s October 2026 announcement describes an initial commercial research engagement with options for further work. It also says the project will compare quantum optimization with conventional approaches. The agreement establishes an early commercial relationship; the optional work and the comparative outcome remain to be demonstrated. [1]
The useful business question is what decision the first phase is designed to unlock. A pilot can test feasibility, establish an integration path, explore a dataset or compare methods. These are different objectives, and a report should identify the actual one. Without a defined next decision, a successful demonstration can be hard to distinguish from an interesting experiment that never changes the customer’s behavior.
An option for additional work is valuable because it can reduce friction if the first phase succeeds. It should still remain separate from work that has already been commissioned. The reporting record needs the contracted scope, any disclosed payment terms, the acceptance criteria and the event that would trigger another phase. A broad collaboration announcement should not become a multiyear revenue forecast simply because it mentions future possibilities.
The technical comparison is part of that commercial evidence. If the project claims value from a quantum stage, the evaluation should isolate that stage under a fair resource budget. Classical preprocessing, data cleaning and model selection can influence the result. A customer may find the overall project useful even if the quantum contribution is small or uncertain. The article should be able to report that outcome without forcing the result into an all-or-nothing narrative.
The domain endpoint must also be kept distinct from the computing endpoint. In a research project involving biomedical data, a better computational ranking or a newly identified pattern is not itself a demonstrated patient benefit. The commercial story can focus on whether the work helped the customer prioritize further research, while any later scientific or clinical claim requires evidence appropriate to that claim. This protects the meaning of both kinds of result.
The strongest follow-up is an observable customer choice. Did the customer accept the deliverable, request another phase, expand the dataset or adopt the workflow in regular work? A renewal can indicate perceived value, but the reason should be established rather than guessed. Where terms are confidential, the story can still report the decision and its scope without inventing contract amounts or assuming recurring revenue.
A clear project card can show the initial commercial stage, the optional stages and the evidence required to move between them. Beside that timeline, show the evaluation question and baseline. This helps readers understand why an early contract matters while keeping the uncertainty visible. It also creates a useful reporting obligation: return when the first phase finishes, not only when a new partnership is announced.
The commercial signal grows when the relationship produces a repeatable decision process. A successful pilot should make the next purchase easier to explain, because the customer knows what the tool does, what it costs to use and where it is limited. Until that happens, the initial engagement is a meaningful starting point. It deserves accurate coverage at that stage rather than an advance promotion to a mature customer business.
Original sources and scope
- QCi and INmune Bio research collaboration ↗Source dated 14 Oct 2026
Commercial first-stage engagement with options. Comparative analysis is planned; no clinical efficacy, approval or quantum advantage demonstrated here.
Private funding totals need a family treeCompany and financial analysis
A first close, final total and second currency can describe the same financing.
Sources reviewed 20 Oct 2026.
Photonic’s May 2026 release reports a final financing total in both U.S. and Canadian dollars and includes an earlier first close. These are not three independent pools of capital. The closing history and the currency presentation must remain attached to the amount before it enters a sector funding comparison. [1]
A financing announcement can describe a new round, an extension, an additional close, a cumulative total or a conversion of an earlier instrument. The words around the amount tell the analyst which relationship applies. A database that extracts only the company name and currency figure can lose that relationship and create growth that exists only in the spreadsheet.
The solution is a financing family tree. Give the round an identity, then attach each closing event to it. Mark an amount as incremental, cumulative or a restatement of another amount. Preserve the document date and the currency in which the source reports it. If the release supplies an equivalent in another currency, record that as an alternate representation unless the source explicitly identifies separate financing.
A hypothetical example shows the logic without assigning invented figures to a real company. A startup announces a first close in its home currency, later announces a final total in two currencies and then describes its lifetime funding in a company profile. Adding every figure would count parts of the same capital repeatedly. A clean record instead shows the first close nested inside the final round, and that round nested inside the lifetime total.
Exchange rates create a separate comparability choice. An analyst may want original-currency figures, transaction-date conversions or a common-date comparison. Each can serve a purpose, but they should not be mixed silently. A change in the displayed converted value can occur even when the underlying financing did not change. The methodology should make that effect visible rather than calling it an additional raise.
Instrument type matters too. A reported financing can include equity, debt or other arrangements, while a broader announcement may combine private capital with public support. Those mechanisms can carry different obligations and conditions. The record should preserve what the primary source actually establishes and leave the undisclosed portion unresolved. A precise allocation inferred from a vague headline is less trustworthy than a clearly labelled mixed total.
The family-tree approach also improves editorial judgment. A final close can be newsworthy because it completes a financing process, even if the incremental addition is smaller than the final total. The headline can explain that event directly. A later cumulative-funding reference may provide context without constituting another fundraising story. Readers gain a more accurate picture of both the company’s resources and the pace of financing activity across the sector.
A funding chart should therefore be the last step, built from reconciled events. Before plotting a bar, the editor should be able to answer which transaction it represents, what has already been counted and why its currency basis matches the other bars. The result may produce a smaller total than an indiscriminate aggregation, but it will describe capital that can actually be traced to the underlying announcements. That is the foundation for any useful comparison.
Original sources and scope
- Photonic Inc closes investment round above US$200m/C$275m ↗Source dated 12 May 2026
The final round total includes the January first close; the two figures are not additive.
Quantum supplier revenue cannot simply be added to customer revenueCompany and financial analysis
A supply-chain map and an end-market estimate answer different economic questions.
Sources reviewed 20 Oct 2026.
Monarch Quantum and Qunnect’s partnership describes photonic productization work for quantum-networking hardware. It is an example of one quantum-related business supplying capabilities used by another. Such relationships matter when building an industry map, but they also complicate any attempt to add company revenues into a single market-size number. [1]
The issue is easiest to see with a hypothetical chain. A component supplier sells an optical module to a system builder, which sells a finished installation to an end user. Both companies can record legitimate business activity under their own reporting rules. Adding both sales can measure transactions along the chain. It does not automatically measure what end users spent on the finished product, because part of that value has moved through more than one company.
Neither view is inherently useless. A supplier-revenue view can help understand manufacturing activity and where firms earn money. An end-demand view can help describe customer spending on completed systems or services. The error is presenting one as the other without defining the boundary. A quantum market estimate needs to state what it counts before the resulting number can be interpreted.
The category boundary creates another challenge. A cryogenic, optical or semiconductor supplier may serve quantum programs alongside other markets. Its entire revenue cannot be assigned to quantum merely because it appears in a quantum directory. Where the company discloses an attributable segment or product amount, the analyst can use it with the definition attached. Where it does not, the exposure should remain qualitative rather than fabricated as a percentage.
Acquisitions can change the accounting boundary while leaving the physical chain similar. A previously external supplier may become part of the same consolidated group as its customer. An industry series that ignores that change can appear to shrink or grow because of ownership and consolidation effects rather than a real change in demand. The company map therefore needs dated parent relationships as well as product roles.
A useful research design starts with the question. If the goal is to map businesses, include relevant suppliers and explain their roles. If the goal is to estimate customer spending, trace the final purchasing relationship and avoid counting the same intermediate value again. If the goal is to understand value creation, examine the economics of individual stages where disclosure permits. These projects may share sources, but they should not share an unlabeled total.
The clearest visual is a short transaction chain with a counting boundary drawn around the chosen measure. Mark component sales, system sales and recurring services as different flows. Real amounts should appear only when the sources identify them and their periods. Unknown flows can remain visible as missing data; they do not need invented values to make the structure understandable.
This approach gives enabling companies the attention they deserve without using them to inflate a market headline. A small supplier can be strategically important even when its revenue is undisclosed. A large diversified company can be relevant without becoming a quantum pure-play. The strength of the analysis comes from identifying what each business contributes, who ultimately pays and which part of the economic chain the numbers actually describe.
Original sources and scope
- Monarch Quantum and Qunnect productization partnership ↗Source dated 10 Aug 2026
Header Aug9/dateline Aug10. Partnership to develop miniature hardware; not proof all proposed field applications are delivered.
The quantum pilot’s missing invoiceCompany and financial analysis
A better result becomes a business case only after the complete workflow is counted.
Sources reviewed 21 Oct 2026.
ORCA’s October 15 PT-3 launch puts a concrete claim on the table: a hybrid extension of NVIDIA’s Proteína model improved the ratio of useful protein designs by 20% against the company’s classical baseline. The reported training combined PT-3 with 32 NVIDIA Hopper GPUs. This is a result about generated candidates; the launch does not establish a 20% increase in successful medicines. [1]
The underlying Proteína research describes a classical model that generates protein backbones and evaluates qualities including designability, diversity and novelty. Those are useful computational endpoints. They remain distinct from a laboratory test of a particular biological function and from the later evidence required for a treatment. The baseline paper is context for reading ORCA’s claim, not independent confirmation of the hybrid result. [2]
The launch also reports a separate energy-scheduling result: a 25,755-variable problem completed in about an hour, more than twelve times faster than ORCA’s preceding PT-2 at the same solution quality. That multiplier compares generations of ORCA hardware, not PT-3 against the best classical solver. The company separately describes solution quality as competitive with a commercial optimisation solver. [1]
A customer needs to know which improvement changes the actual decision. Better candidates could justify extra computing expense if they reduce costly downstream failures. Faster sampling could be less useful if preparation and verification still dominate. These are possible business cases, not outcomes established by the launch. The comparison should begin with a fixed quality target and a complete workflow.
The first practical request is a reproducible comparison: the exact model and classical baseline, tuning effort, training and sampling budgets, number of candidates and uncertainty around the result. A claim about a ratio also needs its starting value. A relative improvement of 20% is different from twenty percentage points, and neither tells the reader how many candidates survived a laboratory test.
Next comes the invoice. Include GPU work, quantum-machine access, data preparation, specialist time and output validation. Separate one-time integration from recurring costs. The relevant measure is what a customer spends to reach an acceptable decision, including unsuccessful attempts. A fast component can improve a slow workflow, but its speed alone does not price the finished service.
The strongest follow-up would let another team repeat the same comparison and explain what changed when the task or dataset changed. Until then, the useful development is a deployed hybrid system with company-reported application results. The next evidence should connect those results to repeatable quality, full cost and an outcome a user actually needs.
Original sources and scope
- ORCA Computing launches PT-3 ↗Source dated 15 Oct 2026
The company announcement is dated October 15, 2026. Commercial-advantage language is attributed to the company and depends on its chosen baseline.
- Proteína: Scaling Flow-based Protein Structure Generative Models ↗
ICLR 2025 work on the underlying classical protein-backbone generator. This does not independently validate ORCA’s PT-3 benchmark. Presented at ICLR 2025; exact first-publication day is not asserted here.
A quantum watchlist needs more than a “last updated” dateCompany and financial analysis
Event time, reporting time and verification time should travel with every important claim.
Sources reviewed 20 Oct 2026.
Xanadu and Bluefors announced a prototype-development collaboration in September 2026. That is a dated statement about a project stage. Reading the announcement again in October does not establish that the prototype has since been delivered, nor does it make the September event new breaking news. [1]
A single last-updated label can conceal several clocks. The event may happen on one day, the announcement may appear later, and a financial statement may report its effects over a different period. The researcher’s retrieval date is another clock entirely. It records when the source was checked, not when the underlying business changed. A useful watchlist preserves these distinctions rather than compressing them into one timestamp.
This matters when a page changes without a clear history. A company homepage may show current branding beside an old announcement. A newsroom feed may reorder items, and a document may be amended. The analyst should identify which part of the page supports the claim and whether it is a stable dated release, a current product description or a mutable summary. The evidence label should match the kind of source actually available.
Financial figures have an additional period boundary. Cash belongs to a stated date; revenue covers a stated interval; guidance describes expectations for a future or incomplete period. Placing them in one card is useful only if those labels remain visible. A recent publication date does not make an earlier balance-sheet value current. Nor should a forecast move into the historical-results column when the calendar reaches its target date without a confirming report.
Project status needs an explicit transition rule. An announced partnership can remain an announced partnership until a source establishes a prototype, delivery or accepted deployment. The absence of a later public update does not prove failure, but it also does not prove completion. A watch card should identify the next evidence that would change the status and leave the unresolved step visible.
Different companies disclose on different rhythms. A listed issuer may provide recurring statements, while a private supplier may publish only selected milestones. The comparison should acknowledge that uneven visibility. It should not interpret a quiet period as a quantitative decline or fill a private company’s missing cash figure with a recent funding total. The right response is a dated disclosure gap and a narrower conclusion.
A practical card can carry four compact fields: event date, source publication date, reporting period if relevant and last verification date. A separate status field says what the evidence establishes. The reader does not need to inspect a database schema to benefit from this; a simple sentence such as “announced in September; delivery not yet verified” can communicate the distinction naturally.
The result is a watchlist that can age honestly. Old facts remain useful as history, pending milestones remain pending and genuinely new evidence changes the relevant field. That makes updates more substantive than repeatedly refreshing a page’s date. Readers can see both what is known and how recently its current status has been checked, which is essential when following an industry whose scientific, commercial and financial timelines move at different speeds.
Related QubitWire coverage and context →
Original sources and scope
- Xanadu and Bluefors modular cryogenic partnership ↗Source dated 29 Sept 2026
Prototype development plans, not a delivered deployment.
Why D-Wave’s bookings and revenue can move in different directionsCompany and financial analysis
A half-year order measure, recognized revenue and a quarter-end obligation balance answer three different questions.
Sources reviewed 20 Oct 2026.
D-Wave reported first-half 2026 revenue of $5.9 million, bookings of $35.5 million and June 30 remaining performance obligations of $40.7 million. Its release defines bookings and remaining obligations separately; the bookings scope also includes some Quantum Circuits business booked immediately before acquisition. These figures describe different boundaries and cannot be substituted for one another. [1]
The most useful way to read that combination is to follow a hypothetical system order through time. A customer can sign before the system is ready to deliver. Work can then proceed through manufacturing, installation and acceptance. Depending on the contract and accounting policy, revenue may be recognized at one stage or across several. Payment can follow yet another schedule. A strong order period can therefore create work to perform before it creates an equally strong revenue period.
That is an explanation of the possible timing mechanism, not a claim that every D-Wave order follows the same schedule.
A bookings measure needs its definition close to the number. Does it include a new signed purchase, an amendment or an acquired order? Can an item later be cancelled? Is it stated gross, or after reductions? A reader cannot settle those questions by assuming that another quantum company uses the word in the same way. The measure is most useful as a description of activity inside its stated rules.
It becomes less useful when lifted out of those rules and treated as cash already available to spend.
Remaining performance obligations provide a different view: work still associated with revenue obligations under the company’s accounting disclosures. They are a balance at a date rather than simply a sum of orders announced during the latest period. The starting balance, newly qualifying contracts, work recognized as revenue and scope changes can all matter when explaining movement. A forecast about when obligations might become revenue belongs beside that balance with its forecast status visible. It should not be drawn as a guaranteed future sales line.
Acquisitions make this reading more demanding. If the business boundary changes, the newest order figure can contain activity that was outside the prior comparison. That does not invalidate the measure, but it changes the question. One comparison asks how the combined organization is developing. Another asks how the earlier business performed on a consistent basis. A useful chart states which question it answers and identifies any acquired activity that cannot be separated.
Leaving that limitation visible is more informative than presenting a precise growth percentage with an ambiguous scope.
For a practical reading sheet, keep three panels: period revenue, period bookings and dated remaining obligations. Attach the definition and business scope to each. Under the panels, add the evidence that can explain movement: accepted deliveries, new commitments, amendments, cancellations if disclosed and acquisition effects. Avoid drawing a direct conversion arrow with an assumed rate. The reader’s next question is concrete: what newly completed work or changed contract status explains the next reported movement?
That question connects commercial demand to delivery without pretending that demand, accounting recognition and cash collection are one event.
Related QubitWire coverage and context →
Original sources and scope
- D-Wave reports second quarter 2026 results ↗Source dated 6 Aug 2026
H1 revenue, bookings and June 30 RPO have different measurement boundaries; confirms Nasdaq QBTS after transfer.
Why Quantinuum can report two very different gross marginsCompany and financial analysis
The reconciliation explains what the adjusted measure removes and what a reader still needs to assess.
Sources reviewed 20 Oct 2026.
Quantinuum’s second-quarter 2026 release reports a GAAP gross margin of negative 64.4% and an adjusted gross margin of 61.7% (rounded to 62% in the headline). Its adjusted gross-profit definition removes equity compensation and related employer taxes attributable to cost of revenue, plus depreciation and amortization attributable to cost of revenue. The two percentages therefore answer differently defined cost questions. [1]
A gross-margin percentage is compact enough to travel without its explanation. That is its attraction and its weakness. Revenue is the denominator, while the chosen cost boundary determines the numerator. Change that boundary and the percentage can change dramatically even though the underlying customer activity has not been rewritten. A comparison between two percentages needs to start with the bridge between them. Calling one number optimistic and the other pessimistic skips the accounting work that makes either number intelligible.
The first question is what the adjustment is intended to isolate. Removing an expense can help a reader inspect a particular operating relationship, but it does not make the removed item irrelevant. Equity compensation is relevant to ownership economics. Depreciation and amortization can help describe the use of assets and acquired rights across periods. Their timing need not equal this quarter’s cash payments, yet a business that relies on equipment and skilled people still needs a way to sustain those resources.
A useful reading keeps the adjusted view alongside those wider obligations.
The second question is whether the comparison is consistent over time. If the definition changes, a line chart may join unlike quantities. Even with a stable definition, a young hardware business can have a revenue mix that changes between system transactions, access and other contracted work. A reader should investigate that mix using the filing rather than assume a single stable unit margin. A small number of differently structured contracts can make a quarterly ratio sensitive to timing.
That is a reason to inspect the underlying period, not a reason to discard the reported result.
The third question concerns peers. A similarly named adjusted margin is not automatically calculated in the same way. Before placing companies in a league table, compare the excluded items, revenue categories and period boundaries. If the definitions cannot be reconciled, display them in separate labelled columns. A blank comparable value is preferable to silently forcing unlike measures into a common ranking. Technical maturity should remain a separate comparison again: a financial cost ratio cannot establish logical-qubit performance or an application advantage.
A clear visual would begin with GAAP gross profit, show each disclosed adjustment once, and arrive at adjusted gross profit before dividing by the same revenue denominator. Beneath it, a second panel would track operating cash and asset investment on their own terms. The panels should not be added together; their purpose is to reveal different aspects of the business. For the next update, the key evidence is whether the reconciliation remains consistent, what drove the underlying revenue mix and which resource costs recur.
Readers then gain an explanation they can test against the next filing, rather than a single margin selected because it looks more favorable.
Original sources and scope
- Quantinuum reports second quarter 2026 results — SEC exhibit ↗Source dated 11 Aug 2026
Q2 margins use different GAAP and adjusted cost definitions. The reconciliation and Up-C economic-interest denominator govern the comparison; no market valuation is supplied.
Rigetti’s warrant gain did not pay the operating billsCompany and financial analysis
A filing can show a narrower accounting loss while the cash-flow statement describes a different funding requirement.
Sources reviewed 20 Oct 2026.
For the six months ended June 30, 2026, Rigetti’s Form 10-Q reports about $19.5 million of net loss and $32.0 million of cash used in operating activities. The filing also reports a $24.1 million gain from changes in warrant-liability fair value for that six-month period. The fair-value gain is not a cash receipt from customers or a warrant exercise. [1]
These figures become easier to read when the income statement and cash-flow statement are treated as connected records with different purposes. Net loss includes expenses and gains under the applicable accounting treatment. Operating cash flow starts with that result and explains adjustments and working-capital movements. A noncash gain can improve the first figure without supplying money for the second. The cash-flow reconciliation is where a reader can see that distinction instead of guessing it from the direction of the headline loss.
Consider an explicitly hypothetical obligation whose accounting value moves with assumptions about a company’s share price. A change in that valuation can alter reported profit or loss even when no customer buys anything and no investor transfers cash. If the obligation is later exercised or settled, that is a different event with its own accounting and cash consequences. Treating the earlier valuation gain as fresh financing would combine two events that may never occur together.
The same discipline applies when a valuation movement makes the reported loss larger: the movement alone does not measure this period’s payments to suppliers.
For a hardware business, operating cash is still only part of the resource picture. Equipment purchases can sit in a different cash-flow category from salaries and ordinary operating payments. Acquisitions, securities transactions and new financing also need their own labels. A useful analysis therefore traces the complete cash movement before discussing a spending rate. Dividing a dated cash balance by one quarter’s accounting loss can produce a neat-looking runway number that ignores noncash adjustments, investment needs and changes in working capital.
It is a model with hidden assumptions, not a disclosed operating horizon.
Delivery adds another layer to the reader’s questions. A system can require engineering, inventory, installation and support before its economic outcome is fully visible. These are questions to investigate in customer and financial disclosures; the warrant gain does not answer them. The relevant evidence would identify accepted systems, payment conditions and the effort required to support another installation. It would also show which costs were exceptional and which are likely to accompany ordinary activity, without assuming that all expenditure remains constant.
The clearest presentation keeps the reporting period fixed and builds a bridge from net loss to operating cash used, retaining the filing’s signs and classifications. Beside it, show investment and financing cash separately. A short note should explain that a noncash gain has no automatic customer-demand meaning. The next filing can then be read against the same structure: did operating cash use change, why did working capital move, and what delivery evidence accompanied it?
This approach makes the business question more precise while avoiding both an inflated interpretation of an accounting gain and a mechanical forecast built from a single period.
Original sources and scope
- Rigetti Form 10-Q for quarter ended June 30, 2026 ↗Source dated 6 Aug 2026
The six-month cash-flow and warrant-fair-value amounts describe the same reporting interval. A noncash warrant gain is not financing cash.
A ten-year quantum supply agreement can have no minimum purchaseCompany and financial analysis
Quantinuum’s filing shows why contract duration, prepayments and purchase obligations need separate fields.
Sources reviewed 20 Oct 2026.
Quantinuum’s June 30, 2026 Form 10-Q describes a ten-year supply agreement with Honeywell Aerospace for ion-trap fabrication, with renewal provisions and no minimum purchase requirement. The filing also reports a supplier prepayment of approximately $14.1 million at quarter-end. A long agreement, an advance payment and a minimum purchase commitment are distinct economic facts. [1]
A long duration can establish a framework for repeated work without specifying how much will actually be ordered. For a technically demanding component, continuity can matter: specifications, process knowledge and qualification effort need a stable home. But the existence of that framework does not let an outside reader multiply an assumed annual order by the contract term and call the result secured supply-chain revenue. The purchase mechanism, capacity arrangements and acceptance obligations have to be read on their own terms.
The absence of a minimum purchase does not mean that the relationship has no economic significance. It means a particular shortcut is unavailable. A reader cannot infer a contractual volume floor from duration alone. The relevant questions move to the operating details: what work has already been authorized, how are later orders placed, which prices or cost rules apply, and what happens if specifications change? Some answers may remain confidential. Those gaps should remain explicit instead of being filled with a manufactured total contract value.
A prepayment introduces another dimension. Cash may leave a buyer before the associated benefit has been fully received, so the balance needs to be traced through later delivery or accounting treatment. The fact of a prepayment does not, by itself, reveal whether it secures capacity, funds work or covers particular units; the agreement and disclosures determine that. A careful chart preserves both the payment date and the stage of the associated work.
It should not label the whole amount as current-period product expense merely because cash moved.
There is also a practical distinction between access to a supplier and a qualified supply path. A fabrication relationship becomes more informative when it is paired with evidence about accepted devices, reproducibility, process changes and contingency planning. Those are proposed follow-up questions, not deficiencies proven by the existence of this contract. The useful commercial test is whether the arrangement reliably supports the buyer’s required work at a cost and schedule the business can sustain. A term-length headline cannot resolve that test.
For readers following quantum industrialization, the most useful contract card has separate rows for duration, renewal, pricing mechanism, minimum commitment, amounts prepaid and acceptance evidence. Each row should carry its source and date so later amendments can be compared precisely. Where the filing gives no public quantity, the value remains undisclosed. Later updates can then report a concrete change: an additional authorized order, a delivery against the advance, a qualification result or an amended term.
That makes the agreement easier to understand than a single “strategic partnership” label. It also prevents the same relationship from being counted once as a large guaranteed order and again as a separate financing event when the evidence supports neither interpretation.
Original sources and scope
- Quantinuum Form 10-Q for quarter ended June 30, 2026 ↗Source dated 13 Aug 2026
Supply agreement, lack of minimum purchase, supplier prepayment and related-party history belong to distinct fields.
IonQ’s next revenue comparison needs a business-scope checkCompany and financial analysis
A completed acquisition can change what is inside the reported company before it changes the meaning of “quantum revenue.”
Sources reviewed 20 Oct 2026.
IonQ’s second-quarter 2026 results release says that SkyWater closed on July 31, after the June 30 quarter-end, and that the release’s results and outlook exclude the addition. That creates a clear historical reporting boundary. It does not provide a ready-made combined-company revenue series for later periods. [1]
An acquisition creates at least two useful comparison questions. How is the combined organization performing now? And how did the earlier organization perform on a consistent basis? Both can matter, but a single growth rate may answer only one. If a newly acquired business enters the accounts during a later period, a reader needs its inclusion date and the reporting treatment before interpreting a change in total revenue. The operating boundary can move even when the period labels on a chart look identical.
This is especially relevant to a quantum-industry publication because business activity and end-use attribution are different layers. A company can own a manufacturing operation that serves several kinds of customers. Ownership by a quantum company does not make every transaction a quantum-computing sale. A defensible industry chart needs a definition of quantum-attributable activity and a source that supports the allocation. Where no allocation is disclosed, the chart should label the total as consolidated company revenue and leave the narrower quantum figure unestimated.
Acquisitions can also change how transactions appear. A sale between independent businesses can become an internal transaction after common ownership. The treatment depends on the actual group structure and accounting, so the analyst should consult the later filing. The general point is that adding the old standalone revenue totals may not reproduce the combined result. It can ignore the period of ownership, internal eliminations or other required adjustments.
A transparent comparison states whether it uses reported figures, disclosed pro forma figures or an explicitly hypothetical illustration.
The next useful evidence is therefore more specific than a higher or lower headline. It includes the acquired contribution where disclosed, the date consolidation begins, the comparative basis and any explanation of changes in the mix of business. A separate capital-allocation record can then track purchase consideration and integration obligations. These are connected business questions, but they should not be collapsed into one measure of technical progress. Acquiring a fabrication capability does not itself establish the performance of a quantum processor built using it.
A reader-facing visual can make the boundary clear with shaded business blocks rather than a speculative forecast. Show the earlier reporting scope through June 30, then mark the acquisition date as a change requiring later evidence. When the next filing is available, add only the disclosed contribution and comparable information. Keep the ordinary reported series intact, and place any like-for-like analysis beside it with its adjustments explained.
The resulting chart answers a practical question: how much of the visible change reflects the existing business, acquired activity or a change in classification? If public information cannot separate those effects, that limitation belongs in the caption. It is part of an accurate explanation of the business, not a reason to invent a precise attribution.
The acquisition boundary does not mean SkyWater had no effect on IonQ’s quarterly costs. IonQ disclosed $24.7 million of commercial SkyWater research and development costs already included in second-quarter adjusted EBITDA before the acquisition closed. The acquired business’s consolidation scope and the release’s separate pro forma cash presentation should therefore be read independently. [1]
Original sources and scope
- IonQ reports second quarter 2026 results ↗Source dated 5 Aug 2026
SkyWater closed July 31, after quarter-end. The release separates the acquired business from its reported results and outlook, while Q2 adjusted EBITDA already includes $24.7 million of pre-close commercial SkyWater R&D. Later consolidation values are not supplied here.
What did DARPA provisionally approve for Xanadu?Company and financial analysis
The October 19 release is concrete evidence of program support, with several later milestones still separate.
Sources reviewed 20 Oct 2026.
Xanadu’s October 19, 2026 SEC-filed release reports provisional approval for up to US$10 million and a one-year DARPA QBI extension, building on Stage B. Approval, completed research and receipts remain distinct. [1]
The first important word is provisional. It describes the state of approval in the announcement and should remain attached when the story is shortened for a headline, card or video. Removing it changes the claim. The second important phrase is up to, which identifies a ceiling. Together they tell readers that the next evidence to seek concerns final execution and the conditions governing support. Those questions can be tracked precisely without assuming that every detail of the agreement is already public.
Program support and technical validation also belong on separate timelines. A research extension can create room to investigate a difficult component or architecture. The outcome of that work remains an evidence question. Progress reports can document what has been attempted, what was measured and which uncertainties remain. A completed technical evaluation would require its own result and scope.
The announcement should therefore be understood through the status it actually reports, without silently promoting the company to a different evaluation stage or treating a future system as complete.
There is a similar separation in the financial record. An approved ceiling, an executed agreement, eligible work, a payment and accounting recognition are different milestones. Their order and timing depend on the actual terms and accounting treatment. The public release does not authorize an outside writer to choose those details. A useful Investing card keeps separate fields for the maximum support and any later disclosed receipts, with a reporting period attached to recognized amounts if they become available.
The blank fields identify what the next financial update would resolve.
For readers interested in the engineering, the useful follow-up question is what evidence the supported work produces. A component result should name its configuration, measurement boundary and limitations. A system claim should explain how components fit together and what was tested jointly. A roadmap can help organize these questions, but its future boxes should remain visually distinct from completed work.
This approach gives the announcement practical value: it points to a sequence of observable technical and contractual developments rather than reducing the story to a large number.
An effective explainer graphic would use two parallel timelines. One follows support status from provisional approval to later documented agreement, work and receipts. The other follows technical evidence from the current research question to measured results and any later evaluation. Only the October 19 state is filled in as established by this release; future nodes remain labelled as evidence to follow. A subsequent article can then identify which node actually changed and cite the new document.
That preserves the significance of the October 19 announcement while giving readers a disciplined way to judge what comes next. It also keeps the company’s funding history, commercial results and computing claims readable on their own terms. A conditional step can be meaningful because it identifies the next question; preserving its conditions makes later changes easier to recognize.
Original sources and scope
- Xanadu provisionally approved for additional DARPA QBI support — SEC exhibit ↗Source dated 19 Oct 2026
Provisional approval, up to US $10 million, one-year extension; not evidence of cash receipt, revenue or completed technical validation.
A strategic investor is not automatically a customerCompany and financial analysis
Qilimanjaro’s first close offers a useful way to separate ownership, industrial plans and procurement evidence.
Sources reviewed 20 Oct 2026.
Qilimanjaro’s October 14, 2026 first close totaled €19.6 million, including €10 million from Indra Group and €9.6 million from SETT, according to the company and SETT. The company describes a later final close as expected. These releases establish investment participation; they do not turn that participation into an independently evidenced system purchase. [1] [2]
A strategic investor can have reasons to care about a supplier’s technology beyond a purely financial return. The relationship may help organize industrial development, product integration or future routes to market. Those possibilities are useful questions for reporting, but they remain possibilities until the parties disclose the relevant actions. A purchase of ownership and a purchase of a product create different records. Treating the first as proof of the second can make early commercial demand look more mature than the evidence shows.
The distinction becomes concrete at the customer’s acceptance decision. A product order needs a scope, a delivery obligation and some basis for determining whether the work is satisfactory. An equity investment instead establishes a capital relationship under its own terms. The same organization could eventually occupy both roles, but each transaction would need its own documentation and date. A directory should therefore be able to show an investor link without automatically adding a customer logo or including the amount in sales.
Industrial plans need a similar evidence trail. Capital can support manufacturing equipment, process development, integration staff or service capacity. Each use has a different path to a measurable outcome. The practical question is what later result would demonstrate that the funded work changed the product or delivery process. A qualified component, an accepted installation or a shorter repeatable integration procedure could be meaningful evidence if documented.
The financing headline alone does not identify which of those outcomes occurred or how much of the capital remains available.
The first-close structure adds a second bookkeeping task. Keep the completed amount as one dated stage, with any expected final close clearly prospective. If a later announcement supplies a larger total, determine whether it includes the first close or describes incremental capital. Preserve the original currency and instrument details when available. This avoids counting the same financing twice while also preventing a planned round extension from being presented as already completed.
The investment history becomes easier to update because each new document changes a defined field.
For a reader following Qilimanjaro, a useful relationship map would have separate links for ownership, development work and customer procurement. The investment links can be filled from the cited releases. Other links should appear only when a contract or direct participant disclosure supports them. Below the map, show the technical milestones that could connect resources to delivery, each with its own acceptance evidence.
The next substantive update would then answer one of three clear questions: did more capital close, did a development milestone pass, or did a customer accept new work? Those questions are closely related, but their separation makes the commercial story more useful and protects the directory from treating every partnership announcement as the same kind of progress.
Related QubitWire coverage and context →
Original sources and scope
- Qilimanjaro announces €19.6 million Series A first close ↗Source dated 14 Oct 2026
The company reports a completed €19.6 million first close. A later close remains expected.
- SETT invests €9.6 million in Qilimanjaro Quantum Tech ↗Source dated 14 Oct 2026
Confirms first-close investor allocation; investment is not a procurement contract.
Company developments
What changed, and what to follow
Como: capacity access is not a new sale at every milestone
The October 15 arrival announcement links the Como deployment to an earlier €10 million SQT agreement covering 50% of capacity for five years, with an option to buy the full system. Track installation, access and financial reporting separately. Arrival does not establish how much revenue belongs in a particular quarter.
Follow the evidence: Which contract disclosure or filing connects the operating milestone to revenue or cash?
Anderon: follow the route from licensed design access to fabrication
Anderon’s first PDK offers licensed access to a documented manufacturing interface. It creates a new checkpoint to follow: external designs reaching fabrication and measured validation. The announcement gives no customer-adoption or revenue total. IBM identifies Anderon as an IBM company, so this development belongs within IBM’s research context rather than a separate listed-security row.
Follow the evidence: What evidence connects design-kit access to a paid and accepted customer outcome?
Google: a resource-state result needs a separate commercial bridge
Google’s October 15 magic-state announcement concerns an experimental resource for future error-corrected computation. It reports no sales or revenue figure. Accepted-state quality, production rate and delivery into an application are technical questions; a commercial service, customer adoption and financial contribution require separate evidence. Do not treat a processor error-reduction factor as a revenue-growth rate.
Follow the evidence: Is the next source a technical measurement, a customer service announcement or a financial disclosure?
Follow the business question
Quantum exposure takes different forms
Five notes connect security, atomic timing and field sensing to their business context. Announcement, availability, customer adoption and revenue are separate steps. Missing information remains unknown.
Research checked . Market prices retain their own provider timestamps. These notes are research information, not investment recommendations.
CloudflareDiversified cloud and security · post-quantum migration
Existing listed-issuer research context
Cloudflare’s quantum relevance here is protecting classical networks. The origin-authentication update adds a security capability inside a broad service business; it does not establish a separate quantum revenue stream.
Research question: Which customers enable the capability, how does it fit their service, and what commercial evidence is actually disclosed?
Cloudflare added ML-DSA support to Custom Origin Trust Store and the per-zone and per-hostname configurations of Authenticated Origin Pulls for Cloudflare-to-origin authentication.
Conditions: Custom Origin Trust Store requires Advanced Certificate Manager. Customers must configure compatible origin systems; global Authenticated Origin Pulls support was deferred in the announcement.
What remains unestablished: Support does not establish that every customer or visitor connection uses post-quantum authentication. The 2029 suite-wide objective remains a roadmap target.
What to follow: Follow documented enablement, deployment scope and disclosed customer use. Keep key exchange, authentication and adoption separate.
The technical release and earlier roadmap are provider-authored. A target date is not a delivered capability.
- Cloudflare: post-quantum authentication to origins ↗ · Provider engineering release · Source dated
- Cloudflare: post-quantum migration roadmap ↗ · Provider roadmap · Source dated
Issuer identity sources
- Cloudflare investor relations: issuer identity ↗ · Issuer information
Read the related analysis → · Read the shared evidence context →
AkamaiDiversified cloud and security · text-only research
Listed issuer · no quote or trade instrument in this note
Akamai’s origin option makes a memorable research distinction: a capability can be available and still be switched off. Evaluate adoption and business disclosure separately from technical availability.
Research question: What does enabling the option require, which connections negotiate it, and is any adoption or commercial effect disclosed?
Akamai identifies end-to-end post-quantum key exchange as generally available on its Enhanced TLS network from 12 August. Its origin behaviour remains disabled by default in the documentation checked here.
Conditions: The origin server controls the negotiated key exchange. Unsupported origins can request a classical alternative; already-open persistent connections retain their existing negotiation.
What remains unestablished: Availability is not universal enablement or complete post-quantum authentication. No adoption rate or incremental revenue is established.
What to follow: Follow service scope, explicit configuration, negotiated connections and disclosed adoption. Missing adoption information is unknown, not zero.
Announcement and current documentation are one provider source family. General availability and the post publication date are separate dates.
- Akamai: end-to-end post-quantum key exchange ↗ · Provider release · Source dated · Event dated
The provider index dates the post 19 August and identifies general availability from 12 August. Direct retrieval timed out; the live product documentation was read.
- Akamai Property Manager: PQC to Origin ↗ · Product documentation
Issuer identity sources
- Akamai investor FAQ: common-stock identity ↗ · Issuer information
- Akamai issuer release: Nasdaq common-equity identity ↗ · Issuer information · Source dated
Read the related analysis → · Read the shared evidence context →
Microchip TechnologyDiversified semiconductors · atomic timing
Existing listed-issuer research context
An atomic clock and a quantum processor solve different problems. Space timing is a specialised activity inside Microchip’s broad electronics business; a physics connection alone does not establish new segment economics.
Research question: Where do the timing products fit in the disclosed business, and what evidence supports actual customer demand?
Microchip announced the Space CSAC-SA65, a radiation-tolerant chip-scale atomic clock for space timing, and identified it as available for purchase.
Conditions: The product emphasizes size, power, radiation tolerance and timing. The historical JILA optical-clock experiment measured time dilation inside an atomic sample; it is a separate system.
What remains unestablished: Do not transfer laboratory optical-clock performance to this commercial device. The announcement supplies no quantum-specific revenue, margins or market share.
What to follow: Read product specifications and demonstrated customer use beside the issuer’s broader business disclosures.
The product release and 2022 physics experiment are distinct evidence events, used here to explain the boundary between commercial timing and laboratory metrology.
- Microchip: Space CSAC-SA65 timing announcement ↗ · Issuer product announcement · Source dated
- NIST: JILA clocks measure time dilation at millimetre scale ↗ · Historical institutional research report · Source dated
ThalesDiversified issuer · text-only cryptographic research
Issuer research only · no quote or instrument association in this note
Cryptographic agility is an operating problem: changing algorithms also means managing keys, compatibility and policy. Read the product development beside Thales’s broader business, with no inferred quantum revenue share or return.
Research question: Which migrations and version-specific assessments are documented, and which business effects remain undisclosed?
Thales describes Luna 8 key protection and support for hybrid cryptography and cryptographic agility during the post-quantum transition.
Conditions: Compatibility, configuration, testing and operating procedures determine how a capability becomes a usable migration.
What remains unestablished: Product support does not establish completed customer migration, product-wide certification, a quantum processor or quantum-specific revenue.
What to follow: Follow concrete deployment evidence and version-specific assurance, with scope and dates attached.
Issuer commentary explains intended product scope. It is not an independent security assessment.
- Thales: post-quantum security and Luna 8 ↗ · Issuer product commentary
Issuer identity sources
- Thales share and shareholding: issuer and market identity ↗ · Issuer information
- Euronext: Thales common stock, ISIN FR0000121329 ↗ · Exchange identity
Q-CTRLPrivate company · non-tradable research
Private-company research · no listed share, quote or proxy instrument
A compelling sensing result is worth following even when there is no ordinary exchange-listed share to buy. Keep scientific evidence, product development and access to an investment as separate questions.
Research question: What independent evaluation, repeatable customer use and business disclosures would show the trial becoming a commercial service?
A quantum gravimeter aided inertial navigation on an 83 km maritime route. The version 1 preprint reports about one nautical mile error over the first 70 km and 2.2 nautical miles at the endpoint.
Conditions: The navigation chain excluded GNSS inputs and matched gravity measurements against a stored map. GNSS was used later to evaluate position error. A separate surveying mode used GNSS.
What remains unestablished: Company-led trial and preprint evidence does not establish independent replication, certification or reliable operation on every route. Sensor performance and navigation-system accuracy differ.
What to follow: Follow independent evaluation across routes, sea conditions, map quality and clearly matched baselines.
The company announcement and preprint describe one trial family. Surveying and navigation are distinct analyses, not independent replications.
- Q-CTRL: maritime quantum gravimetric-navigation trial ↗ · Company research announcement · Source dated
- Everitt et al.: GNSS-free gravity-aided navigation and marine surveying ↗ · Research preprint · Source dated
Read the related analysis → · Read the shared evidence context →
Follow the business question
Follow the step that actually changed
Five notes follow manufacturing, interconnects, software access, private financing and an exploratory interface agreement. Technical evidence and business outcomes have their own dates. Missing information remains unknown.
Research checked . Market prices retain their own provider timestamps. These notes are research information, not investment recommendations.
Xanadu Quantum TechnologiesManufacturing development
Existing listed instrument retained. Nasdaq and TSX listings have distinct venues and currencies; this note adds no market feed, proxy or inferred revenue.
The partnership targets detector and low-loss photonics industrialization. Process qualification and repeatable results would answer a different business question from another statement of the agreement.
Research question: What has crossed from announced process development into dated, qualified and repeatable manufacturing?
The multi-year partnership targets industrialization of superconducting nanowire single-photon detectors and ultra-low-loss silicon-nitride photonics on a 300 mm manufacturing platform in Malta, New York.
Manufacturing partnership announcement · Event datedConditions: Wafer size, detector efficiency, yield and integrated-system performance are different quantities. NIST explains detector physics and tradeoffs; it supplies no measurements of the partners’ process.
What remains unestablished: The announcement does not establish a qualified production process, measured repeatability, shipments, revenue or a finished fault-tolerant computer. Missing yield is unknown rather than zero.
What to follow: Look for dated process qualification, defined yield, repeatability or integrated-component results. An evidence ladder is a reporting taxonomy, not a probability forecast.
The issuer-distributed release is the same event already covered in the canonical manufacturing article. NIST is general technical context, not validation of the manufacturing plan.
- Xanadu / GlobalFoundries manufacturing partnership ↗ · Issuer-distributed announcement · Source dated
The original investor-relations page returned an access block. This is the issuer’s same release distributed through GlobeNewswire, not an independent source family.
- NIST: superconducting nanowire single-photon detectors ↗ · General technical explanation · Source dated
25 September is the page update date. Its detector metrics describe NIST work and must not be attributed to Xanadu.
Issuer identity sources
- Xanadu / GlobalFoundries manufacturing partnership ↗ · Issuer-distributed announcement · Source dated
The original investor-relations page returned an access block. This is the issuer’s same release distributed through GlobeNewswire, not an independent source family.
Read the related analysis → · Read the shared evidence context →
IonQComponent evidence
Existing listed instrument retained. The company’s announcement identifies NYSE: IONQ; the research note changes no ticker, quote venue or provider mapping.
The ion–diamond result is a component experiment with rate and fidelity stated together. Its relevance to an eventual distributed system does not establish product deployment or revenue.
Research question: What useful integrated operation can the connection support once waiting, other links and system costs are counted?
The version 1 preprint reports an averaged heralded Bell-pair rate of 1.03(1) kHz and state fidelity of 87.9(7)% between a trapped barium ion and a silicon-vacancy centre in diamond, including the photon-conversion loss.
Laboratory experiment / preprint · Event dated| Measure | Reported value | What it describes |
|---|---|---|
| Heralded Bell-pair rate | 1.03(1) kHz | Average successful entanglement events per unit time in the stated protocol. |
| Entangled-state fidelity | 87.9(7)% | Quality of the resulting state under the same experimental protocol. |
Heralded ion–diamond Bell-pair generation, including conversion loss; version 1 snapshot.
Conditions: Rate and state fidelity describe different parts of the same experimental protocol. A successful event is a heralded entangled pair, not an application step. Parenthesized uncertainty notation is retained from the paper.
What remains unestablished: This component-level result is not deployed distributed-application throughput, revenue evidence or a universal best-link comparison. A separate local nuclear gate fidelity is not the reported link fidelity.
What to follow: Follow versioned journal evidence and integrated operations that count memory waiting, other links and complete operation costs under matched event definitions.
The preprint and IonQ announcement describe one experimental source family. The company release is not independent reproduction.
- Hartung et al.: kilohertz entanglement in a heterogeneous quantum system (v1) ↗ · Research preprint · Source dated
- IonQ: memory-enhanced quantum interconnect ↗ · Company research announcement · Source dated
Issuer identity sources
- IonQ: memory-enhanced quantum interconnect ↗ · Company research announcement · Source dated
Read the related analysis → · Read the shared evidence context →
D-Wave QuantumSoftware and hardware milestones
Existing listed instrument retained. The October issuer release identifies NASDAQ: QBTS. Current and historical market venue records remain unchanged.
Selected beta access, physical gate measurements and delivery of a gate-model processor belong at different points on a company timeline. Beta participation alone establishes no customer revenue.
Research question: Was the update a versioned software release, an access change, a hardware measurement or an actual deployment?
D-Wave gate-model simulator beta
D-Wave announced a selected-participant beta for a gate-model simulator focused on error-aware programming, before planned general availability and future physical gate-model systems.
Selected-participant software access · Event datedConditions: Keep the simulator’s model, version, included operations and access eligibility attached to any result. Named participation is distinct from paid use.
What remains unestablished: Software access does not establish measured physical gate performance, public access for every visitor, deployed gate-model hardware or undisclosed customer revenue.
What to follow: Follow a documented version or access change, versioned model assumptions and a measured comparison with the corresponding hardware.
The company announcement is one software-access event already covered by the canonical simulator story, not a new physical experiment.
- D-Wave gate-model simulator beta ↗ · Company software announcement · Source dated
D-Wave dual-rail gate experiment
The August paper reported a physical entangling gate for dual-rail erasure qubits encoded in pairs of superconducting microwave cavities, studying whether useful error structure survives the operation.
Measured two-qubit hardware experiment · Event datedConditions: An erasure location can help a suitable code or decoder. Recovery still requires structured encoding; detector mistakes and unflagged errors must be counted. The paper’s larger correction comparisons include simulations.
What remains unestablished: The gate experiment is separate from October beta access. It is not a complete fault-tolerant computer, proof of perfect error flags or a universal reduction of every correction cost.
What to follow: Follow broader operations, measured error-model correspondence and full resource comparisons including imperfect detection.
The publisher record and official PubMed author abstract describe one paper. A repository or index copy is not independent reproduction.
- An entangling gate for dual-rail erasure qubits ↗ · Peer-reviewed hardware experiment · Source dated
Direct full text retrieval was blocked. The official PubMed record provides the author abstract and the 5 August publication date; no new numerical hardware claim is introduced here.
- Official record and author abstract of the dual-rail gate paper ↗ · Primary research record · Source dated
Issuer identity sources
- D-Wave gate-model simulator beta ↗ · Company software announcement · Source dated
Read the related analysis → · Read the shared evidence context →
Universal QuantumPrivate-company financing
Private company · non-tradable research. No listed share, quote, proxy instrument, valuation estimate or investment-access offer is created.
More than US$100 million in financing provides resources for the modular programme. The earlier matter-link experiment retains its February 2023 date and its own measurement definition.
Research question: What new connected-system capability or commercial outcome is demonstrated independently of the financing?
Universal Quantum Series A
University of Sussex and participating investor Nauta Capital reported more than US$100 million in Series A financing for Universal Quantum’s modular trapped-ion programme.
Private-company financing · Event datedConditions: The more-than amount and USD currency belong to financing. Intended development and commercialization are future uses of capital, not completed-system revenue.
What remains unestablished: The round does not establish valuation, public investment access, hardware performance or the quality of an inter-module link.
What to follow: Follow separately sourced technical or commercial outcomes with explicit dates and scope, rather than converting investor enthusiasm into capability scores.
The university spin-out report and participating-investor account concern the same financing. Both have a relationship to the programme; neither independently validates the machine.
- Sussex: Universal Quantum financing ↗ · University financing report · Source dated
- Nauta Capital: Universal Quantum Series A ↗ · Participating-investor report · Source dated
Universal Quantum historical matter-link
The February 2023 paper studied transport of ion qubits between adjacent ion-trap microchip modules, with ion loss and phase coherence evaluated separately.
Measured ion-transport experiment · Event datedConditions: This matter-link physically moves an ion. Ion-transport rate and loss are not interchangeable with heralded Bell-pair rate, remote-gate fidelity or finished application throughput.
What remains unestablished: Historical transport evidence does not by itself establish a completed larger modular computer or a new October 2026 technical result. Financing cannot refresh its measurement date.
What to follow: Look for links and local operations working together, with timing, scheduling and repeated-use reliability included.
This historical paper is a separate evidence event from the 2026 financing, even though both concern the same canonical company.
- High-fidelity quantum matter-link between ion-trap microchip modules ↗ · Historical peer-reviewed experiment · Source dated
Read the related analysis → · Read the shared evidence context →
Quobly and SiPearlExploratory ecosystem agreement
Private ecosystem context · no market instrument. Quobly uses its existing canonical organization. SiPearl is named in the sourced agreement; no unverified organization ID or public ticker is invented.
The non-exclusive agreement explores an interface between conventional and quantum computing. A documented complete workflow would add evidence that partner names cannot supply on their own.
Research question: Which concrete deliverable changes an exploratory agreement into an inspectable integration result?
The non-exclusive memorandum proposes feasibility work combining SiPearl’s Rhea1 processor and Seine reference server with Quobly’s Alloy QPU programme.
Non-exclusive exploratory agreement · Event datedConditions: The first phase is exploratory. Assess a complete workflow including preparation, communication, control and interpretation, under the same task and answer-quality requirement.
What remains unestablished: The agreement is not a shipped joint computer, tested interface, advantage benchmark or disclosed revenue. European design and collaboration do not mean wholly European fabrication.
What to follow: Follow a funded and scoped joint project, documented interface, working integrated demonstration or complete workflow comparison.
The agreement and SiPearl product page supply partner-authored context. The product page describes Rhea1; it does not validate the proposed joint integration.
- Quobly / SiPearl exploratory CPU–QPU agreement ↗ · Company agreement announcement · Source dated
- SiPearl: Rhea1 processor ↗ · Current product documentation
The current page identifies European design, TSMC manufacturing and forthcoming sampling; it does not establish a delivered Quobly–SiPearl server.
Follow the next evidence
Read the business claim in context
Four company developments and twelve reading companions connect an announcement to the documents, limits and next evidence that matter.
Context sources checked . These notes are research information, not investment recommendations. Company review dates, QRank assessments and provider quote times remain separate.
IonQ: a transaction to follow in stagesCompany development
Source dated
IonQ announced an agreement to acquire Elisity. The transaction is pending and subject to closing conditions.
An acquisition announcement changes the questions to ask before it establishes the answers. The proposed Elisity transaction belongs in a business-strategy timeline, with signing, conditions, closing and integration shown separately. It is not a new quantum-processor benchmark.
The useful investor question is what the combined organization can eventually deliver that the separate businesses could not. Product integration, customer evidence and later reporting could answer that question. A large headline value and a broad security narrative do not answer it by themselves.
Read the original agreement and look for a later closing disclosure. An expected quarter is not a completed event. Any future operating benefit needs its own evidence, and any share-price reaction needs a separate time-stamped market source.
Research question: Which integration becomes a usable customer workflow?
Documents to check: Agreement terms, conditions, consideration mechanism, closing document and subsequent operating disclosures.
What this does not establish: No completed purchase, immediate revenue synergy, price target or technical rank movement inferred.
What to follow: A closing disclosure, changed terms or measured post-close operating result.
Original sources and identity context
- IonQ to acquire Elisity to accelerate zero trust for the quantum era ↗ · Company transaction announcement · Source dated
Related reading: A transaction has several clocks · All-stock does not mean cost-free
IBM: workflow capability and business value are different claimsCompany development
Source dated
IBM described directed execution, a beta workflow that moves inspectable circuit preparation and post-processing into client-side steps. Check the documented access and compatibility conditions.
Directed execution is relevant to the organization of a quantum workflow. It can make choices around circuit variation and analysis more inspectable without proving that a physical processor has become faster. The beta label and the documented access conditions are part of the update.
For an investor, a software capability is not automatically a separately reported revenue source. Its possible commercial value may lie in research usability, ecosystem adoption or an easier development process. Those are interpretations to test, not financial results supplied by the announcement.
A useful follow-up identifies the workload, compares the complete workflow and states what became easier, cheaper or more reproducible. Follow these product and research developments alongside financial disclosures; a software update does not by itself establish a new financial segment.
Research question: What changes for a researcher doing the same defined job?
Documents to check: Version-specific documentation, account/backend eligibility and a matched complete-job comparison.
What this does not establish: No universal availability, hardware speedup or quantum-specific revenue estimate.
What to follow: Stable availability, compatibility changes or independently reproducible workflow evidence.
Original sources and identity context
- Directed execution: an inspectable workflow ↗ · Provider technical announcement · Source dated
- Directed execution model documentation ↗ · Official documentation
Rigetti: connect the materials paper to the contributionCompany development
Source dated
Fermilab reported a blinded study of 22 transmons fabricated by Fermilab, Rigetti and NIST. It examined material differences and coherence across that defined sample set.
A collaboration can be significant without belonging entirely to one participant. Read the contributor and sample roles in the blinded materials study. The paper is evidence about a defined device set and analysis, not a ready-made commercial ranking.
The possible business bridge is a process that becomes more predictable. That bridge would need controlled intervention, repeatability and eventual integration evidence. A correlation in a research study cannot supply a manufacturing yield or unit-cost improvement that the source does not report.
Ask why the research could matter to this business and which step remains unproven. A specific next milestone is more useful than inferring value from a familiar company appearing in a collaboration.
Research question: Does a controlled process change reproduce the relationship?
Documents to check: Paper affiliations, sample provenance, characterization scope and subsequent process-level results.
What this does not establish: Do not assign every sample or measured benefit to Rigetti or invent a yield increase.
What to follow: A replicated intervention, production distribution or verified system-level consequence.
Original sources and identity context
- Material origins of variations in qubit performance ↗ · Institutional research account · Source dated
Xanadu: place the saving inside the full algorithmCompany development
Source dated
A preprint by Xanadu-affiliated researcher Danial Motlagh proposes dense QROM encoding to reduce leading Toffoli cost under a stated workspace budget. It reports an algorithmic construction, not measured product runtime.
A data-loading construction is an algorithmic resource result. Its importance depends on how much of a useful computation uses the operation and what workspace the method requires. A better leading gate-count expression is not a measured product-runtime claim.
This distinction does not make the work irrelevant to a business. It identifies the evidence that would connect the research to practical usefulness: an implementation, a complete resource estimate or a task where the reduced operation dominates the budget.
Check the current issuer and listing separately from the paper’s author affiliation. Neither an algorithmic resource saving nor a stock-market listing establishes revenue, product speed or a share-price outcome.
Research question: Which complete workload retains the improvement after all costs are counted?
Documents to check: Research version, cost model, workspace requirements, current issuer identity and a full-workload estimate.
What this does not establish: No automatic revenue gain, product speedup, share-price forecast or unsupported listing metadata.
What to follow: Independent implementation, revised cost analysis or end-to-end task evidence.
Original sources and identity context
- Halving the cost of QROM again via dense encoding (v1) ↗ · Preprint · Source dated
- Xanadu / GlobalFoundries announcement: issuer identity context ↗ · Investor-relations portal · Source dated
A transaction has several clocksReading companion
Signing, regulatory review, closing and operational integration are different events. A timeline becomes misleading when it presents all four as one completed milestone. A date tells the reader something useful only when the state attached to it is clear.
Compare the original expected date with later source-backed changes. The earlier expectation and eventual outcome tell different parts of the transaction history.
To understand an update, ask whether a condition was satisfied, a deadline moved or the transaction closed. Another article repeating the original announcement is not an equivalent change.
Research question: Which clock moved in the newest source?
Documents to check: Original dated agreement, condition status, amended timetable and closing evidence.
What this does not establish: Expected timing must not become a completed event merely because the calendar advanced.
What to follow: A documented state transition or amended condition.
Examples and reference context
- IonQ to acquire Elisity to accelerate zero trust for the quantum era ↗ · Company transaction announcement · Source dated
Related reading: IonQ: a transaction to follow in stages
Bookings, backlog and revenue are not interchangeableReading companion
A signed order, remaining contracted work and recognized revenue describe different parts of a business. They can all be useful, but comparing them as though they were the same quantity obscures delivery timing, cancellation conditions and accounting policy.
Before combining companies in a table, read each issuer’s definition and reporting period. A figure described as bookings may not be directly comparable with another company’s similarly named measure. A disclosed backlog can also include work delivered across several periods.
Compare figures only when the relevant filings, definitions and reporting periods are available. A contract headline or a number from a different period cannot fill a missing disclosure.
Research question: Does the figure describe orders, future work or recognized revenue?
Documents to check: Current filing definitions, period, delivery obligations and material cancellation terms.
What this does not establish: An announced contract is not automatically current-period revenue.
What to follow: A filing changes the relevant measure, definition or delivery schedule.
Examples and reference context
- Investing: existing sources and standards · Dashboard guidance
Related reading: IonQ: a transaction to follow in stages · Find the denominator before reading the speed claim
Quantum exposure is a business mixReading companion
A diversified company may contribute substantially to quantum research while quantum activity represents an undisclosed part of its financial results. A focused quantum company may also contain security, manufacturing or service businesses. A logo alone does not describe the exposure.
Identify the issuer and its documented activities relevant to quantum technology. A description of those activities does not establish a percentage of revenue or imply that all businesses share the same technology risk.
When an acquisition or segment disclosure changes the business mix, compare the dated descriptions before and after the change. The earlier exposure may differ from what an investor owns today.
Research question: What activity does owning this security actually expose a reader to?
Documents to check: Issuer identity, reported segments, specific products and disclosed research relationships.
What this does not establish: Do not invent a pure-play classification or quantum-revenue percentage.
What to follow: A material change in business scope or a new segment disclosure.
Examples and reference context
- IonQ to acquire Elisity to accelerate zero trust for the quantum era ↗ · Company transaction announcement · Source dated
- Xanadu / GlobalFoundries announcement: issuer identity context ↗ · Investor-relations portal · Source dated
Related reading: IonQ: a transaction to follow in stages · Xanadu: place the saving inside the full algorithm
A roadmap should have an acceptance testReading companion
A future system size is easier to announce than a complete acceptance criterion. Ask which operations, error characteristics, connectivity and service conditions must accompany the number before the milestone can be called delivered.
Compare the original dated target with later measured evidence. An elapsed deadline is not proof of delivery, and a revised target should remain distinguishable from the original commitment.
Keep the vocabulary precise. Physical resources, encoded logical information and an operational service are different achievements. A roadmap can be useful planning evidence without being a measurement of current capability.
Research question: What observable evidence would establish that the milestone was delivered?
Documents to check: Original roadmap, measurement definition, operating conditions and subsequent delivery evidence.
What this does not establish: No physical/logical-qubit substitution or automatic success at the target date.
What to follow: A measured result meeting, revising or missing the original criterion.
Examples and reference context
- Early Career award: dark matter with entangled qubits ↗ · Institutional project announcement · Source dated
- Fast logical operations in quantum LDPC codes using simple resource states (v2) ↗ · Primary preprint · Source dated
A research grant is not a commercial customerReading companion
Public support can enable difficult research without demonstrating repeatable product demand. The award, its recipient, the work period and the intended deliverable are the relevant facts. A maximum funding commitment is not necessarily money already received.
A research collaboration can later lead to a commercial relationship, but the later relationship needs its own evidence. The same institution appearing in two announcements does not prove that both describe a customer order.
Use separate categories for grants, research agreements and commercial contracts. That makes the company timeline more informative and prevents a collection of unlike funding headlines from becoming a misleading sales chart.
Research question: What obligation and deliverable does the funding support?
Documents to check: Recipient, award scope, conditions, period and any actual disbursement disclosure.
What this does not establish: No recurring customer revenue or completed experiment inferred from an award.
What to follow: Published deliverables or a separately documented commercial contract.
Examples and reference context
- Early Career award: dark matter with entangled qubits ↗ · Institutional project announcement · Source dated
- Early Career project: magnetic vortices and hidden superconducting loss ↗ · Institutional project announcement · Source dated
Find the denominator before reading the speed claimReading companion
A processor-only comparison may omit setup, compilation, repeated measurements and classical analysis. A practical customer pays for an acceptable answer, not only for the most favourable interval inside the job.
Identify the input, output, accuracy requirement and resources counted on both sides. A strong component improvement can matter, but the rest of the workload determines how much it changes the total.
This is a framework for technical diligence, not evidence that a particular company has omitted costs. Apply it consistently to exciting announcements and to skeptical comparisons alike.
Research question: Which part of the complete job lies outside the reported comparison?
Documents to check: Preparation, execution, repetitions, accepted outputs, classical work and result quality.
What this does not establish: No component reduction translated directly into company productivity or total cost savings.
What to follow: A transparent matched complete-workload benchmark.
Examples and reference context
- Halving the cost of QROM again via dense encoding (v1) ↗ · Preprint · Source dated
- Directed execution model documentation ↗ · Official documentation
Cash runway is a scenario, not a scheduled eventReading companion
A cash balance divided by a recent cash-use rate can illustrate one scenario. It does not predict a financing date. Spending can change with facilities, acquisitions, staffing, working capital and strategy.
Check which cash balance and spending period the calculation uses, and which commitments it excludes. Without current, comparable inputs, the scenario cannot provide a reliable illustration.
Keep the result separate from a forecast or recommendation. A reader can understand the assumptions without being told that the business will inevitably raise capital on a particular date.
Research question: Which assumption most changes the scenario?
Documents to check: Current unrestricted cash, debt restrictions, cash-flow period and disclosed commitments.
What this does not establish: No invented financial inputs or deadline inferred from a simple division.
What to follow: New filings, financing terms or a disclosed spending change.
Examples and reference context
- Investing: existing sources and standards · Dashboard guidance
- IonQ to acquire Elisity to accelerate zero trust for the quantum era ↗ · Company transaction announcement · Source dated
Related reading: A transaction has several clocks
All-stock does not mean cost-freeReading companion
Share consideration can conserve cash while changing ownership claims and exposure to execution risk. A contingent component adds a condition; it does not disappear because the transaction does not use an ordinary cash payment at signing.
The contract determines how consideration is measured and when it becomes due. A current quote may not be the price used by a later contractual formula. The final share issuance must be read from the relevant closing disclosure.
The useful question is what existing shareholders receive in exchange for the new claims on the business. That requires a business and contract analysis, not a claim that one payment form makes the deal free.
Research question: Which conditions determine the final consideration?
Documents to check: Contract formula, contingencies, closing terms and actual issuance.
What this does not establish: Do not derive a definitive share count from an unrelated current quote.
What to follow: Final closing consideration or a later contingent-payment disclosure.
Examples and reference context
- IonQ to acquire Elisity to accelerate zero trust for the quantum era ↗ · Company transaction announcement · Source dated
Related reading: IonQ: a transaction to follow in stages · A transaction has several clocks
A customer count can hide concentrationReading companion
Many deployments do not reveal how much revenue depends on a small number of counterparties. A concentrated early market is not automatically a failure, but concentration and customer count answer different questions.
Read the issuer’s definitions. A deployment, trial, research partner and paying customer may not describe the same relationship. Use the company’s disclosed categories rather than normalizing them into a single unsupported adoption number.
An undisclosed concentration figure remains unknown. Its absence is not evidence of zero concentration, zero churn or a perfectly diversified customer base.
Research question: Which relationships account for the largest economic exposure?
Documents to check: Current filings, customer definitions, concentration notes and contract conditions.
What this does not establish: No zero-churn or diversification inference from a marketing count.
What to follow: A new concentration disclosure or materially changed contract.
Examples and reference context
- IonQ to acquire Elisity to accelerate zero trust for the quantum era ↗ · Company transaction announcement · Source dated
- Investing: existing sources and standards · Dashboard guidance
Related reading: Bookings, backlog and revenue are not interchangeable
A paper can matter before it makes moneyReading companion
A research result can change an engineering programme before it becomes a customer-facing feature. That lag is not a reason to ignore the paper. It is a reason to keep technical and financial evidence in separate columns.
Follow the bridge: replication, controlled intervention, process transfer, integrated operation and eventual customer use. The exact sequence depends on the technology, but each step needs evidence appropriate to its claim.
Participation in an important publication is not a disclosed valuation premium. Look for a plausible mechanism of business value and the next missing proof before drawing a financial conclusion.
Research question: Which engineering step connects this research to a deliverable product?
Documents to check: Research scope, repeatable process evidence, integration and actual use.
What this does not establish: No automatic revenue, margin or valuation increase from publication.
What to follow: A verified transition from research to a defined operational capability.
Examples and reference context
- Material origins of variations in qubit performance ↗ · Institutional research account · Source dated
- Halving the cost of QROM again via dense encoding (v1) ↗ · Preprint · Source dated
Related reading: Rigetti: connect the materials paper to the contribution · Xanadu: place the saving inside the full algorithm
A market number needs its timestampReading companion
Read a quote alongside its issuer identity, exchange, currency, timestamp and data status. A displayed value may be stale even while the rest of a page is available.
If the supported provider is unavailable, use original company sources and research notes while checking the data status. An unavailable price is not zero, and a delayed value is not an executable current offer.
Check the provider attribution and the meaning of the displayed quote time. Exchange coverage, delays and adjustments can differ; a source-check date for research does not refresh a market price.
Research question: When and from which supported source was the value observed?
Documents to check: Provider contract, exchange coverage, timestamp semantics and corporate-action adjustments.
What this does not establish: No invented quote, unsupported real-time label or zero substitution for unavailable data.
What to follow: Provider refresh, outage, recovery or corrected adjustment.
Examples and reference context
- Investing: existing sources and standards · Dashboard guidance
Read the disagreement before choosing a winnerReading companion
Two credible results may concern different workloads, costs or operating conditions. A useful comparison explains the mismatch before placing both results on one axis.
Read hardware evidence, business disclosures and editorial interpretation separately. A missing QRank score does not establish technical inferiority, and a strong technical result does not automatically make a security attractive at an unspecified price.
A genuinely matched comparison can change the research picture. Until then, two clearly bounded results can be more useful than a universal ranking built from unlike measures.
Research question: Are the compared claims actually about the same task and acceptance condition?
Documents to check: Matched resource definitions, dates, conditions and limitations on both sides.
What this does not establish: No QRank-to-buy/sell translation or universal winner from unlike metrics.
What to follow: A directly comparable result or material correction.
Examples and reference context
- QRank: research assessment and methodology · Research methodology
- Fast logical operations in quantum LDPC codes using simple resource states (v2) ↗ · Primary preprint · Source dated
SOURCES & STANDARDS
Clarity over hype.
Documented quantum activity. Original sources. A clear line between company research and market data.
Where prices come from
TradingView supplies the market board, charts and financials. Exchange data may be delayed and availability varies by listing. After a session closes, the last available quote remains. Check the provider’s market status and quote time. Use “Hide market data” to remove updating displays. Data coverage and delays
How companies are selected
This curated research directory records companies with documented quantum computing, enabling technology or quantum security activity. It uses one listing reference per profile and four exposure categories. A directory profile is not certification of a currently active listing; corporate actions and listing details must be checked against current issuer sources. Category membership is editorial classification, not a stock ranking. Private companies and ETFs are outside this company directory.
How to read the financials
Compare revenue, cash use, funding needs and dilution alongside the company’s own filings. Provider financials refer to the whole listed company. Recent listings may include predecessor or SPAC periods and have limited history. Research questions on this page are prompts for investigation, not claims of current performance.
Research dates, watchlists & corrections
The original directory cohort was reviewed on 7 September 2026. Profiles added later show their own recorded review date or “Profile review date unavailable”. Publication and research-note dates do not replace a profile review date. None is a quote timestamp. Corporate actions and provider support can change. Company follows are saved in this browser when signed out and in your account when signed in. They are not trade orders or email alerts. Read published company coverage in Your Updates. Suggest a correction
For research and general information. Not personalized investment advice. Share prices can be volatile and capital is at risk.
Read, question, follow the source
From company announcement to evidence
Follow the instrument, the reporting period and the technical boundary. These guides provide research context; market data keeps its own source and timestamp.
Company evidence guideIQM: installed-system acceptance becomes an investor questionFollow an installed quantum system from supplier delivery to customer acceptance.
IQM’s current evidence trail connects two activities that readers often evaluate separately: supplying superconducting quantum systems and reporting as a public company. Its July 2026 transaction documentation identifies Nasdaq American depositary shares under IQMX, with each ADS representing one IQM share. Its first public-company results cover the first half of 2026. These are useful anchors for a profile focused on how an installed system becomes an accepted customer asset. They do not make a delivery announcement equivalent to a completed technical acceptance test.
An installed-system profile should describe the boundary of the customer’s purchase. A processor, refrigerator, control electronics, software interface, maintenance agreement and training package may arrive on different schedules. The reader needs to know which components are included, who operates the machine, and what the customer can change without invalidating support. Ownership can be valuable when an institution wants to study calibration or integrate a machine into its own computing environment. It can also move operational work from the supplier to the customer. Neither consequence follows from qubit count alone.
Consider a research centre evaluating two proposals. One provides scheduled access to a supplier-operated service; the other installs equipment locally. The local machine could improve experimental control while requiring staffing, facilities and planned downtime. A useful comparison would hold the research programme constant and compare completed experiments over a stated period, access to calibration records, recovery from failed runs, and the ability to reproduce a result after maintenance. Purchase price would be only one input. This is an editorial comparison framework, not a report of an IQM customer contract.
The same boundary helps interpret financial reporting. An order, a backlog entry, a shipment, customer acceptance and recognised revenue describe different stages of a commercial relationship. Their definitions belong beside the numbers. A change in backlog may reflect new commitments, delivery progress, cancellations, currency movements or another disclosed adjustment. Readers should not be asked to infer the cause from a single total. An evidence card can instead connect the reporting period to management’s definition and the relevant customer or deployment document, while marking any unreported acceptance conditions as unknown.
- Issuer
- IQM Quantum Computers Plc
- Public exposure
- Direct quantum hardware issuer
- Exchange
- Nasdaq Global Select Market
- Ticker
- IQMX
- Traded instrument
- American depositary shares, each representing one IQM share
- Evidence boundary
- Delivery, acceptance, support and recognised revenue are distinct milestones
- Acceptance terms
- Not verified for any individual customer contract
Questions to take with you
What does the ADS label change?
It identifies the traded instrument and its relationship to the underlying shares. Readers should use that instrument when checking issuer filings or a licensed quote provider; a warrant or Helsinki share line needs its own identity and market metadata.
What would make an installation update substantive?
A customer statement about accepted performance, available access, operational responsibility or reproducible use would add information beyond a photograph or shipment date. Each claim should name the system and the conditions under which it was measured.
Evidence context only. This guide does not change QRank scores or supply a current price.
The original completion release returned HTTP 403. The same issuer release on Nasdaq confirms the US ADS identity; the results release was directly checked.
Sources and their boundaries (3)
- IQM completes combination; ADS trading begins July 2 ↗IQM investor relations · 2026-07-01
Completed combination; Nasdaq Global Select Market ADSs; IQMX; one share per ADS
Warrant symbol and economics are separate; do not use the release as a live quote.
Retrieval limitation described in the review note - IQM first earnings as a public company ↗IQM investor relations · 2026-08-04 in release body
Public-company reporting covers first half and second quarter ended June 30, 2026
Reporting page metadata displays August 3; retain body date and do not invent acceptance milestones.
- IQM completes combination — issuer release on Nasdaq ↗IQM via Nasdaq · 2026-07-01
One American depositary share represents one IQM share; Nasdaq Global Select Market trading under IQMX.
Issuer release establishes instrument identity, not a current price.
Company evidence guideXanadu: a foundry partnership needs a manufacturing evidence ladderConnect the new foundry agreement to the measurements that would establish manufacturing readiness.
Xanadu’s October 6, 2026 announcement of a partnership with GlobalFoundries creates a concrete manufacturing question for its profile: which components move through which production process, and what evidence will show that the process is ready for a larger system? The issuer’s current material identifies Nasdaq and TSX symbol XNDU. Nasdaq identifies the traded shares as Class B Subordinate Voting Shares. This record connects that security identity with a component-level reading of the partnership, without treating the announcement as a measured production yield.
Manufacturing language can refer to several different achievements. A process design can be compatible with a foundry before a qualified production run exists. A fabricated component can pass a laboratory test before packaging, interconnects and system integration meet the required performance. A repeated process can still have variable yield across a wafer or between production lots. Readers should ask which of these stages the supporting document actually describes. That approach makes an industrial partnership informative while keeping the remaining engineering work visible.
For a photonic quantum system, the component chain is especially important. Light generation, manipulation, routing, detection and classical processing contribute different constraints. A good organization card should therefore pair a manufacturing update with a simple component map. The map would identify the component’s function and the measurement needed to accept it, rather than assigning one maturity label to the whole machine. If a source discusses detector fabrication, the linked card should not imply that every optical circuit, network connection or logical operation has received the same validation.
An illustrative supplier review makes the distinction practical. Suppose two candidate processes produce devices with similar laboratory performance, but only one has disclosed packaging reproducibility. The second process might still be promising; the purchasing decision depends on which risk matters for the next build. The appropriate comparison would include the test sample, distribution of results, rejected devices, integration conditions and planned production cadence. These are proposed questions for future evidence, not claims about the private terms of Xanadu’s agreement. Missing numbers remain missing rather than being filled from an industry average.
- Issuer
- Xanadu Quantum Technologies Limited
- Ticker
- XNDU
- Exchanges
- Nasdaq and TSX, as identified by issuer
- Traded instrument
- Class B Subordinate Voting Shares (Nasdaq identity verified)
- Public exposure
- Direct photonic quantum computing issuer
- Manufacturing yield
- Unverified; no numeric yield claimed
- Evidence step
- Announced strategic partnership
Questions to take with you
Does a foundry agreement establish mass production?
It establishes the agreement described by the parties. Production readiness needs additional evidence about fabricated devices, yield, repeatability, packaging and accepted system performance. The record deliberately treats those as separate steps.
Why retain the share class?
The class is part of the security’s identity. It helps prevent confusion with other voting classes or instruments and points readers toward the correct shareholder disclosures. This content does not infer voting rights beyond the class name.
Evidence context only. This guide does not change QRank scores or supply a current price.
Sources and their boundaries (2)
- Xanadu and GlobalFoundries strategic partnership ↗Xanadu investor relations · 2026-10-06
Announced manufacturing partnership; issuer identifies Nasdaq/TSX XNDU
Issuer announcement; no independently measured production yield inferred.
- XNDU security identity ↗Nasdaq · Accessed 2026-10-17
Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares
Quote values not collected or reproduced.
Company evidence guidePasqal: keep the listed company and the executable analogue task togetherA current PSQL identity card paired with the full meaning of an analogue computation.
Pasqal completed its business combination in August 2026, and its subsequent financial reporting identifies Pasqal Holding SA as Nasdaq-listed under PSQL. The transaction release distinguishes ordinary shares from warrants. That completed status matters because earlier announcements still describe a proposed transaction, and a current footer can appear beneath an older article. A reliable profile should establish the issuer’s present identity from the later evidence and then separately explain what a reader can actually execute using Pasqal’s analogue platform.
The technical part of the profile should begin with a task description. An analogue programme specifies a physical evolution under the available controls; its meaning cannot be reduced to a familiar gate-circuit diagram without checking the mapping. The useful questions concern the allowed geometry, interactions, pulse constraints, initial state and measured output. A software example becomes more informative when the reader can connect each modelling choice to the device or emulator that will run it. That connection is an editorial target for the profile, not a claim that every example is currently available on hardware.
Imagine a team studying an optimisation formulation using an atom arrangement. The team should preserve the classical problem instance, the mapping into the physical model and the rule used to turn measurements back into candidate solutions. It should also record how invalid or missing outcomes are handled. Otherwise a change in post-processing could appear to be a hardware improvement. Repeating a small, well-described task can be more useful than publishing a large atom count with no accessible output definition. Scale and reproducibility answer different questions.
Commercial reporting adds another set of boundaries. Platform access, installed hardware, development services and collaboration programmes need not generate revenue in the same way. A reader-facing profile should link any financial figure to the relevant period and reporting definition, and should avoid assigning all issuer revenue to one technically interesting activity. Pasqal’s first-half report and the date of its later transaction also represent different time windows. A period-end figure must retain its own date even when a post-closing cash figure is more recent.
- Issuer
- Pasqal Holding SA
- Exchange
- Nasdaq
- Ticker
- PSQL
- Traded instrument
- Ordinary shares; PSQLW warrants are a separate instrument
- Public exposure
- Direct neutral-atom quantum computing issuer
- Execution mode
- Analogue task; exact device and access conditions must be attached to each example
- Period boundary
- First half ended June 30; business-combination closing in August
Questions to take with you
Can an old proposed-listing article remain linked?
Yes, as transaction history with its original date and status. The current identity card should cite later completed-transaction and reporting evidence, so a reader does not mistake the earlier proposal for the current state.
What belongs with an analogue demonstration?
The original problem, physical mapping, device or emulator, control constraints, measured outputs and decoding rule. These fields let a reader tell whether a revised result changes the computation or only the surrounding workflow.
Evidence context only. This guide does not change QRank scores or supply a current price.
Sources and their boundaries (3)
- Pasqal and Bleichroeder complete business combination ↗Pasqal · 2026-08-27
Completed combination; ordinary shares PSQL and warrants PSQLW stated separately
Trading commencement described as expected in this release; use later report to establish current listing.
- Pasqal first-half 2026 financial results ↗Pasqal investor relations · 2026-09-24
Pasqal Holding SA Nasdaq PSQL; first-half reporting period
No live quotes; post-closing and period-end values must not be mixed.
- Pasqal hardware platform ↗Pasqal · Accessed 2026-10-17
Hardware and analogue platform positioning
Product roadmap and delivery dates require exact product scope; no unrestricted hardware access inferred.
Company evidence guideOxford Ionics after acquisition: preserve the provenance of the benchmarkKeep original experiments, acquisition history and later integration results in separate dated records.
IonQ completed its acquisition of Oxford Ionics on September 17, 2025. The completion release establishes a corporate relationship that a current organization directory should preserve: Oxford Ionics is not presented here as a separately traded issuer. IonQ’s earlier transaction announcement also contains future technical targets. Those targets belong to the dated roadmap record, while the completion event belongs to the corporate timeline. Combining them into a single present-tense claim would obscure what happened and what was expected to happen later.
The practical editorial challenge is benchmark provenance after an acquisition. A result originally associated with one team, device and experimental method may later appear in the parent company’s wider narrative. The original result should retain its device identity, publication date and measurement protocol. Corporate ownership can change without making measurements from different systems directly comparable. A profile should help readers follow that history rather than replacing the old source with a new corporate logo and a larger number.
Suppose an organization page contains three performance figures: a physical gate measurement, a complete-system benchmark and a future logical accuracy target. Their percentages may look similar in a short card, but their meanings differ. A useful comparison would identify the measured operation, the number of tested instances, the treatment of state preparation and measurement, and whether the number is measured or projected. If those fields cannot be aligned, the page should explain the mismatch. It should not rank the figures merely because they can all be displayed with percent signs.
Acquisition integration also has a technical boundary. Combining expertise, intellectual property and manufacturing relationships can create opportunities, yet the benefits require implementation. Readers can follow concrete evidence such as a shared control interface, a demonstrated system combining technologies, a released architecture document or a customer deployment. Staff biographies are unnecessary for this task. The profile can describe the organization and its technology lineage without expanding the excluded People section or turning individual researchers into the main content.
- Corporate relationship
- Acquired by IonQ; completion announced September 17, 2025
- Standalone ticker
- None asserted
- Public exposure
- Indirect through parent issuer; use existing IonQ security record
- Benchmark requirement
- Original device, protocol and date retained after corporate changes
- Roadmap status
- Earlier targets are not promoted to achieved status
- People scope
- Organizational and technical provenance only
Questions to take with you
Does a corporate change invalidate an older result?
No. It changes the organizational context, not the experiment that was performed. The result should retain its original provenance and be linked to the current ownership timeline.
Can two fidelity values be compared directly?
Only after their operations, error models, treatment of preparation and measurement, sample definitions and statistical methods are understood. A projected logical value should not be displayed as though it were the same kind of evidence as a measured physical gate.
Evidence context only. This guide does not change QRank scores or supply a current price.
Sources and their boundaries (2)
- IonQ completes Oxford Ionics acquisition ↗IonQ investor relations · 2025-09-17
Completed acquisition; Oxford Ionics joins IonQ
Historical completion source; current parent quote data not collected.
- IonQ acquisition agreement and roadmap ↗IonQ · 2025-06-09
Earlier agreement; forward-looking technical targets
Targets must remain forward-looking and tied to their date; not evidence of subsequent achievement.
Company evidence guideArqit: a quantum-safe label needs a key-establishment boundaryClassify ARQQ through its security products and examine the trust boundary behind the label.
Arqit’s issuer reporting describes its business through symmetric-key agreement and related encryption products, including SKA-Platform and NetworkSecure. Its 2026 prospectus identifies ordinary shares on the Nasdaq Capital Market under ARQQ. The appropriate QubitWire classification is security exposure associated with quantum-resistant communications, not ownership of a quantum-computer manufacturer. This profile asks readers to examine where keys come from, which parties are trusted and what deployment evidence supports a product claim. It supplies no live quote or investment recommendation.
A security product is easier to understand when its boundary is explicit. Protecting a communication link involves endpoints, authentication, key establishment, key storage, software updates and operational policy. A statement about the strength of one cryptographic component does not automatically establish the security of all these parts. Readers should ask which threat model the supplier is addressing and what the adversary is assumed to control. An explanation can be accessible without pretending that the underlying assurance work reduces to a single slogan.
The most useful organizational evidence would connect a described deployment to a specific integration. For example, a customer might use a service to establish keys between network devices. The profile should identify whether the evidence is a trial, a licensed deployment, a reseller arrangement or a production service, and should preserve the customer’s own account where available. These commercial stages are not interchangeable. A partnership can create a route to adoption without proving that every downstream user is already protected or that the product has become a material revenue source.
Readers also need a clear separation between symmetric-key approaches and the standardized public-key algorithms discussed in post-quantum migration guidance. They can appear within the same broader security programme while solving different parts of the problem. The profile should link the precise assurance document or standard when a certification claim is made. It should never infer that the presence of the words quantum-safe establishes certification, nor should it claim that one vendor product completes an organization’s whole migration. Inventory, interoperability and operational testing remain distinct tasks in a deployment assessment.
- Issuer
- Arqit Quantum Inc.
- Exchange
- Nasdaq Capital Market
- Ticker
- ARQQ
- Traded instrument
- Ordinary shares
- Public exposure
- Quantum-resistant security software; not a quantum-processor manufacturer classification
- Assurance status
- No blanket certification claimed
- Deployment stage
- Must be established per named customer or product integration
Questions to take with you
Is this the same kind of exposure as a QPU maker?
No. The profile concerns security products intended to address cryptographic threats, including future quantum threats. The business and technical evidence therefore centre on deployment, assurance and integration rather than processor benchmarks.
What should accompany a quantum-safe claim?
The algorithm or protocol, threat model, trust assumptions, integration boundary and applicable assurance evidence. A broad label cannot replace those details or establish the security of every endpoint.
Evidence context only. This guide does not change QRank scores or supply a current price.
Sources and their boundaries (2)
- Arqit annual report ↗Arqit investor relations / SEC filing · 2025-12-09
SKA-Platform and NetworkSecure symmetric-key business description
Issuer description is not independent certification or a complete deployment assessment.
- Arqit 2026 prospectus ↗Arqit investor relations / SEC filing · 2026-01-12
Ordinary shares ARQQ on Nasdaq Capital Market
No price data retained; warrants have separate identity.
Company evidence guideSEALSQ: certification belongs to an exact product and versionFollow each chip from a certification target to an exact, checkable assurance record.
SEALSQ’s October 2026 reporting describes a business spanning secure semiconductors, public-key infrastructure and post-quantum security products. The issuer identifies Nasdaq symbol LAES. Its product announcements and certification roadmap discuss several named families and milestones. The useful new profile is a product-by-product assurance map: which item is being discussed, what stage of evaluation it has reached and which evidence applies to that exact configuration. A company-wide statement about security should not silently become a certification badge on every product.
Certification language has several stages that deserve distinct labels. A design may target a standard, enter evaluation, complete a laboratory activity, receive a certificate or ship in a validated configuration. These events have different meanings. A roadmap date is especially easy to misread once the date has passed. The page should not automatically promote a target to completed status. It should link to the relevant scheme’s certificate or validation record, retain the tested version and state any conditions attached to the result.
A reader-friendly evidence table could place product family, hardware revision, firmware, algorithm support, evaluation stage and certificate identifier in separate columns. Unknown fields should remain explicit. This is more useful than a single green check because it shows whether the assurance matches the device a customer intends to deploy. It also helps distinguish algorithm implementation from system-level key management, provisioning and update processes. A product can contain a standardized algorithm while the surrounding deployment still requires its own configuration and operational assessment.
Commercial statements need an equally careful boundary. Preliminary revenue, an active sales pipeline, a design win and a shipment subject to customer qualification describe different evidence. A pipeline is not recognised revenue, and a prospective customer programme does not guarantee future sales. The October issuer update can be retained as a dated business source, while the technical panel tracks the specific chip and assurance documents. This allows the reader to understand the relationship between product development and commercial adoption without collapsing every milestone into a single growth narrative.
- Issuer
- SEALSQ Corp
- Exchange
- Nasdaq, verified against exchange security page
- Ticker
- LAES
- Traded instrument
- Ordinary Shares, verified on Nasdaq security page
- Public exposure
- Secure semiconductors, PKI and post-quantum security products
- Certification scope
- Exact product, revision and scheme record required
- Financial status
- October figures explicitly preliminary and unaudited
Questions to take with you
Does a certification roadmap establish certification?
No. It states planned milestones. Completion requires the relevant authoritative record and the exact product configuration to which it applies.
Why state the share class explicitly?
The instrument being described must match the exchange record. Nasdaq identifies SEALSQ Corp Ordinary Shares as LAES; that identity does not supply a current price or validate any product claim.
Evidence context only. This guide does not change QRank scores or supply a current price.
Sources and their boundaries (3)
- SEALSQ preliminary nine-month 2026 revenue update ↗SEALSQ investor relations · 2026-10-15
Issuer Nasdaq LAES; preliminary unaudited business update and product milestones
Pipeline is not revenue; certificate scope requires the scheme record; no price data.
- SEALSQ certification roadmap ↗SEALSQ · 2026-03-06
Named QS7001 and QVault evaluation targets
Targets are not automatically achieved; exact announcement day not asserted here.
- SEALSQ Corp Ordinary Shares (LAES) ↗Nasdaq · Accessed 2026-10-17
Exact issuer, ordinary-share class and LAES symbol
Identity only; quote data unavailable in retrieved page and not supplied.